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Abstract 
Glaucoma is a very prevalent eye disease with more than 60 million people affected 
worldwide. The only form of therapy is the artificial lowering of the intraocular pressure of 
the aqueous humor, which is the main cause for the disease. This can be achieved for 
example by the application of an intraocular implant to drain excess liquid. Due to a non-
optimal biocompatibility these intraocular stents often induce inflammation and fibrosis of 
their surrounding tissue. This subsequently blocks the outflow of liquid through the 
implant and results in long-term failure of the therapy. 
The goal of this thesis was the development of a new type of glaucoma implant made from 
titanium enhanced by hyaluronan hydrogels. The basic concept was the coating of the 
outer surfaces of a small tube with hydrogels made from hyaluronic acid to enhance cell 
adhesion for a better biocompatibility and a lower occurrence of inflammation and fibrosis. 
Simultaneously the interior was to be filled with hyaluronan hydrogels with slightly 
different properties to block a clogging of the drainage path by cell growth and act as a 
valve to regulate the intraocular pressure. In addition the economical and work safety 
aspects for an industrial mass production and biomedical application of these implants 
were considered. 
In order to achieve this goal, a number of methods to fabricate, and tools to analyze, 
hydrogel-enhanced glaucoma implants have been investigated in this thesis. Reaction 
sequences were developed to simultaneously crosslink and immobilize hyaluronan 
hydrogels on glass and titanium surfaces by a combination of several established methods. 
In addition, fluoresceinamine was integrated into the process to generate fluorescently 
labeled hydrogels, which was an effective tool for further analysis. Also, a number of 
methods were designed to observe the behavior of the hydrogel-modified implants when 
exposed to external pressures. It was possible, by using these methods, to verify the 
stability of the immobilization, with hydrogels within the tubes being able to withstand the 
pressures encountered in the glaucomatous eye without breaking apart. Furthermore it was 
shown that a regulation of external liquid pressures by these hydrogel-filled tubes was 
possible which illustrated these implants’ potential to drain excess intraocular fluid from 
the glaucomatous eye without causing hypotony. The mechanism of the pressure 
regulation was further explored and related to the presence of channels within the 
hydrogels that enabled liquid flow at certain pressure levels. Since the natural occurrence 
of these channels during the production process of the implants was initially random, two 
methods were developed to allow their artificial and reproducible creation. This was 
achieved either by the use of a laser to burn channels into the hydrogels or by the 
implementation of small glass fibers prior to the gel formation within the tubes.  
The methods established and the results gained in this thesis provide the means to generate 
hydrogel-enhanced implants and illustrate their general usability in glaucoma therapy by 
reducing intraocular pressure. In addition the process for the implant creation was 
successfully streamlined to allow for a cost effective, low-hazard production on an 
industrial scale. Future research based on the established concept will comprise the 
optimization of the hydrogels’ capabilities to either improve or resist cell adhesion as 
  
necessary. Also setups will have to be designed for a miniaturization and industrial mass 
fabrication of the implants. 
 
 
 
 
 
 
 
 
 
  
Zusammenfassung 
Das Glaukom, oder grüner Star, umfasst eine Reihe von Augenkrankheiten, die mehr als 
60 Millionen mal weltweit diagnostiziert wurden. Hauptursache für die Entstehung eines 
Glaukoms ist ein erhöhter Augeninnendruck. Die einzige bisher angewendete 
Behandlungsmethode besteht in einer künstlichen Reduktion des Augeninnendrucks. 
Hierfür kann zum Beispiel ein Implantat, das überschüssiges Kammerwasser aus dem 
Auge abfließen lässt, eingesetzt werden. Häufig kommt es jedoch auf Grund 
unzureichender Biokompatibilität zu Entzündungen und Narbenbildung im umliegenden 
Gewebe des Implantats. Hierdurch wird der Flüssigkeitsfluss blockiert und die Therapie 
muss abgebrochen bzw. das Implantat erneuert werden. 
Im Rahmen dieser Doktorarbeit sollten Glaukomimplantaten einer neuen Generation 
entwickelt und, deren Biokompatibilität mit Hyaluronsäure basierten Hydrogeln verbessert 
werden. Das Grundkonzept sah vor, die Außenseite kleiner Titanröhrchen mit diesen 
Biopolymeren so zu beschichten, dass eine Zellbesiedlung vereinfacht und das Auftreten 
von Entzündungen und die Bildung von Narbengewebe reduziert wird. Im Inneren der 
Röhrchen sollten Gele mit anderen Eigenschaften immobilisiert werden, um einen 
Zellbewuchs zu verhindern und den Augeninnendruck zu regulieren. Bei der 
Methodenentwicklung wurden außerdem wirtschaftliche und sicherheitstechnische 
Aspekte für eine industrielle Massenproduktion berücksichtigt. 
Es wurde eine Reihe von Methoden entwickelt, um solche neuartigen Implantate 
herzustellen und deren Eigenschaften zu charakterisieren. Zunächst wurde eine Auswahl 
von Reaktionen aus bereits etablierten Methoden kombiniert um eine gleichzeitige 
Gelbildung und Immobilisierung von Hyaluronsäure auf Glas- und Titanoberflächen zu 
erreichen. Weiterhin wurde Fluoresceinamin in den Herstellungsprozess der modifizierten 
Hyaluornäsure integriert. Dies ermöglichte die Synthese fluoreszierender Hyaluronsäure 
bzw. HA-Gele, die besser beobachtet werden konnten. Außerdem wurde eine Reihe von 
Methoden entwickelt, die es erlaubten die Reaktionen der hydrogel-modifizierten 
Implantate zu beobachten, wenn diese externen Flüssigkeitsdrücken ausgesetzt werden. 
Die Stabilität der Immobilisierung der Hydrogele auf den Implantatoberflächen konnte 
damit getestet und überprüft werden, ob die Gele einem typischen glaukomatösem 
Augeninnendruck stand halten können, ohne zerstört zu werden. Außerdem konnte gezeigt 
werden, dass die HA-Gel gefüllten Röhrchen prinzipiell einen externen Flüssigkeitsdruck 
regulieren können und damit geeignet sind überschüssiges Kammerwasser aus dem Auge 
zu entfernen ohne einen Unterdruck zu verursachen. Der zugrunde liegende Mechanismus 
dieser Druckregulation wurde aufgeklärt und mit dem Auftreten von Kanälen innerhalb der 
Hydrogele in Verbindung gebracht. Diese lassen einen Flüssigkeitsfluss ab einem 
bestimmten Druck zu. Da die Kanäle während dem Herstellungsprozess der Implantate 
zunächst nur zufällig auftraten, wurden zwei Methoden entwickelt um eine künstliches und 
reproduzierbares Entstehen der Kanäle zu gewährleisten. Die Kanäle wurden entweder 
nachträglich mit einem Laser in die Hydrogele "gebrannt" oder durch die Implementierung 
dünner Glasfasern im Inneren der Röhrchen während der Gelbildung ermöglicht. 
  
Die in dieser Arbeit entwickelten Methoden und gewonnenen Erkenntnisse bilden die 
Grundlage um Intraokluarimplantate einer neuer Generation herzustellen. 
Modellimplantate wurden außen und innen mit Hydrogelen beschichtet und es wurde 
gezeigt, dass diese in der Lage sind Drücke zu regulieren. Implantate, die sich in Zukunft 
an diesen Modellen orientieren, werden in der Lage sein den Augeninnendruckim zu 
regulieren und damit als Therapie des Glaukoms einsetzbar sein. Nächste 
Forschungsschritte sind die Optimierung hinsichtlich der Zelladhäsion, sowie die 
Miniaturisierung der Implantate. 
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1. Introduction 
 Thesis Overview 1.1.
The impact of glaucoma on our healthcare system is considerable and with an aging 
population the problem is bound to increase. One form of therapy is the use of an implant 
to reduce intraocular pressure, which is considered to be the main risk factor for the 
development and progress of the affliction. However, the failure rate of these implants is 
not acceptable, creating the need for further improvements for an improved application 
(See Section 1.2 for further discussion).  
The main problem surrounding implant failure is non-optimal biocompatibility (See 
Sections 1.2 and 1.3). The aim of the thesis was the development of a new type of 
intraocular implant, modified with hydrogels made from hyaluronan enhancing the 
therapeutic properties.  Hydrogels made from hyaluronan have already been used 
successfully in tissue engineering, and have also shown promise in a glaucoma stent with 
enhanced capabilities (see Section 1.4). The basic concept relied on a small tube made 
from titanium, a biocompatible biomaterial, which is already used in many biomedical 
applications (see Section 1.5). On the outer surface of the tubes hyaluronan (HA) 
hydrogels are grafted for promoting cell proliferation, reducing inflammatory responses of 
the surrounding tissue and further enhancing biocompatibility. For the interior of the tube, 
the idea was to fill it with a hyaluronan-based hydrogel possessing cell repellant 
characteristics for preventing clotting due to cell growth. Additionally this hydrogel should 
perform as a valve and regulate intraocular pressure within the glaucomatous eye (Figure 
1).  
In this thesis the methods for immobilization of hydrogels made from hyaluronic acid to 
small glass and titanium tubes, acting as model implants were developed. Furthermore it 
was investigated, whether a controlled regulation of an external liquid pressure was 
possible. 
To that end, an already established method for modifying hyaluronan with thiol groups 
(Section 2.1.2) to generate hydrogels using crosslinkers containing multiple acrylamide 
functions (Section 2.3) was adapted and refined. For visualization on a small scale, a 
combined modification of hyaluronan with thiols and fluorescein was established in order 
to generate hydrogels with fluorescent properties (Section 2.2.2). Following that, the 
selective immobilization of hydrogels to glass and titanium surfaces was developed. The 
goal was creating “model” or “prototype” implants in the form of small tubes carrying 
hydrogels selectively on their inner and/or outer surfaces (Section 2.3.2). In order to 
evaluate a resistance to external liquid pressure, two methods were established: the first 
utilized constant pressure buildup in a syringe while the second employed the hydrostatic 
pressure of a liquid column (Sections 2.4.2 and 2.4.3). Measurements with these methods 
showed that liquid flow through the hydrogel-filled model implants and regulation of the 
external liquid pressure was possible. Subsequent experiments with fluorescence revealed 
pressure regulatory abilities in some samples due to the presence of small channels within 
the hydrogels (Section 2.5.1).  
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Subsequently an artificial generation of these channels was successfully established, either 
mechanically or by the application of lasers (Section 2.5.2). Provided that future 
miniaturization is feasible, the methods developed within this thesis showed that the 
manufacture of these new types of implants is possible. 
 
Figure 1: Basic principle for the creation of a new type of glaucoma implant. The basic design is a titanium tube (a) 
capable of draining fluid from the glaucomatous eye in order to reduce the intraocular pressure. Hydrogels made from 
hyaluronan are selectively grafted on the outer surface (b) and into the interior (c) of the tube. These modifications 
should on the one hand enable an improved cell proliferation to increase the biocompatibility of the tube (d) while 
preventing a blockade of the interior through cell proliferation (e). The hydrogel on the interior further acts as a valve and 
control the amount of liquid drained from the eye for a regulated decrease of intraocular pressure. (f) 
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 The glaucoma disease 1.2.
Overview 
The term “glaucoma” encompasses a group of progressive diseases that affect the eye, 
which share the common symptom of a slow degeneration of the visual nerve.1 All 
variations are progressive and can potentially lead to a total loss of vision.2 The occurrence 
of glaucoma is very low before the age of 40 and increases with the age of the patient.3 
This affliction comes in different variations2, but the most prevalent manifestation of 
glaucoma in the western hemisphere is “Primary Open-Angle Glaucoma” (POAG).4 A 
main risk factor for the development of POAG is increased intraocular pressure1, and so far 
the main therapy is a reduction of this pressure, even when no increased values were 
detected5.  
Glaucoma is a prevalent disease and its impact on healthcare is not to be underestimated; 
studies conducted by the WHO in 2010 estimated that around 57 million people worldwide 
suffered from vision loss from this disease with more than 3 million afflicted by acute 
blindness due to glaucoma, elevating the disease to the second highest cause of blindness.6 
Estimations for 2020 and 2040 expect 76 million and 111.8 million cases, respectively, of 
glaucoma worldwide due to an aging population.4 For that reason it is important to further 
develop therapies to cure or slow the progression of the disease. 
 
Pathophysiology 
The cause of visual loss in POAG is the gradual and progressive degeneration of the retinal 
ganglion cells.2,7 These neurons are part of the retinal nerve fiber layer, converge at the 
optic disc where they form the optic nerve that exits the eye through the lamina cribrosa.1 
They are responsible for the transfer of visual signals to the brain and rely on a supply of 
trophic factors to survive.8 During the development of POAG, a gradual apoptosis of these 
ganglion cells is induced, leading to a deformation and loss of functionality of the optical 
disc and irreversible damage of the visual nerve (Figure 2).7 There are different factors 
contributing to the development of POAG9 and the pathophysiology has not yet been fully 
understood.1,2,7 However, it has been shown that one of the main contributors to the 
outbreak and progress of the disease is elevated intraocular pressure (IOP) of the aqueous 
humor (Figure 2).1,2,10 This phenomena is often caused by an increased resistance of the 
trabecular meshwork to an outflow of liquid from the aqueous humor into the Schlemm’s 
canal11, resulting in the IOP rising to levels above the normal values of 21 mmHg12. This 
can result in a deformation of the lamina cribrosa13 and a blockade of axonal transport of 
trophic factors.14 As a result of this trophic deficiency an apoptosis of retinal ganglion cells 
is induced, leading to a gradual loss of vision.15,16 Furthermore, this initial loss of ganglion 
cells can amplify further degeneration due to the formation of a toxic environment, 
accelerating the progress of the disease.9 
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Figure 2: (a): Depiction of a cross section of part of the human eye illustrating the origin of the disease being an elevated 
pressure within the aqueous humor of the anterior chamber. (b): This increase pressure puts a strain on rest of the eye 
causing damage to the optic disk. The retinal ganglion cells degrade ultimately resulting in a loss of vision. 
As already outlined, the whole pathophysiology has not been fully understood17 and 
patients can develop symptoms similar to POAG at normal pressure levels (“normal 
tension glaucoma”).18 Still, the main risk factor for the development of the disease is 
elevated intraocular pressure2 and the main focus of therapies is a reduction of this 
intraocular pressure, even when values are at normal levels.1,5,9,19 
 
Treatment 
The visual loss from glaucoma is irreversible1, but the progression can be impeded by a 
reduction of the intraocular pressure.19 Currently pressure reduction is the only established 
therapy even for people with normal levels of IOP5. To that end, several different therapies 
have been utilized: 
Pharmaceutical treatment 
Usually, the first line of treatment in the progress of glaucoma is the use of medical agents, 
most commonly in the form of eye drops.9 They consist, for example, of prostaglandins 
that can directly reduce the intraocular pressure of the glaucomatous eye.20 While this 
method is relatively cheap and the application to the glaucomatous eye is rather simple to 
perform21, the issue of side effects22 and a low compliancy of the patients, with more than 
half of them failing to follow their prescribed medication schedule23, proves to be a 
recurring problem. 
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Laser application 
The use of lasers to reduce intraocular pressures (“laser trabeculoplasty”) was found to be 
an effective alternative to medical treatment.24 In this form of therapy, laser light is used to 
lower the resistance of the trabecular meshwork to liquid outflow from the aqueous humor 
(Figure 3a).25 The mechanism of the pressure lowering effect is not yet fully understood 26 
and a number of different methods have been established with different laser types and 
pulsing times without any showing clear superiority to the others.25 Still, laser 
trabeculoplasty is a sufficient alternative or addition to medical treatment for a reduction of 
the intraocular pressure.24 The main drawback preventing the method to be the gold 
standard in glaucoma treatment is the relatively high failure rate, with up to 42% of 
patients regaining elevated IOP after five years.27 
Surgical treatment 
Another method that was established separately from medical treatment was the surgical 
removal of a small part of the trabecular meshwork and its surrounding tissue in order to 
enhance aqueous outflow, called trabeculectomy (Figure 3b).28 While the treatment was 
successful in reducing IOP29, some studies showed significant side effects, such as 
infections30, the formation of cataracts31, and hypotony due to an uncontrolled leakage32 
which often necessitated extensive postoperative care. 
Application of intraocular implants 
A method that was established as an alternative to trabeculectomy was the implementation 
of an intraocular implant in order to create an artificial channel for the drainage of excess 
fluid within the aqueous humor.33 This concept was first introduced by Molteno in 196934 
and later refined35 to treat patients suffering from glaucoma. The implant that Molteno 
designed consisted of a small tube connected to a plate. The tip of the tube was inserted 
into the anterior chamber and the plate attached to the sclera, creating a pocket that 
contained a spherical cavity filled with drained intraocular fluid (“bleb”). Fibrous tissue 
formed around the bleb, allowing a slow drainage of the excess liquid via diffusion and 
resulting in a decrease of the intraocular pressure (Figure 3c).34,35 
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Figure 3: (a-c) Basic concepts of the glaucoma treatment using different methods: (a) Laser trabeculoplasty: The 
trabecular meshwork is treated with a laser to improve the natural drainage of intraocular fluid. (b) Trabeculectomy: An 
artificial channel is created surgically to drain excess fluid and lower the intraocular pressure. (c): Intraocular implant: 
Application of an intraocular implant to reduce the pressure by draining liquid from the anterior chamber into a small 
pocket (“bleb”) from where it is expunged by diffusion. (d): Main cause for the failure of these implants due to non-
optimal biocompatibility: An inflammatory reaction of the body results in the formation of scar tissue around the bleb 
blocking the outflow of intraocular liquid.  
While these early implants were able to lower the intraocular pressure in glaucomatous 
eyes and slow the progress of the disease35, they did not come without several of problems 
which led to a number of modifications of the original design; among other things, they 
offered no resistance to aqueous outflow, which often led to hypotony through 
uncontrolled drainage.33 This resulted in the introduction of pressure-sensitive valves to 
increase pressure resistance.36 The other important modification was the increase of 
surface area improving implant’s ability to lower the intraocular pressure compared to the 
original concept by Molteno.37 Today, the designs of modern implants are derived from 
these early concepts and used regularly in glaucoma therapies.33 
Still, a number of issues persist that limit the effectiveness of this treatment, both short- 
and long-term. While less frequent with the introduction of valves, pressure regulation is 
still not optimal and in some cases hypotony was observed.36 Also, it was found that 
certain types of implants can diplopia, probably related to the form of the implant’s end 
plate.37,38 Moreover, with some models using pressure-sensitive valves to prevent 
hypotony, obstructing that valve could result in a blockade of the outflow, making the 
mechanical parts of the implant an additional risk factor for therapy failure.39 However, the 
main reason for implant failure was related to bleb infection and fibrosis33.  
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It has been shown that the permeability of the bleb wall was related to its thickness and 
extensive formation of scar tissue could hinder the diffusion of liquid through the bleb. 
This would subsequently prevent the implant from performing its required function (Figure 
3d).40,41 While the distribution of intraocular fluid into the subconjunctival space of the eye 
itself already triggers a fibrous response from the surrounding cells42, non-optimal 
biocompatibility and suboptimal design of the implants are considered to be the main risk 
factors for extensive scarring, resulting in the long-term failure of intraocular implants.33 
Even with all the different concepts and modifications available today, an optimal design 
has not been found and even modern designs showcase suboptimal success rates43 with the 
main hindrance being the formation of scar tissue around the bleb. Therefore further 
optimizations are necessary with future research necessitates an improvement of material 
biocompatibility and implant design.33,44 
The modification of the implants surfaces with hyaluronan hydrogels is an attempt to solve 
the three issues of hypotony, implant occlusion, and bleb fibrosis. Coating the outer walls 
of the tubular implant with a layer of hydrogel would make the surface more attractive for 
cells and lower the occurrence of an immunogenic reaction of the surrounding tissue. This 
in turn could result in the development of an inflammatory reaction and bleb fibrosis 
should be lowered. As a result, the stent’s biocompatibility with its environment and its 
performance in glaucoma therapy would be improved. Preventing cells from migrating into 
the tube a blocking the drainage path for excess intraocular fluid should be possible by 
filling hydrogels to the interior. Furthermore, by regulating the amount of drained liquid 
with a hydrogel, instead of a mechanical valve, the failure rate of the implants could be 
reduced by avoiding the mechanical stress inherent with the use of valves. 
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 Biomaterials and biocompatibility 1.3.
The concept of using a biomaterial, or a material designed to interact with tissues of the 
human body without causing inacceptable damage45, is as old as human civilization. In 
Ancient Egypt around 2500 B.C., golden wire was used to link teeth together and artificial 
replacements for missing teeth made from brass, ivory, gold and wood were already being 
commonly used.46 With advancing technology, the use of biomaterials became more 
sophisticated. While early prosthetics were of a simple design, utilizing mostly one-jointed 
pieces, and made from basic materials such as wood and leather and simple multi-jointed 
metallic devices later in history, modern prosthetics can be very complex and are 
manufactured using advanced materials.47 The improvement of existing biomaterials in 
order to enhance their performance was often done for medical reasons, due to often 
unwanted side-effects. Early metallic implants, including screws to aid the healing of 
fractures48, were made from low grade steel or chromium alloys.49,50 However, the 
application of these devices produced a number of undesirable side-effects, such as 
corrosion49, physical wear51, or the release of metal ions into the surrounding tissue.52 This 
could subsequently cause adverse reactions in the biomaterial’s host, including 
inflammation and osteolysis53, metal sensitivity50 or even toxic reactions to the metal ions 
released from the implants54. As a result, efforts have been made to find less chemically 
reactive biomaterials in order to reduce these adverse effects, with later generation metallic 
implants being made from stainless steel, cobalt-chromium and titanium alloys55. Today’s 
biomaterials are even more evolved and diverse with implants being created from 
polymers56, ceramics57 or even living cells58, and hybrid materials such as metals coated 
with ceramic59 or polymeric60 layers. 
Concerning the previously mentioned adverse side effects, the concept of 
“biocompatibility” was coined in 197061,62, and since then has gained massive popularity, 
especially in the new millennium (Figure 4). 
 
Figure 4: Number of publications with “biocompatibility” as topic. The data was taken from the “Web of Science” 
database63 by searching for “biocompatibility” and refining the results for each individual year. 
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The concept of biocompatibility in the most basic levels is concerned with the way in 
which biomaterials interact with tissues and how to minimize the potential negative effects 
from the application of biomaterials as a therapy.45 The main desired biocompatibility 
properties in early biomaterial studies required components that were non-toxic, non-
allergenic, non-carcinogenic, had low inflammatory response from the surrounding tissue, 
and minimized other negative effects on the body.62 For example, early orthopedic 
implants made from low grade stainless steel had non-optimal biocompatibility due to 
corrosion.49 As a result, modern implants are made from less corrosive materials, such as 
high grade stainless steel, Co-Cr alloys or titanium, thereby increasing the biocompatibility 
of these devices.55 
Over time, however, the concept of biocompatibility evolved from being only a material-
specific constant, with the best biocompatible materials being as chemically inert as 
possible, to a more synergistic system utilizing a broad understanding of several factors45. 
First, the biocompatibility of a material was not an intrinsic property of the material but 
rather one dependent on its application. PTFE, for example, is a popular biomaterial due to 
its inertness to chemical reactions and is being used for different types of medical 
applications.64 However, when PTFE was used for hip implants, an abrasion of the 
material due to wear caused adverse reactions in the surrounding tissue and led to therapy 
failure.65,66 Furthermore, in medical cases where a specific reaction of the tissue to the 
implant was actually desired for a successful therapy, chemically inert materials, such as 
the aforementioned PTFE, sometimes led to non-optimal outcomes as a result of their 
inertness67. As a result, the concept of biocompatibility was expanded from simply 
material properties to a broader understanding that the biocompatibility of a material is 
always dependent on the intended application.45,68 Therefore in 1987 biocompatibility was 
defined as “the ability of a material to perform with an appropriate host response” and 
more recently expanded by Williams to “the ability of a biomaterial to perform its desired 
function with respect to a medical therapy, without eliciting any undesirable local or 
systemic effects in the recipient or beneficiary of that therapy, but generating the most 
appropriate beneficial cellular or tissue response in that specific situation, and optimising 
the clinically relevant performance of that therapy.“45  
Recently, this new way of thinking resulted in a wholly new concept for developing 
biocompatible materials, as proposed by Williams68. In short, when a biomaterial is 
considered for a given therapy, researchers must evaluate desired cell reactions (cell 
proliferation on surface material, protein adsorption etc.) and negative responses 
(inflammation, calcification etc.). Furthermore, cells interacting with the biomaterial can 
be placed into three distinct groups:  
• Target cells: Cells that are the target of the therapy with the biomaterial. A specific 
reaction from these is desired. 
• Defensive cells: Mostly immunogenic cells who can create adverse reactions to the 
implementation of the biomaterial 
• Interfering cells: Cells that don’t resist the biomaterial but generally hinder the 
therapy 
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In order to achieve good biocompatibility, the desired effects of the therapy should be 
maximized while minimizing adverse reactions and side effects. In other words, the 
response of the target cells should be positive while the response of defensive and 
interfering cells should be as low as possible. A more in-depth discussion of this concept 
can be found in the respective literature and extends the scope of this chapter.68,69 Today, 
biocompatibility is more important than ever and the concept plays an important role in 
almost all biomedical applications.45 
As outlined in Section 1.2, non-optimal biocompatibility of glaucoma implants currently in 
use has been determined to be the main culprit for therapy failure. The goal of this project 
was to possibly enhance the biocompatibility of glaucoma stents by coating their outer 
surfaces and filling their interiors with hydrogels made from hyaluronan. The intention was 
to increase the biocompatibility of glaucoma implants through a reduction of inflammatory 
reactions from the defensive cells and bleb fibrosis by using hydrogel layers promoting cell 
adhesion, making the stent’s surface more attractive to cells and possibly enhancing the 
performance of the implants and improving the chances of positive outcomes when used as 
therapy for glaucoma.  
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 Hyaluronan hydrogels 1.4.
Hydrogels 
One very important class of biomaterials that have already been utilized in various 
applications70 and were used in this project are hydrogels. They consist of three 
dimensional networks of interconnected polymers, carrying hydrophilic groups, with a 
defining ability to contain large amounts of water.70 These networks can be made from 
various starting materials, including but not limited to natural polymers like alginate71, 
gelatin72 or hyaluronan73, synthetic sources like polyethylene glycol (PEG)74, Poly(N-
isopropylacralymide) (PNIPAM)75 and poly(hydroxyethyl methacrylate) (PHEMA)76, or 
composite materials like Zinkoxide77.  
Hydrogels were first recognized as a potential biomaterial by Wichterle in 196078, and 
since then have found a wide range of applications in various scientific and industrial 
fields70. In biomedical sciences they achieved broad use in tissue engineering79, including 
the creation of artificial muscles80, as a therapy against thrombosis after arterial damage81, 
and as an effective agent for wound dressing82. In pharmaceutical applications, 
environmentally sensitive hydrogels were used as a means for controlled drug release.83 In 
biotechnology, surfaces modified with hydrogels have been used to manipulate cell 
adhesion84 or as biosensors85. Potential applications for hydrogels also include the 
purification of water86 or use as a delivery system for the controlled release of fertilizers87 
and water88 to crops in order to enhance the efficacy of agricultural techniques. Almost 
every modern diaper utilizes superabsorbent hydrogels for an enhanced intake of liquid.89 
These examples are only a small fraction of possible applications and many more can be 
found in corresponding literature.70,84,90-92 
The types and classes of hydrogels are as diverse as their applications, with differences 
ranging from their physical properties, their source materials (natural, synthetic, etc.), and 
rates of biodegradation over their generation methods, nature of crosslinking, and swelling 
behavior to properties such as pH responsiveness, net ionic charge, and biodegradation 
(Figure 5).70 The most basic distinction between different types relates to their method of 
creation, differentiating between physical and chemical hydrogels90. In physical, or 
reversible, hydrogels, crosslinking between the individual polymer chains is a function of 
physical interactions between these chains, such as ionic forces, hydrogen bonding, 
physical entanglements, or hydrophilic and hydrophobic forces (Figure 6a/b).70 Calcium 
ions, for example, were used to crosslink alginate chains together via ionic forces93, while 
soft hydrogels made from chitosan used only hydrophobic forces and hydrogen bonding to 
bind together the polysaccharides94. While hydrogels are usually considered to be rather 
soft and brittle materials, recently developed physical hydrogels made from 
polyampholytes, utilizing ionic bonds of varying strengths between polymers, show a 
relatively high toughness and viscoelasticity.95 These interactions are dependent on 
characteristics of the corresponding environment, such as pH, temperature, presence of 
detergents etc., resulting in the formation of physical hydrogels being reversible, which 
potentially allows for controlled dissolution.90  
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Figure 5: Overview of the different types and classes of hydrogels based on different parameters. Picture adapted from 
Ullah.70 
Chemical, or permanent, hydrogels are formed by the formation of covalent links between 
the original polymers, either by a direct reaction between functional groups connected to 
the polymers or the application of bi- or multifunctional crosslinkers to create the 
networks.70 The nature of the chemical reactions used for hydrogel generation can be 
diverse and is only limited by the available chemistry. Free radical reactions with specific 
monomers (acrylates, etc.) and crosslinkers (Figure 6c) have been used to create 
polyethylene glycol96 or PNIPAM97 hydrogels, among others. The radical chain reaction 
was initiated by “classical”, such as Azobisisobutyronitrile (AIBN)97, or photosensitive 
initiators allowing for photopolymerizable hydrogels, which have found broad use in 
bioengineering.98 Alternatively, all kinds of condensation reactions between polymers and 
crosslinkers carrying chemically active groups have been employed to create different 
hydrogels (Figure 6d). Chemical strategies for hydrogel fabrication include a reaction 
between isocyanate groups and alcohols to form urea and urethane bonds99, Michael 
reactions between amines100 or thiols101 and acrylic groups, disulfide formation from 
thiols102, reactions between amines, alcohols or carboxylic acids and epoxides103, between 
amines and active esters104 or the application of click chemistry105. Through a combination 
of different polymers and methods, including the co-polymerization of two different 
polymers106 (Figure 7a) or the formation of interpenetrating networks by first creating a 
swollen hydrogel followed by the polymerization of a second intermeshing network107 
(Figure 7b), even more complex hydrogels were obtained. This diversity in starting 
materials and polymerization chemistry allows for a large amount of hydrogels with 
different features and makes this type of biomaterial extremely useful for various 
applications.70 
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Figure 6: Overview of different methods for the creation of hydrogels. (a): Physical hydrogels using ionic interactions 
from charged polymers combined with ions or polymers containing the opposite charges. (b): Physical hydrogel using 
hydrophilic interactions from a hydrophobic polymer modified with hydrophilic groups. (c): Chemical hydrogels using 
radical reactions from monomers or polymers containing groups capable of radical chain reactions. (d): Permanent 
hydrogels using chemical reactions such as Michael-Additions, peptide couplings etc. from polymers and multifunctional 
crosslinkers. Pictures redrawn from Hoffman et al.90 
 
Figure 7: Creation of more complex hydrogels by (a): The co-polymerization of two different starting polymers (b): The 
polymerization of one hydrogel into a pre-existing second one. Pictures adapted from Hoffman et al.90 
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As already outlined, a defining feature of hydrogels is their ability to take in large amounts 
of water, resulting in swelling of the hydrophilic polymer networks.108 The kinetics of this 
swelling behavior can be complex and are highly dependent on the hydrogel’s 
properties.109 Briefly90, due to the presence of hydrophilic groups within the polymer 
networks, water can infiltrates dry hydrogels, hydrating these hydrophilic groups (“primary 
bound water”). This starts an initial swelling of the networks and exposes hydrophobic 
groups, which can also bind water using hydrophobic interactions (“secondary bound 
water”). Due to osmotic forces, more water, which is not bound to the network and 
therefore can move more freely, infiltrates the network, further swelling it further (“free 
water” or “bulk water”). This swelling continues until a balance between osmotic forces 
that try to further dilute the network even more and the physical retractive force of the 
polymer chains is reached (Flory-Rehner theory).92 At that point the gel either starts to 
disintegrate (when degradable) or remains in a steady equilibrium swelling state.90 As 
already mentioned, the kinetics of the swelling can be rather complex and are highly 
dependent on the parameters of the hydrogel (ionic charge, mesh size, crosslinking density 
chain length, etc.) and the environment (ionic concentrations, temperature pH etc.).92,109 
The swelling behavior further influences other gel properties, such as elasticity, the 
average pore size, and diffusion rates of smaller molecules within the polymer 
network.110,111 This contributes to the capabilities of hydrogels for the intake of nutrients 
for cells90, the release of drugs112, or cell adhesion on the gel’s surface96 and therefore is an 
important parameter for the use of hydrogels in different types of applications. 
 
Hyaluronan hydrogels 
One type of material that has been successfully used to generate hydrogels is hyaluronan 
(hyaluronic acid, hyaluronate, HA).113 This polysaccharide is a glycosaminoglycan 
(GAGs) that consists of unbranched, often high molecular weight chains of alternating β-
1,3- and β-1,4 linked units of glucuronic acid and N-acetylglucosamine (Figure 8).114  
 
Figure 8: Molecular structure of the repeating unit of hyaluronic acid. It consists of glucoronic acid and N-
acetylglucosamine connected with β-1,3 and β-1,4 links. 
Hyaluronan is predominantly found in connective tissues (synovial fluid, etc.)115, skin 
tissues116, and the aqueous humor of the human eye117, but is also present in smaller 
amounts in all parts of the body115. HA differentiates itself in a number of ways from other 
GAGs. First, it is synthesized in the plasma membrane instead of the Golgi apparatus.114 
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Furthermore, it is neither covalently modified with core proteins118, although some serum-
derived proteins do bind covalently with covalently with the GAG119. It is furthermore not 
sulfated, giving hyaluronen the simplest primary structure of all GAGs.120 While most 
GAGs are rather short, forming chains with a molecular mass of <50 kDa, HA usually 
generates huge molecules with a mass of up to 7*106 kDa.115 HA is known for possessing 
some peculiar properties, such as the ability to bind around one thousand times its own 
weight in water, resulting in viscous and elastic solutions at concentrations as low as 1 
mg/ml.121 Viscosity increases exponentially with HA concentration110, although it does not 
form solid gels at high concentrations.114 Furthermore, HA networks exhibit water 
homeostasis (prevention of bulk water flow), a non-ideal osmotic pressure which increases 
exponentially with the concentration, and the ability to prevent other macromolecules from 
diffusing within the polysaccharides.122 These properties of hyaluronan are related to its 
structure in solution. While the primary structure is rather simple compared to other GAGs, 
the secondary and tertiary structures are much more complex and indeed not yet fully 
understood.121 Earlier models proposed the secondary structure to be a stiff ribbon-like 
helix, formed due to intramolecular hydrogen bonds,123 which create entangled networks at 
higher concentrations,124 resulting in the previously described rheological properties. 
However, solid state X-ray and NMR measurements also showed the HA’s ability to form 
double-helical structures125 while liquid NMR and simulations found even more stable 
conformations with only minimal differences in energy states.126 As a result, it is more 
likely that hyaluronan rapidly undergoes different conformations with passing 
intermolecular interactions instead of remaining in the stiff ribbon-like helical structure for 
extended times.127 However, the hydrodynamic structure of hyaluronan is not yet fully 
explained,121 and its architecture in vivo may differ from what is observed in the lab.128 
Nonetheless, it is remarkable how a molecule with a seemingly simple architecture is 
capable of rather complex secondary and tertiary structures. 
This same trend, complexity from simplicity, continues when looking at the biological 
functions of hyaluronan. While in earlier times it was mostly disregarded as a filler 
material and lubricant for joints, this point of view changed with the discovery of 
hyaladherins, proteins which specifically react with hyaluronan.129 Today it is known that 
HA plays a role in a large amount of biological processes, at times with opposing roles 
depending on its size, including but not limited to simple space filling properties, hydration 
of the skin, anti-inflammatory and anti-angiogenic functions, a suppression of cell-cell or 
ligand-receptor interactions, embryogenesis, inflammatory inducement, and wound 
repair.128 This participation in a vast amount of functions makes this seemingly simple 
molecule an integral part of the ECM130 and allows it to play an important role in many 
biological processes. 
Due to these properties and biological functions hyaluronan has also found use in many 
biomedical applications. The physical properties of HA have been used as a protective 
layer in cataract surgery131, the treatment of joint diseases132, or the promotion of wound 
healing118. Of note is also the ability to obtain the GAG from non-animal (e.g. bacterial) 
sources. 133 Chemically modified HA was successfully used in the surgical reduction of 
adhesions induced by physical trauma, for tissue augmentations, and for therapeutic 
applications by linking biologically active agents.134  
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Furthermore, and perhaps most importantly with respect to this thesis, hyaluronic acid 
hydrogels also found use as biomaterials in biomedical applications like tissue 
engineering135. HA is an excellent candidate for the creation of biomaterials due to its 
excellent biocompatibility, which is a result of its non-immunogenic and anti-inflammatory 
characteristics 132 and the fact that it is naturally a component of the extracellular matrix. 
Also, the potential to chemically modify the polysaccharide in various ways allows the 
adaptation of the polysaccharide for a number of different purposes (Figure 9).113,135  
 
Figure 9: HA-molecule with outlined functional groups on which chemical modifications are usually performed: The 
carboxyl function of the D-glucoronic acid (red), the hydroxyl group of the D-N-acetylglucosamine (blue) and the 
reducing end of the polysaccharide chain (green).  
Specifically the idea of manipulating cell adhesion to hydrogel-modified surfaces is an 
already well-established concept. Poly(ethylene glycol) (PEG) hydrogels showed good cell 
repellent properties136 and investigations of hyaluronan hydrogels illustrated their potential 
to create cell adhesive surfaces.101,137 Furthermore the group of Spatz demonstrated the 
ability to switch between cell adhesive and cell resistant PEG hydrogel properties by the 
introduction of additional functional groups.138 
For these beneficial properties, specifically its good biocompatibility and availability for 
chemical modifications, hyaluronic acid hydrogels were used in this thesis for the 
development of enhanced glaucoma implants. As outlined before (see Section 1.2), the 
main reason for the failure of glaucoma therapy with intraocular implants is an 
immunogenic reaction of the body to the implant, resulting in the formation of fibrous 
tissue and subsequent blockage of liquid drainage. Since hyaluronan is already present 
within the human eye and possesses the aforementioned (size-dependent) anti-
inflammatory and anti-immunogenic properties, it is an ideal candidate for a potential 
reduction of the immunogenic reaction of the host tissue to the implant by masking its 
surfaces with hydrogels made from hyaluronic acid and facilitating cell adhesion on its 
outer surfaces. Moreover, it was already shown that modified hyaluronan enhanced the 
biocompatibility of metallic surfaces,139 and Shu et al. has already demonstrated positive 
cell proliferation on the surface of hyaluronan hydrogels.101,102,137 The diversity of possible 
crosslinkers (see Section 1.6) and the potential to further modify hyaluronan with other 
reactive groups enables the potential creation of HA hydrogels with different properties, 
allowing for a great deal of optimization. For these reasons, hyaluronan was the ideal 
candidate to be used in this project for an enhancement of glaucoma stents. 
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 Titanium: An efficient biomaterial 1.5.
Properties of titanium 
Titanium is one of the most established biomaterials in medicine due to its inherent 
beneficial properties as an implant material for medical applications.140 Titanium, 
discovered in the second half of the 18th century141, makes up 0.6% of the earth’s crust, 
mostly in the form of FeTiO3 and TiO2, and is among the most common structural metals, 
along with magnesium, aluminum, and iron.142 The first industrial method of producing the 
material was invented in 1937 (the Kroll process), in which solid TiO2 is first transformed 
into gaseous TiCl4 followed by a reduction with magnesium at high temperatures (Figure 
10)142. Although it has been optimized, this method is cost intensive143 but remains the 
predominant way of obtaining pure titanium on an industrial scale.144 
 
Figure 10: Reaction equations for the production of titanium from Ti(IV)-oxide in a two step process: First TiO2 is 
transformed into gaseous TiCl4 followed by a reduction to Ti(0) with magnesium at high temperatures. 
The metal found its use in many different fields of application, including the automobile 
and aerospace industry, due to its low density143,145. In medical sciences, titanium and its 
alloys have gained rapid popularity as a very biocompatible biomaterial140, and is used in 
hip146, dental147 or joint148 implants. The biocompatibility of the metal comes from a 
number of intrinsic properties. Titanium offers good resistance to corrosion149 and physical 
wear150, minimizing the potential release of metal ions and debris into the surrounding 
tissue that trigger adverse reactions (See Section 1.3). Furthermore, it offers a general 
inertness to chemical reactions151, a lower (pure titanium) or higher (alloys) density and 
Young’s modulus than other metallic biomaterials (steel, etc.)152. It also has the ability to 
induce protein adsorption and cell proliferation on its surface, potentially increasing the 
acceptance of surrounding tissue to implants made from titanium151,153. Most of these 
features originate from surface properties of the metal. Titanium has a high affinity for 
oxygen, and as a result, pure titanium and most of its alloys readily form a layer of TiO2 on 
its surface through a gradual oxidation of the Ti(0) to Ti4+ by the environment. This is 
followed by association with O2-, resulting in a Rutil structure that allows oxygen diffusion 
and a gradual growth of the layer into the bulk material from the surface (Figure 11).142. 
This layer is resistant to most chemical reactions and prevents the relatively aggressive 
physical environment in tissues from further dissolving implants made from titanium, 
including via complexion of the metal ions.140,142 As a result, titanium is chemically inert 
and withstands corrosion well for extended amounts of time, making it a desirable 
biomaterial.148 Furthermore, water and acids as well as basic hydroxyl groups are part of 
the TiO2 layer, making the surface hydrophilic and allowing it to act as an amphoter.154 In 
addition, organic molecules are able to adsorb or covalently bind to the surface, as well as 
small, oxygen containing molecules such as phosphate or nitrate.140  
 
 
1. TiO2 + 2 C + 2 Cl2 TiCl4 + 2 CO 
2. TiCl4 + 2 Mg 2 MgCl2 + Ti 
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The hydroxyl groups result in a slightly negative surface charge at physical conditions (pH 
= 7.4), resulting in the adhesion of Ca2+ ions155 which aid in the attachment of more 
biological macromolecules including glycosaminoglycans156 or proteins157. In vivo these 
surface properties allow for the creation of a protein layer around an implant which 
promotes the attachment and proliferation of cells on its surface, which together with the 
non-toxicity and chemical inertness of the material, contributes to the overall good 
performance and biocompatibility of titanium implants in tissues.140 
 
Figure 11: Depiction of the surface structure of unmodified titanium showing the metallic bulk with an oxygen 
gradient near the interface and a passivizing TiO2 layer with bound hydroxyl groups and adhered H2O as well as 
organic contaminations at the surface. Picture adapted from Brunette.140 
 
Surface modifications 
While titanium itself has good biocompatibility, the pure metal often has suboptimal 
performance in practical biomedical applications. Contamination and non-uniform surfaces 
often occur during the manufacture of these implants.158 For long-term applications (>10 
years), physical wear of the metallic devices is still an unsolved problem.159 Furthermore, 
for different applications different surface properties such as specific roughness levels for 
optimal bone attachment are required.160 The concept of “hemocompatibility”161 
introduced a number of new requirements for titanium implants with respect to contact 
with blood.162,163 As a result, a host of surface modifications have been established140,158, 
including physical methods like laser polishing164 and sandblasting165 of the surfaces, 
chemical methods like acidic166 or basic167 treatment, the application of inorganic coatings 
like hydroxyapatite59 or silica168, or the use of chemical vapor deposition processes to 
create diamond coatings169.  
Contamination Ti(0) Ti(+IV) O OH H2O
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One concept for the surface modification of titanium that has been also applied for this 
thesis is the attachment of biological molecules to enhance the implant’s performance. This 
can contribute to lowering inflammatory responses of the surrounding tissue, triggering 
specific cellular reactions, resisting bacterial infections, and increasing the long-term 
stability.153 Among these modifications were the immobilization of peptides to provide 
better osseointegration170, the use of hyaluronan and chitosan to improve resistance to 
bacterial growth171, the immobilization of enzymes to create bioactive interfaces166, and 
many more.140,153,158 In order to permanently attach these molecules to titanium surfaces, a 
number of methods have been successfully developed. These include the adhesion of 
phosphates to create self-assembled monolayers or the reaction with silanes 166 to graft 
reactive groups to the titanium surfaces which subsequently reacted with the biological 
molecules resulting in a covalent immobilization of these molecules.172,173,174 
Due to these properties of chemical inertness, tendency for cell adhesion, and chemical 
modifiability, titanium is a great biomaterial that is already being used in a large number of 
biomedical applications.140 Therefore, it was also selected as the main body for the model 
glaucoma implants developed in this thesis. 
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 General challenges and their proposed solutions 1.6.
For the development of the hyaluronan hydrogel enhanced glaucoma implants, a number of 
basic problems had to be solved. A method for the creation of the hyaluronan hydrogels 
and a protocol for the immobilization of these hydrogels to titanium surfaces had to be 
established. Furthermore, analytical techniques had to be developed for determining a 
potential controlled reduction of external pressure through the hydrogel-filled tubes. 
Finally, the parameters of the intraocular stents had to be optimized to reduce the external 
pressure to specific desired levels. 
Additionaly, since the hydrogel-modified devices were ultimately meant to be 
manufactured on an industrial scale and used as intraocular implants in glaucoma therapy, 
some extra general requirements had to be fulfilled for the establishment of the methods 
used to generate them. For work safety reasons, a low cost of waste disposal and for the 
prevention of potential complications in a medical context the use of harmful materials had 
to be avoided. For the same reasons, the use of potentially hazardous chemicals also had to 
be minimized. Furthermore, also due to cost reasons and in order to reduce the occurrence 
of potential errors during a large scale manufacturing process, a goal of fabricating the 
intraocular implants in as few steps as possible was established. In addition, each of these 
steps ideally should be at a minimum level of complexity. For that reason, the concepts 
used in this thesis to realize the goal for the implant creation were developed with respect 
to a minimal complexity, a reduction of production steps, and an avoidance of toxic and 
harmful reagents whenever possible. 
Implant design and hydrogel generation 
For the formation of the hyaluronan hydrogels, a number of concepts were already 
established in literature (see Section 1.4). Among these, a method developed by Shu et al. 
was selected to be used for the design of the glaucoma implants:101,102,137 In the first step, 
hyaluronan was modified with thiol groups by coupling dithiobis(propionic hydrazide) 
(DTPH) to the HA carboxylic acid groups followed by a reduction of the disulfide bond 
via dithiothreitol (DTT) (Figure 12a). The thiolated hyaluronan (HS-HA) was then mixed 
with crosslinkers containing acrylic groups to initiate a Thiol-Michael addition (Figure 
12b)175, forming connections between the individual hyaluronan chains and creating the 
hydrogel (Figure 12c).  
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Figure 12: Schematic drawing of the chemical reactions for generating hyaluronan hydrogels, which was adapted in this 
thesis. (a): Two-step reaction of the modification of HA with thiol groups using an EDC mediated peptide coupling 
reaction of DTPH to HA carboxyl groups followed by a reduction of the disulfide bonds to thiols. (b): Reaction 
mechanism of the Thiol-Michael addition between thiols and acrylic groups that was used to crosslink the hyaluronan 
chains. In the first step the thiols are de-protonated by the hydroxyl groups either via the basic or nucleophilic method (i) 
followed by the nucleophilic attack at the β-carbon of the acrylic function (ii). Mechanisms adapted from literature.102,175 
This method came with a number of advantages. DTPH was easily synthesized from 
dithiobis(propionic acid) (DTPA), which is inexpensive, in non-hazardous conditions with 
ethyl acetate as the only organic solvent, and catalytic amounts of sulfuric acid being the 
most dangerous chemical involved (See Section 4.1.2). The HA modification itself also 
could be performed in a simple two-step synthesis mostly in non-toxic conditions (See 
Section 2.1.2) and minimal use of harmful chemicals with the exception of DTT. These 
conditions make the method viable with respect to an industrial application as discussed 
before. The only downside of this concept is the potential re-oxidation of the thiols to 
disulfides in the presence of oxygen under basic conditions102, requiring careful pH control 
and the exclusion of oxygen during the hydrogel synthesis, as well as some specific 
preparation requirements for long-term storage (see Section 4.1.2). 
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Furthermore, the Thiol-Michael addition can be performed on any kind of crosslinker 
containing multiple acrylic groups. Shu et al. has already used poly(ethylene) glycol 
derivates101 and Hagel et al. successfully generated HA hydrogels using crosslinkers 
derived from desmosine176, and in this thesis N,N’-Methylenebisacrylamide (BIS, MBAA) 
was successfully used for hydrogel synthesis as well (See Section 2.3.1), illustrating the 
flexibility of the method for creating hydrogels. This potentially enables the generation of 
hydrogels with different properties depending on the type of crosslinker used and later 
allows an optimization of the characteristics of the glaucoma implant with respect to cell 
adhesion (outer surfaces) or repellence (implant interiors). For example ionic crosslinkers 
were used to change the net charge density within the hydrogel. As outlined before 
(Section 1.4), a successful cell adhesion onto the HA hydrogel modified surfaces was 
already demonstrated by Shu et al.101, further illustrating this method’s potential for the 
enhancement of the biocompatibility of the glaucoma implants. 
 
Immobilization strategy 
A few possibilities for the immobilization of the hyaluronan were considered. They all 
included the modification of the titanium surfaces with reactive groups using silanes 
followed by a covalent reaction of the hyaluronan with these reactive groups. Similar to 
silica surfaces177, the silanization method was used on titanium and other metal oxides173 
due to the presence of surface-bound hydroxyl groups reacting with alkoxysilanes. For the 
reaction between the hyaluronan and the silanized surfaces, several options were available. 
For example, a method that has been successfully applied by Thierry.178 It proposed the 
coupling between a carboxylate terminated hyaluronan and surface-bound amino groups 
form a stable peptide bond. However, this would have demanded for an additional 
modification of the hyaluronan with functional groups at the terminal end, complicating 
the synthesis protocol in the process. Additionally thiols are not stable in basic conditions 
over a longer period of time. Thus, a multiple-step grafting process would be required, 
starting with the immobilization of HA still carrying non-cleaved DTPH, followed by 
incubation in a DTT solution to (re-)activate the thiol groups before the hydrogels are 
formed (Figure 14). The whole concept, and similar ones that involve additional reactive 
groups would be too elaborate, so other options that would not necessitate further 
modifications of the hyaluronan itself were considered. For example, the grafting of either 
thiol or acrylic functions to the metal and the use of either a direct (surface acrylic) or 
crosslinker-mediated (surface thiol) Michael Addition were explored. The advantage of 
this approach is the combination of the immobilization and the hydrogel generation in a 
one-step reaction, allowing for fewer required production steps. However, this creates 
competition between surface-bound and HA-bound reactive groups, making the kinetics of 
the hydrogel formation more dependent on the amount of active groups on the titanium 
surface. In order to mitigate this effect, epoxides were grafted to the surface (Figure 13a). 
These epoxides can subsequently react with hydroxyl groups of the hyaluronan in a 
nucleophilic ring-opening mechanism (Figure 13b)103.  
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Figure 13: Schematic drawing over the concept of the combined hyaluronan hydrogel formation and surface 
immobilization on titanium. (a): Titanium naturally forms an oxide layer containing hydroxide groups (simplified) which 
can react with (3-glycidoyxpropyl)trimethoxysilane to create a layer of epoxide groups on the surface. (b): Hydroxyl and 
thiol groups of hyaluronan can react with the epoxides, subsequently immobilizing the HA on the Ti surface. (c): The 
Thiol-Michael Addition and epoxide ring-opening reaction can both be conducted with the same reactions parameters 
allowing for the immobilization and hydrogel formation to be done in one step. 
 
Figure 14: Schematic drawing of a potential concept adapted from Thierry178 for the immobilization of HA hydrogels. It 
involves the immobilization of a carboxyl function at the terminal end of the saccharide chain reacting with surface 
bound amino-groups. Due to the sensitivity of the thiol groups to re-oxidation into disulfides, multiple steps would have 
been required to modify the hyaluronan and to conduct the immobilization of the hydrogel as opposed to the pathway 
used in this thesis (Figure 13). 
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The described strategy allowed for immobilization and hydrogel formation in a single step 
(Figure 13c), lowering potential costs in an industrial setup while including more reactive 
groups in addition to the thiols, which would also react with the epoxides179. Moreover, 
epoxides decay over time in alkaline conditions by a ring opening reaction with 
hydroxides180. The number of covalent links formed between the titanium substrate and the 
hydrogel might not be as high as in other immobilization concepts due to the competing 
reactions, but it also eliminates all unreacted surface bound-groups that might otherwise 
cause reactions with the surrounding environment and cause adverse reactions within the 
host tissue. Nevertheless, this approach was selected since it promised the easiest route to 
the generation of hydrogel-modified model implants. In this case the only downside was 
the fact that the immobilization might not be as strong compared to other concepts without 
competing reactions. 
 
Analytical methods 
Some analytical methods used in this thesis were already well established. 1H-NMR was 
applied to monitor the synthesis of the starting materials (DTPH, HS-HA), and for the 
degree of HA modification with thiols the Ellman’s test was used.102 To ascertain the 
success of the silanization on flat surfaces contact angle measurements181 could easily be 
conducted in order to determine changes in the surface energy by the introduction of new 
functional groups.182 However, for some parts of the projects, custom made analytical 
methods were developed. In order to verify a successful immobilization of hyaluronan on a 
small scale and on rounded surfaces (e.g. small tubes), the polysaccharide was modified 
with fluorescein in addition to thiols to create HA with fluorescent properties in addition to 
the crosslinking capabilities (HS-FA-HA). This allowed for visualization of hyaluronan 
immobilized to the outer and inner surfaces of small tubes and on titanium surfaces. 
Furthermore, the fluorescent hydrogels could be visualized even on a small scale, e.g. 
layers with a small thickness and the interiors of small tubes, allowing for a better visual 
analysis of hydrogel formation. In addition, the non-toxicity of fluoresceinamine183 would 
potentially allow for further potential applications of HS-FA-HA and their respective 
hydrogels in a biomedical context, making this the ideal fluorescent dye for this project. 
Evaluating the behavior of hydrogel-modified prototype implants to external liquid 
pressures also required custom made setups that were capable of quickly evaluating 
whether the hydrogels would permit liquid flow at all, as well as how a change of certain 
parameters (e.g. dimensions and hydrogel properties) would influence this behavior. 
Another setup was necessary to see, in the case that a liquid flow through the intraocular 
implants was achieved, whether they were able to regulate the outflow to attain certain 
pressures, and how the parameters of the implant and the accompanying hydrogels could 
be modified to achieve these pressure levels. To verify and optimize these pressure 
regulatory properties was of great importance since one required ability of the implants 
was to decrease the intraocular pressure of the glaucomatous eye without causing hypotony 
(see Section 1.2). In order two fulfill these requirements for analytical methods to ascertain 
the pressure regulation of the hydrogel-modified implants two custom-made setups were 
created. One used a constant pressure buildup in a syringe connected to the samples for a 
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quick evaluation of the general ability of the model implants to permit a liquid flow. In 
addition the immobilization stability of the hydrogels in the tube’s interiors could be 
quantified. The other method applied a hydrostatic pressure in a column to evaluate the 
absolute values for the pressure regulation (see Section 2.4.3 for more information). With 
these methods it was possible to characterize the properties of model stents. And they 
provided helpful tools for future optimizations of the new intraocular implants to achieve 
an ideal level of pressure regulation for an improved biocompatibility. 
 
Summary 
In this chapter a concept is proposed which allows creating a new type of intraocular 
implants. It is based on a surface modification of titanium with epoxides using a reaction 
between surface-bound hydroxyl groups and alkoxysilanes and the modification of 
hyaluronan with thiols. These intital steps are necessary for the crosslinking reaction with 
multifunctional acrylic groups and the surface immobilization of HA, using a nucleophilic 
ring-opening on the epoxides (Figure 15). Both reactions can be performed under the same 
conditions, allowing for hydrogel formation and surface binding in a single step, 
simplifying the process considerably, as opposed to a multi-step process. 
 
Figure 15: Schematic drawing of the concept used for creating hydrogel-modified glaucoma stents. In two separate steps, 
hyaluronan is modified with thiol groups and the surface of titanium with epoxides. Following that, the hydrogel 
formation via a Thiol-Michael Addition and the surface immobilization via a nucleophilic ring-opening of the epoxides 
can be done in one single step. 
This combined concept enables the creation of glaucoma stents using a simple reaction 
pathway utilizing mostly non-harmful and low cost ingredients. By varying the type of 
crosslinker and the modification grade of HA with thiols and enabling different 
crosslinking densities, hydrogels with varying properties can be generated. This allows for 
a simple optimization of the model glaucoma implants with respect to cell adhesion and 
pressure reduction. 
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2. Results & Discussion 
 Chemical modification of hyaluronan 2.1.
2.1.1. Fluorescent labeling 
As outlined in section 1.6, hyaluronan was labeled with a fluorescent dye to generate HA 
and hydrogels with fluorescent properties for an improved analysis of its immobilization to 
surfaces (Section 2.2.2) and model implants (Section 2.2.3). Furthermore the fluorescent 
labeling helped understanding the mechanism of the liquid flow through HA hydrogel-
filled tubes (Section 2.5.1). In order to attain the labeling, 5-aminofluorescein 
(fluoresceinamine, FA) (Figure 16) was linked covalently to hyaluronan.  
 
Figure 16: Molecular structure of 5-aminofluorescein 
 
FA had a number of properties advantageous to the work with the hydrogels. Notably, it 
operated in the visible spectrum (pH = 9: λex = 485 nm λem = 514 nm) with a high quantum 
yield and good photosensitivity.184 Furthermore, FA possessed a rather low toxicity183, 
which made handling of the fluorophores easier without extra precautions, as opposed to 
quantum dots185, and it prevented any interference with possible cell experiments. In order 
to link FA to hyaluronan, a peptide coupling reaction between the amine groups of FA and 
the carboxylic groups of the hyaluronan backbone was used. It was mediated by N-(3-
Dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) and N-Hydroxysuccinimide (NHS) 
(Figure 17), a method that has already been employed previously for modifying HA with 
FA.186,187  
 
Figure 17: Reaction used to modify hyaluronan with fluoresceinamine: An EDC/NHS mediated peptide coupling 
reaction was employed to bind the amine group of fluorescein to the carboxyl groups of the HA disaccharide units. 
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Modifying HA with fluoresceinamine competed with introducing anchor groups for 
crosslinking the hydrogels (see section 2.1.3 for further discussion). The reaction could 
further influence hydrogel properties by changing the hydrophobicity of the network by 
reducing the amount of carboxylic –OH groups.188 For that reasons parameters were 
chosen to achieve a low degree of substitution with FA (see Section 4.1.3). The 
experimental outline followed the work of Sehgal et al. who investigated the degree of 
substitution of EDC-mediated peptide couplings based on several parameters.189  
The reaction yielded a product (FA-HA) in form of a yellow substance with wool-like 
consistency (Figure 18a), fluorescent properties (Figure 18c) and average product yields 
ranging from 70% to 90% (w/w).   
 
Figure 18: (a): Image of unmodified hyaluronan (white powder) and HA labeled with fluoresceinamine (yellow wool) 
illustrating the changes in color due to the labeling reaction with FA. (b): Bright-field microscopy image of dry 
fluorescent hyaluronan. (c): Fluorescence microscopy image (λex = 470 nm , λem = 525 nm) of the same sample revealing 
the fluorescent properties of FA-HA. 
Degrees of substitution, defined as the amount of FA divided by the number of 
disaccharide units within the hyaluronan, were generally between 0.006 and 0.012 (n/n). 
These values were low due to the choice of reaction parameters (n(NH2)/n(COOH) = 1.46; 
n(EDC/n(NHS) = 0.5; reaction time = 5h; pH = 7).189 They were selected for generally 
achieving the desired low yield of FA modification. Additionally the low observed 
solubility of FA in aqueous medium contributed to these low degrees of substitution. 
However, they were sufficient for visualizing hyaluronan using fluorescence microscopy 
(Figure 18c). Subsequently FA-HA was used for immobilization experiments with non-
crosslinked HA on glass and titanium surfaces (Section 2.2.2) and small model implants 
(Section 2.2.3). Analyzing the mechanism of the observed pressure reduction (Section 
2.5.1) was also possible with this degree of fluorescent labeling. Therefore no further 
optimizations of the reaction parameters were undertaken. 
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2.1.2. Modification of hyaluronan with thiol groups 
 As outlined in Section 1.6, the strategy for generating hyaluronan hydrogels included the 
modification of HA chains with thiol groups. For this, a method developed by Shu et al. 
was used, in which dithiobis (butanoic hydrazide) (DTBH, Figure 19a) or dithiobis 
(propanoic hydrazide) (DTPH, Figure 19b) were covalently linked to hyaluronic acid. In a 
subsequent step selective oxidation of the disulfide bonds via dithiothreitol (DTT) yielded 
hyaluronan modified with thiol groups (HS-HA) (Figure 19c).101,102,137 The group of Shu et 
al. further showed that the EDC-mediated peptide coupling was more effective when 
hydrazides were used instead of amides and that DTPH generally had a higher reactivity 
than DTBH due to a lower pKa.102 Taking this into account, DTPH was used instead of 
DTBH to prepare HS-HA in this thesis. It was subsequently was used for generating and 
immobilizing hyaluronan hydrogels to different solid surfaces (See Section 2.3.1). 
 
Figure 19: (a): Chemical structure of dithiobis (butanoic hydrazide). (b): Chemical structure of dithiobis (propanoic 
hydrazide) (DTPH). (c): Overview of the reaction pathway for creating hyaluronan with thiol groups including a EDC 
mediated peptide coupling reaction between hyaluronan and DTPH followed by a reduction of the disulfide groups with 
DTT. 
 
DTPH was synthesized from dithiobis(propanoic acid) according to the protocol developed 
by Shu et al.190 and analyzed using 1H-NMR (300 MHz, D2O). The thiolation reaction was 
performed according to Shu et al.102 with some minor alterations (See Section 4.1.2). The 
biggest change in the protocol was the use of HA with lower molecular weights (Mn = 100 
kDA, 60 kDa, 10 kDa) compared to the size Shu used (Mn = 120 kDa)101,102,137. The 
amount of HA bound thiol groups was controlled by varying reaction times: 5 – 30 minutes 
for a low to medium degree of substitution and 1 – 2 hours for a higher degree of 
substitution, defined as the amount of thiol groups divided by the amount of disaccharide 
units.  
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The general success of the thiolation was confirmed by nuclear resonance spectroscopy on 
protons in deuterated water (1H-NMR (D2O)). 
 
Figure 20: (a): 1H-NMR (300 MHz) of HS-HA. (b): The peaks were attributed to the individual H-atoms according to 
Shu et al. and Son et al.102,191 
Spectra were analyzed according to Shu et al. and Son et al.102,191 The multiple overlapping 
signals shown in Figure 20a at δ = 4.1 – 3.3 ppm and 4.6 ppm originated from the pyranose 
-CH- groups of the disaccharide units. The singlet at δ = 2.03 ppm belonged to the N-
acetyl methyl protons and the peaks seen at δ = 2.88 ppm and 2.74 ppm were attributed to 
the –CH2-CH2 groups of the thio(propanoic hydrazide) (TPH) chains. These results were 
similar to 1H-NMR of HS-HA published by Shu et al.102, confirming that the modification 
of HA with DTPH was a success.  
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For verifying success of the disulfide oxidation, which resulted in the thiols required for 
subsequent hydrogel generation, and to determine the degree of substitution with thiol 
groups (“thiolation grade”, “TG”), a modified Ellman’s test was applied (See 4.1.2).192,193 
HA of varying sizes (Mn = 10 kDa; 60 kDa; 100 kDa) was reacted with DTPH for different 
times followed by sample analysis using Ellman’s test (Figure 21). 
 
Figure 21: Degree of substitutions with thiol groups using DTPH for hyaluronan of varying sizes and for different 
reaction times. The values of 120 kDa were taken from Shu et al. for comparison102. The results show a tendency for a 
slower reaction speed for hyaluronan with a smaller size. Average thiolation grades were determined by at least three 
individual Ellman’s tests each with the standard deviation as error bars. 
The results clearly showed that generating different thiolation grades was achieved by a 
modulation of the reaction times of the peptide coupling between HA and DTPH. This 
enabled creating hydrogels with different degrees of crosslinking by these variable 
amounts of thiol groups. Furthermore, at Mn = 100 kDa, a gelation of the reaction solution 
during the peptide coupling was observed over the course of the modification. This was 
attributed to the both hydrazide groups of DTPH reacting with different hyaluronan chains 
forming crosslinks. This effect has been described before by Shu et al.102 and was also 
observed with the DTPH modification of the Mn = 60 kDa, although less pronounced with 
viscosity only increasing partially. This was also the explanation for comparatively lower 
TG of Mn = 100 kDa at t = 120 min. One the one hand maintaining the pH at 4.75 in the 
viscous solution was not possible, leading to lower reaction velocities and the movement 
of HA was potentially also slowed down within the network. As a result, no experiments 
with the thiolation of larger size HA were conducted in order to retain maximum level of 
control of the reaction parameters. Instead hyaluronan of Mn = 10-100 kDa was evaluated 
further for creating hydrogels. 
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The results further indicated a possible dependency thiolation grades on the sizes of 
hyaluronan used, with a lower thiolation grade of smaller HA after the same reaction time 
than fractions of larger size. This was not fully explained (See Section 3.1.1) and further 
research (HA of bigger sizes (Mn > 100 kDa), different reactions) needs to be conducted 
for fully exploring this mechanism. Nonetheless, the results show clearly, that modifying 
hyaluronan chains of variable lengths with thiol groups was possible and hydrogels formed 
for almost all examined HS-HA fractions, excluding Mn = 10 kDa (See Section 2.3.1). 
 
2.1.3.   Combination of thiolation and fluorescent labeling of hyaluronan 
In the previous sections it was shown that fluorescent labeling (Section 2.1.1) and 
modification of HA with thiol groups (Section 2.1.2) was achieved individually. In order to 
create fluorescent hydrogels for an improved visibility, a simultaneous modification of HA 
with FA and thiols was required. To that end, a reaction sequence was established that 
allowed for a reproducible addition of both molecules (Figure 22). This sequence was set 
up that way for preparing HA with reproducible thiolation grades. It was shown, that some 
properties (elasticity, swelling behavior etc.) of hydrogels were dependent on crosslinking 
density176. In turn, this crosslinking density was dependent on the amount of anchor groups 
available for crosslinking, in this case the thiol groups. Therefore it was important to also 
create HS-FA-HA in a way for ensuring reproducible thiolation grades. The fluorescent 
labels, at least in the scope of this thesis, were only added for general visualization of the 
hyaluronan and not required for crosslinking or quantitative measurements. As a result a 
reproducible modification of HA with FA was not as important in the context of this 
project. Therefore, the reaction sequence for HS-FA-HA was established with a goal of 
ensuring maximum reproducibility of the thiolation grade. 
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Figure 22: Overview of the combined modification of hyaluronan with a fluorescent dye and thiol groups. First 
hyaluronan was reacted with DTPH followed by a binding of fluoresceinamine to get fluorescent DTPH-HA. In a last 
step the disulfide bonds were cleaved to yield HS-FA-HA. This sequence was established to get a maximum 
reproducibility for the thiol group addition. 
The first consideration concerning establishing reaction sequence was the order in which 
FA and DTPH should be connected to the hyaluronan (Figure 23). Both modifications 
targeted the carboxyl groups of the HA disaccharide units. Consequentially, after the first 
reaction step, the amount of available reaction partners for the second modification is 
decreased, resulting in a lower degree of substitution (Figure 23). 
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Figure 23: Overview of the two possible reaction paths to generate HS-FA-HA involving either (a) the modification first 
with DTPH followed by FA or (b) the addition of FA as a first and the reaction with DTPH as a second step. Depending 
on the sequence, the grade of modification of (a) FA would be influenced by DTPH or (b) DTPH would depend on the 
amount of FA bound to HA. Since the degree of substitution for the thiol groups was more important for the hydrogel 
properties, option (a) was selected. 
Modifying HA with DTPH as a first reaction has an impact on the degree of substitution 
with FA (Figure 23a) conducted in a second step and vice versa. As mentioned before, the 
degree of substitution with thiol groups was the defining parameter for crosslink density.101 
For that reasons the reaction pathway involving DTPH binding in the first step followed by 
the fluorescent labeling reaction (Figure 23a) was selected. 
The other consideration determining the sequence of reaction steps shown in Figure 22 
was, whether the DTT disulfide reaction would be performed before (Figure 24a) or after 
(Figure 24b) the fluorescent labeling with FA.  
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Figure 24: Overview of the possible reaction pathways involving disulfide reduction to thiols by DTT and fluorescent 
labeling with either the disulfide reaction (a) or the labeling (b) as a first step. Since thiols are vulnerable to a re-
oxidation, and would re-form disulfides during the reaction between HA and FA, the disulfide reduction was conducted 
as the last step.  
Under basic conditions and in the presence of oxygen, thiols start re-oxidizing disulfide 
formation, which would result in changes of thiolation grades and the formation of 
crosslinks between HA chains.102 Therefore, if the disulfide reduction was performed 
before the binding of FA (Figure 24a), which was done in a neutral to basic medium (see 
4.1.3), a prevention of the re-oxidation of the resulting thiols would require working under 
oxygen exclusion. This would have necessitated more elaborate experimental setups. 
Hence, disulfide reduction with DTT (Figure 24b) was performed as last step following the 
modification of the HA with FA. 
These considerations resulted in the combined reaction sequence shown in Figure 22. It 
required more purification steps in between the individual reactions (see Section 4.1.4), as 
opposed to a modification with only thiols.137 But it also ensured reproducible thiolation 
grades and was therefore choses for the production of fluorescently labeled HS-HA (HS-
FA-HA). This allowed for the creation of fluorescent hydrogels for analytical purposes 
(Section 2.3.1). 
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These results confirmed, that the chosen reaction pathway was suitable for preparing HS-
FA-HA which thiol groups required to generate hydrogels fluorescence properties 
necessary for more elaborate analytical experiments. Simultaneously modifying HA with 
both groups also did not influence the thiolation grade. This was confirmed by creating 
HS-HA and HS-FA-HA from the same fraction of DTPH modified hyaluronan for 
different reaction times and analysis by Ellman’s test (Figure 25; see Section 4.1.4 for 
further details). 
 
Figure 25: Comparison of the thiolation grades of HS-HA and HS-FA-HA (Mn = 60 kDa) from the same fraction of 
DTPH modified hyaluronan for different reaction times. Average thiolation grades were gained from at least three 
individual Ellman’s tests each with standard deviations as error bars. 
The data showed that, apart from random errors during synthesis and purification of the 
individual HS-HA and HS-FA-HA fractions, covalently binding fluoresceinamine in 
addition to modifying HA with thiols using the developed reaction sequence (Figure 22) 
had no significant influence on thiolation grades. Therefore it was used for all further 
preparations of HS-FA-HA. 
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2.1.4. Summary and conclusion 
In this section the different methods used to synthesize starting materials for creating 
hyaluronan hydrogels with or without fluorescent properties were presented. For 
fluorescent labeling, fluoresceinamine was linked to hyaluronan via an EDC mediated 
peptide-coupling reaction (See Section 2.1.1). FA was chosen for this because of its non-
toxicity, which decreased potential hazards during the handling process and may be 
important for future cell experiments. The resulting degrees of substitution with the 
fluorescent dye were kept low (0.6%-1.2% (n/n)) because of the selected reaction 
parameters and low solubility of fluoresceinamine in aqueous solutions (See Section 
4.1.3). However, degrees of substitution were similar to the values gained by Ogamo et al., 
who proposed a method for reacting HA with FA involving a 3:1 mixture of hydrochloric 
acid and pyridine186. In the reaction pathway developed in this thesis no organic solvent 
was used, which reduced the number of potential issues for safety and waste disposal in 
potential mass fabrication. Later measurements involving fluorescent hyaluronan showed 
the amounts of fluorescent dye bound to HA to be sufficient for generating detecable 
signals. 
For creating anchor groups necessary for establishing crosslinks between HA chains 
resulting in hydrogel formation, a method developed by Shu et al.101 was successfully 
adapted. This method involved EDC-mediated peptide coupling between hydrazide 
functions of DTPH and carboxyl groups of HA. By varying the reaction times, different 
thiolation grades were achieved and reaction kinetics for the thiolation were size dependent 
with lower size HA reacting more slowly with DTPH. 
Furthermore, both reactions were combined to generate HA with both FA and thiol 
modifications (Section 2.1.3). The reaction sequence was chosen to ensure reproducible 
degrees of modification with thiols, which influenced both crosslinking densities and 
hydrogel properties.176 The reproducibility of the degree of substitution with FA was 
neglected because the dye produced the necessary signals for detection. Furthermore, 
fluorescent labeling was only used for qualitative measurements in this thesis (See 
Sections 2.2, 2.3.2 and 2.5.1) and a reproducible degree of substitution was therefore not 
necessary. Also FA modification via the reaction sequence presented in this section (Figure 
22) did not noticeably influence thiolation grades (Figure 25). 
The methods established in this chapter were applicable to generate the required starting 
materials for the subsequent generation and immobilization of (fluorescent) hydrogels 
(Section2.3). Moreover, these methods were also utilizable for potential mass fabrication 
of glaucoma stents since they required mostly inexpensive and non-toxic materials as well 
as no harmful organic solvents. This would significantly lower hazard safety and waste 
disposal requirements. For these advantages, these methods were used in the following 
chapters to covalently immobilize hyaluronan and HA hydrogels to model implants and 
analyze their properties. 
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 Immobilization of hyaluronan to glass and titanium surfaces 2.2.
2.2.1. Development of a silanization protocol 
In order to reliably perform as a possible treatment for the glaucoma disease, it was 
required of the potential glaucoma stents to enable a regulation of intraocular pressure for 
long periods of time.19 Therefore it had to be ensured, that the performance of intraocular 
implants would not deteriorate over time. One aspect contributing to a potential long-term 
stability was, that hydrogel parts of these implants would consistently remain in place. For 
that reason, it was necessary to permanently immobilize hydrogels to implant surfaces. As 
outlined in Section 1.6 reacting HS-HA to surface-bound epoxide groups was selected to 
achieve immobilization. The epoxides themselves were bound to surfaces via silanization 
with (3-Glycidyloxypropyl)trimethoxy-silane (GPS) (Figure 26).  
 
Figure 26: Chemical structure of Glycidyloxypropyl)trimethoxy-silane. 
The use of silanes for grafting reactive groups to solid surfaces was applicable to both 
glass177 and titanium166 since both materials shared a similar surface chemistry.140,177 Glass 
samples were used as model surfaces in addition to titanium for their transparency, which 
enabled a microscopic analysis of further stent parameters (See also Sections 2.2.3, 2.3.2 
and 2.5.1) by using HS-FA-HA.  
For cleaning and activation of the surfaces, the commercially available “Extran® MA01” 
(Extran) was used, an alkaline solution containing washing detergents. Immersion in a 
basic solution was sufficient to hydroxylate the surface of titanium194 and with Extran this 
step was combined with additional cleaning. The detergent solution also had the advantage 
of being cheap and non-hazardous, both benficial for a potential industrial application. 
Other methods, like the exposure of the surfaces to H2SO4/H2O2 (3:1 v/v) (Caro’s 
solution)195, plasma treatment170 or plasma treatment followed by immersion in nitric acid 
and H2O173 were also considered. However, they were not further followed up for several 
reasons: Treating glass tubes with Caro’s solution was attempted but resulted in small 
bubbles forming on their interiors, which resulted in a non-reproducible inner surface 
activation. This could have been circumvented by using a syringe pump to remove 
bubbles. However, due to the dangerous nature of Caro’s solution196 this path was not 
further pursued. Especially in an industrial environment this would not have been feasible, 
where extra safety precautions might have meant a considerable increase in production 
costs.  
The use of a plasma machine brought up similar problems: The plasma was generated 
locally at the top of the machine and reactive species spread out from there into the plasma 
chamber (Figure 27). For the glass tubes, with the interiors being partially shielded from 
the plasma, it also was not guaranteed, that the activation on the inside would be uniform 
and reproducible. Additionally, maintaining a plasma machine was potentially more 
expensive than simply using an alkaline solvent.  
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Taking all this into account a basic solution was used for the surface activation,194 since it 
guaranteed an equal concentration of active species all over the tube’s surfaces while 
minimizing potential hazards.  
 
 
Figure 27: Simplified sketch of the plasma activation of small tubes. The plasma was generated locally at the top of the 
machine. The tube’s inside was partially shielded from the reactive species possibly resulting in a non-uniform and non-
reproducible surface activation. 
 
For the silanization process itself, a method involving the immersion in a silane/toluene 
solution was selected. It was shown, that forming monolayers of GPS on silicon substrates 
was possible197 and therefore this method was adapted for the use on titanium and the 
model glass surfaces. In order to verify the applicability of this method flat titanium and 
glass slides were modified with different silanes and the surface energies of these samples 
determined via contact angle measurements198. Besides GPS a hydrophobic silane in the 
form of 1H,1H,2H,2H-Perfluoro-trichlorosilane (PFS) (Figure 28a) and a hydrophilic 
silane ((3-Aminopropyl)triethoxysilane (APTES) (Figure 28b) were used for comparison.  
 
Figure 28: Chemical structures of PFS (a) and APTES (b). 
The application of these silanes would result in surfaces with different energies due to the 
different active groups. Especially PFS was known to result in very hydrophobic 
surfaces199 and was expected to show the biggest changes in surface energies compared to 
APTES and GPS. The liquids used for contact angle measurements were ddH2O, 
ethyleneglycol and mixtures of MilliQ and ethyleneglycol, which covered a liquid/vapor 
tension range of 49.15 mN/m (100% ethyleneglycol) to 72.58 mN/m (100% MilliQ).200 
The energies were calculated based on the young’s equation using an equation of state 
approach according to Balkenende.198  
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The relation between the contact angle of a liquid and the surface energies was given by 
the formula 
cos𝜃 =   −1+ 2 𝛾!"𝛾!" 𝑒!!,!!!"#$%(!!"!!!")	   Equation 2:1 
with Θ being the contact angle, γSV the surface-vapor energy and γLV the liquid-vapor 
energy. The formula was simplified by excluding the exponential part since it would be 
almost equal to one. It was aimed for only a qualitative comparison between the differently 
modified surfaces instead of an accurate determination of their energies. Therefore this 
decrease of accuracy by this simplification was acceptable on this context and allowed for 
a linear fit, which was more easily performed with a lower amount of data-points 
compared to an exponential fit. In turn this reduced the time required to gather enough data 
for a reasonable surface energy determination. 
The results of these contact angle measurements (Figure 29) showed a distinctive variation 
of the surface energies for glass and titanium substrates, depending on the silanes.  
 
Figure 29: Surface energies of flat glass (a) and titanium (b) samples modified with different silanes using surface 
activation by Extran and silanization in a silane/toluene solution. The surface energy of the non-silanized glass sample 
was not determined since contact angles were too low for all tested solutions to be recorded. Average contact angles were 
calculated from ten drops with errors obtained from the variance of the linear fits and the standard deviations of the 
average contact angles. 
For both materials the surface energies of samples modified with GPS and APTES were 
similar to each other. Modifications with PFS however caused a significant difference of 
the energy compared to the other silanes. This confirms the applicability of the developed 
protocol using Extran® MA01 for activation followed by immersing samples in 
silane/toluene solutions. In subsequent chapters the efficiency of the silanization was 
further confirmed by covalently immobilizing hyaluronan (Sections 2.2.2 and 2.2.3) and 
HA hydrogels (Section 2.3.2) to silanized surfaces. 
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2.2.2. Immobilization of hyaluronan to flat glass and titanium surfaces 
In Section 2.2.1 a method to graft epoxide groups to titanium and glass surfaces was 
established. It was also shown before, that reacting epoxides to the primary alcohols of 
saccharides in solution was possible103 and GPS was already successfully used to 
immobilize dextran to surfaces201. Due to these findings, immobilizing hyaluronan to 
epoxide-modified surfaces should be feasible. However the concept had to be verified 
experimentally. Furthermore, it was necessary to see, whether the hyaluronan would 
adhere to the surfaces due to an unspecific absorption, which would not be stable in the 
long term, or covalently link to the silanes. To that end, small glass and titanium sheets 
were silanized partially using a custom-made reaction chamber (Figure 30). The chamber 
was fastened on top of the sample in the holder covering it partially. By filling it with 
silane/toluene solutions only a small part in the middle of the substrate’s surface was 
exposed to GPS. Afterwards the samples were immersed in a HS-FA-HA solution and 
incubated in the presence of oxygen. 
 
Figure 30: Schematic drawing of the custom-made chamber for partially modifying surfaces of flat glass and titanium 
slides with silanes. The liquid container covered only part of the samples and exposed only that part to silane solutions.  
 
Fluorescently labeled HA was used for detecting a successful immobilization, either 
visually or by fluorescence microscopy. HS-FA-HA was used instead of FA-HA to allow 
for a partial re-oxidation of thiols to disulfides resulting in a gel formation. This also 
resulted in an increased number of HA molecules bound to the surface, amplifying the 
signals due to the presence of a higher number of fluorophores (Figure 31a/b). Careful 
rinsing in water removed the gel layer from the samples except for the silanized parts 
(Figure 31c/d). After drying the samples they were also analyzed by fluorescence 
microscopy, which further verified a strong presence of hyaluronan in the previously 
silanized area of the sample (Figure 31e/f). 
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Figure 31: Results of immersing partially silanized glass and titanium slides in HS-FA-HA solutions. A layer of HA gel 
formed on the titanium (a) and glass (b) samples due to disulfide formation. After rinsing in water HS-FA-HA only 
remained on silanized parts of titanium (c) and glass (d). This was further visualized by fluorescence microscopy (λex = 
470 nm , λem = 525 nm) on titanium (e) and glass surfaces (f). 
 
These results on the one hand further verified, in addition to the surface energy 
measurements (Section 2.2.1), that silanization using Extran fur the surface activation and 
silane solutions in toluene were applicable to graft GPS to glass and titanium surfaces. 
Since the improved attachment of HA to silanized parts compared to blank surfaces 
illustrated the strength of the covalent links and verified the applicability of the established 
method. 
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2.2.3. Selective Immobilization of hyaluronan to small glass tubes 
In section 2.2.2 the selective and covalent immobilization of hyaluronan to flat glass and 
titanium surfaces modified with epoxide groups was established. However, the intraocular 
stents would be in the shape of small tubes (see Section 1.6). Therefore the next step was 
to check, whether the methods presented in 2.2.1 and 2.2.2 were applicable as well to 
tubes. Furthermore, it was necessary to modify the outer and inner surfaces of the stents 
individually with HA hydrogels possessing potentially different properties in respect to cell 
adhesion (see Section 1.6). For that, immobilizing hyaluronan selectively to the outer or 
inner surfaces of the small tubes had to be developed.  
Small glass tubes (L = 10 mm, ID = 0,5 mm, OD = 1 mm) were manufactured by the glass 
workshop of the Max Planck Institute as models for the intraocular stents. They were used 
instead of titanium tubes most of the time since the later were non-transparent. Therefore 
immobilizing HA successfully to the inner surfaces of titanium would not have been 
possible. Since silanization and covalent HA immobilization was applicale for both 
materials (Section 2.2.2) glass was used as model substrates for most further experiments. 
Additionally FA-HA was used instead of HS-FA-HA, since properly removing the 
resulting gels on the tubes’ interiors was not guaranteed. Instead FA-HA was used and 
weaker fluorescent signals detected by longer excitation times. Two different setups were 
designed for immobilizing hyaluronan selectively only to outer or inner surfaces of these 
glass tubes (Figure 32). 
 
Figure 32: (a): Picture of the small glass tubes (L = 10 mm, ID = 0,5 mm, OD = 1 mm) that were used for the directed 
immobilization of hyaluronan and most other experiments in this thesis. (b): Experimental setup for the immobilization 
of hyaluronan to either the inner (i) or outer (ii) surfaces of these small glass tubes. 
For modifying the tubes’ inner surfaces with fluorescent hyaluronan, silanized samples 
were connected to each other in series using small pieces of elastic QCMD tubing (Figure 
32b, i). A FA-HA solution was then injected into the setup bringing only the interiors of 
the samples into contact with the fluorescently labeled hyaluronan.  
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For grafting FA-HA to outer surfaces, the entrances of the tubes were sealed using elastic 
polymer resistant to the infiltration of watery solutions (Figure 32b, ii). By fully immersing 
silanized glass tubes in a FA-HA solution exposed only their outsides while the polymer 
shielded the inner parts. After immobilization was finished, this polymer was easily 
removed, which potentially allowed for further modifying the insides. 
After extensive washing samples they were examined using fluorescence microscopy. It 
was necessary to distinguish between possible fluorescence signals originating from HA 
covalently linked to the surfaces or from an unspecific adsorption. To that end tubes 
modified with GPS and non-silanized samples were incubated side-by-side in an FA-HA 
solution and subjected to the same washing protocols (See Section 4.2.4) before analyzing 
them by fluorescence microscopy (Figure 33). 
 
Figure 33: Brightfield (a + c) and fluorescence (b + d) (λex = 470 nm , λem = 525 nm) microscopy images of silanized 
(GPS) and non-silanized glass tubes, that were selectively exposed to FA-HA on their inner (a + b) and outer (c + d) 
surfaces. Both silanized and non-silanized tubes are visible in brightfield images (a + c) but fluorescence signals were 
only detected from the silanized samples (b + d).  
The images showed a clear difference of fluorescent signals between silanized and non-
silanized samples. GPS modified glass tubes were visible under fluorescence while 
unmodified ones did not show significant signals. These results verified that the 
hyaluronan was bound selectively and covalently to surfaces carrying epoxides. They 
further ruled out unspecific adsorption since non-silanized samples did not show any 
fluorescent signal. It was concluded, that the silanization and immobilization protocols 
developed in Sections 2.2.1 and 2.1.2 were applicable also to the model implants. 
Furthermoren individual modification of the inner (Figure 33b) or outer (Figure 33d) 
surfaces of the tubes with these methods could be demonstrated. These setups were later 
also used to selectively immobilize HA hydrogels on the inner and outer surfaces of glass 
and Ti tubes (Section 2.3.2). 
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2.2.4. Summary and Conclusion 
In this section the concept proposed in Section 1.6 for immobilizing hyaluronan to glass 
and titanium surfaces was successfully established. The polysaccharides were covalently 
and selectively immobilized by modifiying the target surfaces with silanes bearing epoxide 
groups (Section 2.2.1), followed exposing them to hyaluronic acid solutions (Section 
2.2.2). Surface activation and silanization were performed in liquid environments because 
the alternatives proved to be disadvantageous when compared. By using fluorescently 
labeled hyaluronan, the applicability of the immobilization to glass and titanium surfaces 
was confirmed (Section 2.1.1).  
The method was developed further for selectively immobilizing hyaluronan to glass tubes 
(Section 2.2.3). To that end two simple methods were established to specifically target 
only their outer or inner surfaces. Fluorescent hyaluronan was successfully immobilized on 
these parts of the silanized samples individually (Figure 33). Also, by comparing silanized 
and non-silanized tubes immersed in FA-HA a specific and covalent immobilization could 
be verified (Figure 33). 
These collected results show the feasability of the methods proposed in Section 1.6 for 
covalently and selectively immobilizing HA to glass and titanium surfaces. While the 
individual concepts, reacting hyaluronan with epoxides in solution103 and immobilizing 
similar molecules on solid surfaces using GPS201, were already known, a combination of 
both was not done before for this system. This concept promises long-term stability for the 
intraocular implants, which was necessary for a successful therapy, by covalently attaching 
potential hydrogels. Furthermore, in terms of an industrial application, the method could be 
applied easily to a higher number of samples enabling a high-throughput modification of 
intraocular implants using non-expensive and mostly non-toxic materials. At this point of 
the thesis no information was available for the relative strength of the immobilization, but 
measurements on gel-modified tubes were performed to gain further insights into this issue 
(Section 2.4.2). 
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 Formation and immobilization of hyaluronan hydrogels 2.3.
2.3.1. Synthesis of acrylamide-crosslinked hydrogels 
As outlined in Section 1.1, developing a new implant for glaucoma therapy enhanced by 
hydrogels made from hyaluronic acid was the aim for this thesis. To that end, methods for 
modifying hyaluronan with thiol (Section 2.1.2) and fluorescent (Section 2.1.1) groups 
were already established and a combination of both processes successfully implemented 
(Section 2.1.3). Furthermore, immobilizing fluorescent hyaluronan to flat glass and 
titanium surfaces (Section 2.2.2) and small glass tubes acting as model implants (Section 
2.2.3) was demonstrated. Forming (fluorescent) hydrogels from HS-(FA)-HA and enabling 
a selective immobilization to the outer and inner surfaces of glass and titanium tubes was 
the next step, discussed in this section. 
As outlined in Section 1.6 the method published by Shu et al.101, utilizing a base-catalyzed 
Thiol-Michael reaction175,202 (Figure 34), was adapted and modified for the hydrogel 
creation. The crosslinkers Shu used carried multiple acrylamide groups that were able to 
react with the thiols of HS-FA-HA, thus establishing crosslinks between the 
polysaccharides. 
 
Figure 34: Concept for crosslinking HA hydrogels by a Thiol-Michael reaction between the SH groups of hyaluronan 
and acrylic groups of multifunctional crosslinkers. 
Several parameters were considered and adapted for developing the synthesis protocol: 
Solvent properties: 
Shu et al. created their hydrogels by first dissolving HS-HA in a Phosphate Buffered Saline 
(PBS) solution followed by a manual adjustment of the pH to 7.4. 101 Hagel et al. similarly 
formed their hydrogels by adjusting the pH to 9.0 and incubating HS-HA/crosslinker 
solutions over night.176 This manual adjustment posed a problem for transferring these 
methods to the creation of hydrogel-enhanced implants. Only small amounts of HA (3-15 
mg) in small volumes of solvent (100-1000 µL) were usually prepared in this thesis, since 
the tubes are small, and no modified HA was to be wasted. Since no micro pH electrodes 
for measuring such small volumes were available at that time it was difficult to manually 
adjust the pH after dissolving HS-HA. However without these manual adjustments of the 
pH this step led to an acidification of the solution (Figure 83). 
To cope with this problem, the reaction parameters used by Hagel et al.176 were adapted by 
including a buffer of Tris(hydroxymethyl)aminomethane (TRIS) in Balanced Saline 
Solution (BSS) at a pH of 8.5 to 9.0: BSS was used instead of water because it is 
commonly used in medicine for eye irrigation, mimicking the ion concentrations of the 
intraocular fluid.203  
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As a result gels were synthesized in an environment similar to the physical environments. 
In addition gel formation was conducted in oxygen-depleted solvents to prevent re-
oxidation of thiols to disulfides due to the basic environment102,176.  
 
Crosslinker: 
Two commonly used model crosslinkers were considered for generating the hydrogels. 
Poly(ethylene glycol) diacrylamide (PEGDAA), which was already employed by the Shu 
et al. group and had a rather long chain-length.101 N,N’-Ethylenebis(acrylamide) (MBAA) 
was selected as a short crosslinker with a size similar to the desmosine inspired 
acrylamides developed by Hagel et al.176 (Figure 35).  
 
 
Figure 35: Chemical structures of the N,N’-Ethylenebis(acrylamide) (a) and Poly(ethylene glycol) diacrylamide (b) 
crosslinkers which were used for initial studies on the formation of HA hydrogels.  
 
Acrylamides were selected over potential acrylate derivates due to a better long-term 
stability of the hydrogels. Shu et al. reported, that stability of hydrogels formed with 
Poly(ethylene glyol)diacrylate (PEGDA) and PEGDAA was similar101. Hagl et al. 
however, reported a decomposition of the hydrogels with their desmosine-inspired 
crosslinkers when acrylates where used for preparing their hydrogels.176 Since they had to 
perform in a long-term function as part of glaucoma implants it was expected of them to be 
stable over longer periods of time. Since acrylamides reportedly showed a better 
performance in that respect MBAA and PEGDAA were therefore selected as crosslinkers. 
 
Hyaluronan size: 
As mentioned in Section 2.1.2, the modification of HA with thiols was performed on three 
different sizes (Mn = 10 kDa, 60 kDa and 100 kDa). Consequently they were also used to 
generate hydrogels and further choices narrowed down depending on the results.  
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Small molds (diameter = 10 mm, depth = 5 mm,) were manufactured for synthesizing 
hydrogels using a 3D printer. In a first experiment, the performances of MBAA and 
PEGDAA for gel formation were tested with Mn = 60 kDa HS-HA. Both crosslinkers 
readily formed hydrogels, albeit with vastly different gelation times. Solutions of HS-HA 
and MBAA remained in a liquid state for >30 min and solid gels were retrieved after 24 h 
of incubation time at 37° C (Figure 36c). Using PEGDAA on the other hand induced a 
gelation process very quickly, with an increase in viscosity after less than one minute and 
solid gels after less than five minutes (Figure 36d), which was also reported by Shu101. The 
gel formation was extended to ten minutes by cooling down both HS-HA and crosslinker 
solutions to 0° C prior to mixing. The modification of model implants with hydrogels 
sometimes necessitated a prolonged handling of HS-HA/crosslinker mixtures before 
gelation occurred (see Sections 2.3.2 and 4.3.2). Since MBAA gelation times as PEGDAA 
it was selected as model crosslinker for further experiments. 
 
Figure 36: Images of hydrogels (V = 250 µL; Mn(HA)= 60 kDa; β(ΗΑ) = 15 mg/ml; TG = 0.18; hydrogels formed in 
TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) prepared with MBAA (a) after 24 hours incubation at 37°C and PEGDAA 
(b) after five minutes at room temperature. 
 
When hydrogel synthesis was performed with MBAA and different sizes of hyaluronan it 
turned out, that not all three of the available HS-HA sizes were utilizable for the hydrogel 
creation: While at Mn = 60 kDa and 100 kDa, HS-HA/MBAA mixtures readily formed 
gels (Figure 37), no gel formation was observed when using Mn = 10 kDa HS-HA. 
Therefore, further experiments were performed with the other two size fractions. 
 
Figure 37: Images of HS-HA/MBAA mixtures (V = 500 µl; β(HA) = 15 mg/ml; TG = 0.57, dissolved in TRIS/BSS 
(c(TRIS) = 0.4 mol/l; pH = 8.5)) after 24 hours incubation at 37° C with sizes of Mn = 100 kDa (a), Mn = 60 kDa (b) and 
Mn = 10 kDa (c). 100 kDa and 60 kDa mixtures formed hydrogels while 10 kDa remained a liquid mixture. 
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Also, by mixing HS-FA-HA with MBAA hydrogels with fluorescent properties were 
obtained (Figure 38). These gels had an inherent yellow-orange color (Figure 38a) and 
showed a visible fluorescence (Figure 38b). It illustrated, that the concept of labeling the 
hyaluronan with FA to yield hydrogels with fluorescent properties was successful and 
didn´t interfere with gelation. Fluorescent hydrogels were useful for the examination of 
their covalent immobilization to the surfaces of model implants (Section 2.3.2) and the 
investigation of their ability to regulate external pressures (Section 2.5.1). 
 
Figure 38: (a) Hydrogel (V = 500 ml; Mn(HA)= 60 kDa; β(ΗΑ) = 15 mg/ml; TG = 0.18; hydrogels formed in TRIS/BSS 
(c(TRIS) = 0.4 mol/l; pH = 8.5)) using MBAA and fluorescently labeled hyaluronan. (b) The same hydrogel under UV 
illumination, showing its fluorescent properties. 
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2.3.2. Immobilizing hyaluronan hydrogels to epoxide modified surfaces 
For achieving long-term performance of the intraocular implants it was necessary to 
immobilize the hydrogels to their surfaces, preventing their removal if exposed to an 
external force such as the elevated intraocular pressure. To that end, a concept of 
covalently linking HS-HA to surface-bound epoxides was proposed (Section 1.6). The 
general applicability of this concept was already verified for non-crosslinked hyaluronan 
(Section 2.2). Also generating hyaluronan hydrogels without immobilization was 
established by mixing HS-HA with suitable crosslinkers carrying multiple acrylamide 
groups (Section 2.3.1). As a next step, both methods were combined for simultaneously 
forming and immobilizing HA hydrogels to solid surfaces. This combination was tested 
first on a macroscopic scale by creating immobilized hydrogels on silanized flat glass and 
titanium slides. For this, the same 3D-printed molds introduced in Section 2.3.1 were used. 
They were filled with a HS-HA/MBAA mixture, the top of the wells were sealed with a 
silanized or non-silanized substrate and finally turned upside down (Figure 39). That way 
HS-HA/MBAA solutions were in contact with silanized titanium or glass surfaces to 
enable simultaneous crosslinking and immobilization. HS-HA/MBAA mixtures contact 
with silanized slides formed gels adhering to their surfaces and even exposing them to 
small external forces did not remove the gels (Figure 39b-c). For non-silanized surfaces, 
hydrogels either remained within the wells where they were formed after removing the 
slides or were displaced easily by the exposure to small external forces. This demonstrated 
that the proposed concept for the one-step gel formation and immobilization to the 
silanized surfaces (See Section 1.6) was successful.  
 
Figure 39: (a): Setup used for the one-step formation and immobilization of hyaluronan hydrogels (Mn(HA)= 100 kDa; 
β(HA)= 15 mg/ml; TG = 0.57; hydrogels formed in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) to flat titanium and glass 
surfaces. Hydrogels immobilized on flat glass (b) and titanium (c) surfaces using this method resisted a removal by the 
application of small gravitational forces. 
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In the next step, transferring this concept to small glass tubes was demonstrated. The setup 
that was already utilized for non-crosslinked hyaluronan was used (Section 2.2.3, Figure 
32) for selectively immobilizing HA gels instead. For better visualizing these hydrogels 
HS-FA-HA was deployed to allow fluorescence microscopy (Figure 38). Similar to the 
immobilization of hyaluronan without crosslinking (Section 2.2), glass tubes were 
employed first instead of titanium for better visualizing them using bright-field and 
fluorescence microscopy (Figure 40). 
 
Figure 40: Brightfield and fluorescence images of silanized tubes modified with FA labeled HA hydrogels (Mn(HA)= 60 
kDa; β(HA)= 15 mg/ml; TG = 0.18; hydrogels formed in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) on their outer 
surface ((a): Brightfield (b): Fluorescence) and interiors ((c): Brightfield (d): Fluorescence). 
 
The pictures of the sample modified on the outer surface (Figure 40a-b) showed a layer of 
fluorescent hydrogel, which remained there even after exposure to small external forces 
(See Section 2.4.2). The same experiment with non-silanized tubes resulted in either no 
hydrogels adhering to their surface after removal from the incubationary solution or a 
quick detachment when applying external forces. The thickness of the layer on the outer 
surface varied because  tubes were manually removed from a much larger hydrogel (see 
Section 4.2.4) causing an uneven breaking of the parts remaining on the surfaces.  
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The results further showed (Figure 40c-d), that filling the interiors of small tubes with 
hydrogels was possible. Covalent immobilization working as intended, since noticeable 
external forces were required for their removal (for further elaboration see Section 2.5.1). 
Hydrogels synthesized within non-silanized glass tubes instead were easily removed, 
which further illustrated the necessity and applicability of the covalent immobilization 
strategy proposed in Section 1.6. 
Since the intraocular stents would be made from titanium the same experiment was 
repeated with small titanium tubes as models (ID: 0.3 mm; OD: 0.5 mm; L: 10 mm; Figure 
44a). HS-FA-HA/MBAA hydrogels were grafted to the outer and inner surfaces with the 
same protocol already employed for glass samples. The successful one-step 
gelation/immobilization on the outside was confirmed using bright-field and fluorescence 
microscopy (Figure 41b-c). 
 
Figure 41: (a): Picture of titanium tubes used for the gel immobilization (Mn(HA)= 60 kDa; β(HA)= 15 mg/ml; TG = 
0.18; hydrogels formed in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) experiments. (b-c): Brightfield (b) and 
fluorescence (c) images of a titanium tube (L = 10 mm; ID = 0.3 mm) with a fluorescent hydrogel immobilized on its 
outer surface. 
The hydrogels shown in Figure 41 resisted detachment from the surfaces by small forces, 
as opposed to non-silanized tubes. Those results were in accordance with the experiments 
conducted on flat titanium surfaces (Figure 39) and the small glass tubes (Figure 41). 
Monitoring hydrogel immobilization titanium tubes’ interiors by microscopy was not 
possible at that point due to their non-transparency.  
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However, an indirect method devised to measure the resistance of the hydrogels to external 
pressures (Section 2.4.2) was used for verifying the existence of stable hydrogels there as 
well (Figure 51). The results shown in this section were a final proof that the concept 
devised in Section 1.6 was, at least on the outer surfaces, applicable for generating 
intraocular titanium stents modified with hyaluronan hydrogels. 
2.3.3. Summary and conclusion 
In this section the synthesis of hyaluronan hydrogels (Section 2.3.1) and their subsequent 
immobilization to flat glass and titanium surfaces (Section 2.2.2) as well as small tubes 
(Section 2.3.2) was established. MBAA and PEGDAA were selected as model crosslinkers 
since they promised to form hydrogels with long-term stability opposed to acrylatesMBAA 
was used further since the relatively longer gelation time of HS-HA/MBAA opposed to 
HS-HA/PEGDAA mixtures allowed for easier handling when modifying glass tubes. 
Furthermore, three sizes (Mn = 10 kDa; 60 kDa; 100 kDa) of HS-HA were investigated for 
the formation of hydrogel. Only 60 kDa and 100 kDa HS-HA formed hydrogels (Figure 
37) and were used for further experiments. In addition fluorescent hydrogels were prepared 
by using mixtures of HS-FA-HA and MBAA (Figure 38). They were subsequently used 
for better visualizing covalent hydrogel immobilization on a small scale (Section 2.3.2, 
Section 2.5.1). 
One-step hydrogel formation and immobilization was successfully demonstrated on flat 
glass and titanium surfaces (Figure 39), as well as on outer and inners surfaces of small 
tubes (Figure 40, Figure 41). No statement at this point was made for the strength of the 
immobilization. Specifically, whether hydrogels would resist external forces, such as 
intraocular pressures, without removing themselves from the implants. This was further 
examined in Section 2.4.2. However, the results shown in this chapter were a proof of 
principle that the concept proposed originally (Section 1.6) for the one-step grafting of 
hydrogels from HS-HA to epoxide-modified surfaces can potentially be employed for 
manufacturing hydrogel-enhanced glaucoma implants. 
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 Development of analytical tools for determining the pressure 2.4.
resistance of hyaluronan hydrogel-modified tubes 
2.4.1. Constrained swelling of hydrogels in small tubes 
As already outlined hydrogels have the ability to take in water in a large excess to their 
own weight, which causes a swelling of the polymer network.108 The general mechanics of 
this swelling are already well established108 and data has already been published on the 
swelling behavior of hyaluronan hydrogels for different crosslinkers and crosslinking 
densities.101,176 The aim of the experiments presented in this section was to compare the 
swelling of hydrogels that were immobilized on the interior of small tubes (“constrained 
gels”) with non-immobilized (“unobstructed”) gels. This was necessary since a further 
evaluation of implants (pressure regulation etc.) or their application into a glaucomatous 
eye should be performed only when the gels’ properties would be stable. 
  
Since hydrogel swelling causes an expansion of volume108, it was expected that them 
forming within tubes would lead to a reduction of swelling capabilities compared to 
unobstructed samples. Furthermore, swelling of hydrogels was dependent on the 
composition of the surrounding medium due to an influence of osmotic forces on the 
process.109 In order to mimic the physical environment within the human eye the 
experiments were performed in BSS which is commonly used in eye surgery.203 For 
generating distinguishahle mass changes during swelling, larger glass tubes (L = 10 mm; 
ID = 5 mm; OD = 1 mm) were used generating constrained hydrogels. For minimizing the 
variance of samples they were prepared using the same HS-HA/MBAA mixture (Mn(HA)= 
100 kDa; β(HA) = 15 mg/ml; TG = 0.57). Each hydrogel was incubated separately in BSS 
with frequent buffer replacements and weights were measured on regular intervals with. 
For comparing swelling rates among gels with slightly varying starting masses, their 
relative gains were calculated from these starting values. The more common way of 
relating the swelling to masses of non-hydrated (= “dry”) hydrogels101 was not pursued 
because the ions from BSS would form crusts during lyophilization and create additional 
weight. The option of extensively washing hydrogels in ddH2O to remove ions from the 
hydrophilic networks101 was also not taken, since no data on the amount of washing for the 
HS-HA/MBAA systems were available necessitating additional optimizations. Also, 
preliminary experiments of incubating hydrogels in ddH2O showed a tendency of them to 
break into fragments causing further random errors by losses of mass. Instead relative mass 
gains were based on the starting weights of hydrogels before swelling to compare 
constrained with unobstructed samples. Also, since the HS-HA/MBAA hydrogels only 
acted as model systems, in-depth swelling experiments were not necessary until a 
crosslinker for manipulating cell adhesion would be selected. Only a theoretical relation on 
dry masses was established from calculations using the starting materials were used for 
comparing the data with literature (See Section 4.4.2 for further elaboration). However, as 
explained, they were only partially backed by experimental data since no real dry masses 
were reliably obtained. 
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The results of these comparative measurements between constrained and unobstructed 
hydrogels are summarized in Figure 42. 
 
Figure 42: Average relative mass gains (m/m0) for constrained and unobstructed hydrogels (Mn(HA)= 100 kDa; β(HA) = 
15 mg/ml; TG = 0.57 (n/n)). Hydrogels were formed in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5) with constrained 
samples immobilized on the inner surfaces of glass tubes (L = 10 mm; ID = 5 mm; OD = 1 mm). Averages taken from 
three individual samples with the standard deviations as error bars. (a): Mass gains relative to the pre-swollen starting 
masses after the hydrogels were formed. (b): Mass gains relative to the theoretical dry masses calculated from the 
amounts of starting materials. 
The results showed a number of differences between both types of hydrogels. 
Unobstructed samples had a more rapid initial mass gain than constrained ones before 
declining into a steady state lower than their own starting masses. This was explained by 
the presence of TRIS within the hydrophilic networks, which initially caused an increased 
osmotic force from the surrounding medium. Due to pore-size dependent diffusion through 
the hydrogel90, TRIS left the system over time decreasing the overall molecule 
concentration within the network.  
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This resulted in reducing osmotic forces on the hydrogel, which shrunk to a new steady 
state with a new balance of osmotic and retaining forces.109 This was verified by a 
comparative swelling experiment where hydrogels with the same parameters were formed 
and incubated either in BSS (pH = 7.4) or TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 7.4) 
(Figure 43). After 811 hours the gels incubated in TRIS/BSS were also placed BSS and 
further changes recorded. As a result their masses were reduced to the same amounts than 
the gels swollen in BSS from the beginning. Since the removal of TRIS was the only 
change made to the system, these results validated the originally proposed mechanism. 
 
Figure 43: Comparison between the swelling rates of hydrogels (Mn(HA) = 100 kDa; β(HA) = 15 mg/ml; TG = 0.57) 
relative to their starting masses either in BSS or TRIS/BSS (c(TRIS) = 0.4 mol/l). For the TRIS/BSS fraction the buffer 
was replaced by BSS at t = 811 hours causing a reduction of the relative mass similar to the BSS fraction. Four samples 
were incubated in each medium and the average calculated from all samples with the standard deviation as the error bars. 
The differences between swelling of unobstructed and constrained hydrogels (Figure 42) 
were related to covalent immobilization into glass tubes. The physical barriers of their 
walls blocked possible expansions while volume reduction was inhibited by the covalent 
bonds between hydrogels and glass surfaces. As a result the pore size of these samples, 
which is related to the amount of water in the network90, was smaller during the first 45-50 
hours where the unobstructed gels showed a higher mass gain. This reduced size of the 
pores in turn led to more limited diffusion90 of TRIS molecules within the constrained gels 
and slowed down their removal from the system. The physical barriers of the tubes’ walls 
further limited molecule exchange with the only hydrogel/medium interfaces located at the 
ends of the tubes. These effects combined were considered to be responsible for the higher 
swelling level of the hydrogels immobilized within the tubes compared to the unbound 
sample. Especially the covalent immobilization serves also for a possible explanation for 
the formation of channels in samples where a pressure-induced liquid flow was observed 
(further discussed in Section 2.5.1).  
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From the results of these comparative swelling experiments it was decided to incubate 
hydrogel-modified tubes at least 48 hours before conducting any further measurements 
since no significant changes in mass were observed from the data after this time. Long-
term swelling, might reveal further changes in the constrained hydrogels’ masses. But for 
further evaluations of these samples’ properties (pressure resistance etc., see the following 
sections) the selected incubation time was sufficient to ensure an optimal reproducibility. 
As already mentioned, the relative swelling rates depending on the dry masses (Figure 42) 
were not completely accurate due to being calculated from an estimated value, they were 
still comparable to previously published results. The final mass gain in steady state of the 
unobstructed gels was higher than the results gained from the groups of Shu et al.101 and 
Hagel et al.176, which was attributed to different parameters used (Table 1). 
 
Table 1: Comparison between synthesis parameters and measured swelling ratios of HA hydrogels used in this thesis and 
in literature. *CL/SH denotes the ratio of acrylic groups of crosslinkers and thiols of HA. **Two different swelling ratios 
were given for two desmosine-inspired crosslinkers one charged (first number) one uncharged (second number). 
***Average swelling value calculated from the last four datapoints taken from swelling experiments with unobstructed 
hydrogels (Figure 42). Error = standard deviation.  
	  
Mn(HA)	  
[kDa]	  
β(HA)	  
[mg/ml]	  
TG	  
(n/n)	   Crosslinker	   CL/SH*	   Swelling	  Ratio	  
Shu	  et	  al.101	   120	   10	   0.42	   PEGDAA	   1	   39.41	  
Hagel	  et	  al.176	   450	   28	   0.49	   Desmosine	  inspired	   1	   27/30**	  
Thesis	   100	   15	   0.57	   MBAA	   1	   43.7	  +/-­‐	  0.4***	  
 
As previously mentioned, the accuracy of the determined swelling ratio was not verified 
since the dry mass was only calculated theoretically. However, it was still comparable to 
the results published by Shu et al. and Hagel et al. and only support the findings from these 
groups. When a crosslinker for the generation of hydrogels capable of reliably 
manipulating cell adhesion is chosen, more in-depth characterization of the swelling will 
be necessary. As mentioned before, the desmosine-inspired linkers from Hagel et al. are 
potential candidates for these. Therefore the data already published by this group will be 
useful for future optimizations of the implants.  
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2.4.2. Continuous pressure application 
In the previous sections it was demonstrated that the basic concept for fabricating 
hydrogel-modified intraocular implants proposed in Section 1.6 was applicable to fabricate 
small glass and titanium tubes (Section 2.3). For applying them in glaucoma treatment they 
need to have properties for regulating intraocular pressures3. Their covalent immobilization 
had to be strong enough for resisting the pressures occurring in the glaucomatous eye 
without them fracturing and leaving the implants. Furthermore they had to allow liquid 
flow through the tubes for draining excess intraocular fluid. Additionally they had to 
perform as a valve and prevent pressure in the eye from dropping too low due to extensive 
drainage. Therefore it was necessary to determine, whether these properties were present in 
the model systems established in this thesis and how to possibly optimize parameters for 
an effective pressure regulation. To that end, two analytical methods were developed to 
apply liquid pressure on hydrogel-filled tubes, referred to as the “Continuous Pressure 
Application” (CPA), and “Hydrostatic Pressure Application” (HPA, see Section 2.4.3) 
methods. Both were used to evaluate different aspects of the aforementioned pressure 
related properties. 
The CPA was designed to apply and continuously increase an external force on a liquid 
column in a closed system. This subsequently influenced pressures of that column on the 
HA-modified test tubes. Reactions of these samples to those pressures were monitored 
indirectly by a force sensor of a BOSE Electroforce device (Figure 44).204 For analyzing 
reactions of hydrogel-filled tubes to liquid pressures, they were connected to the syringe 
and the displacement head was moved down at a constant rate, exerting a constantly 
increasing force on the plunger (Figure 44b). This resulted in a force being exerted on the 
liquid within the syringe translating into linearly increasing pressures on connected 
samples. Their reactions would translate into deviations from this linear increase and was 
monitored in real time by analyzing the forces measured by the force sensor located at the 
bottom of the setup. 
 
Figure 44: (a): Schematic illustration of the experimental setup used for CPA measurements consisting of a plastic 
syringe inside a sample holder connected to elastic tubing. A displacement head above the setup was able to move at 
predetermined velocities. (b): Basic principle of the CPA measurement. By moving the displacement head a constant 
force is exerted on the plunger. This subsequently increases the liquid pressure on the sample until a reaction (e.g. gel 
expelled, liquid flow) occurs. Forces were recorded by the sensor at the bottom of the device (c): Picture of a real-life 
CPA setup. 
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Pressures were determined from the force values recorded by the sensor and knowledge of 
the plunger’s surface area according to the following equation: 
 	   P = 𝐹𝐴	   Equation 2:2 
 
with “P” being the pressure, “F” being the measured force and “A” being the surface area 
of the plunger pressing on the liquid in the syringe. For data analysis pressures were 
plotted against the displacement of the plunger. Total values for displacement were 
transformed into “relative displacement”, an artificial value used to standardize curves that 
were recorded from experiments of varying lengths. It was calculated according to 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒  𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒𝑚𝑒𝑛𝑡 = 𝐶𝑢𝑟𝑟𝑒𝑛𝑡  𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒𝑚𝑒𝑛𝑡𝑀𝑎𝑥𝑖𝑚𝑢𝑚  𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒𝑚𝑒𝑛𝑡	   Equation 2:3 
 
with “Current displacement” being the currently recorded displacement and “Maximum 
displacement” the maximum value the plunger was displaced during a complete 
measurement. Relative displacement was calculated since for these measurements only the 
pressure values in general, e.g. maximum pressures, plateau pressure, were important for 
an analysis of the pressure behavior. The actual displacement values were of little interest 
at that point and normalizing them to relative values simplified comparisons between 
measurements of differing lengths. 
Depending on the type of sample, different kinds of curves were attained: 
1. Sytem characterisation with empty tubes 
To begin with, it was necessary to characterize the basic properties of the setup such as the 
forms of the curves obtained from measurements and their dependency on different 
parameters of the system. For this, empty tubes were subjected to CPA measurements and 
the resulting pressure-displacement curves analyzed. 
In a first step, the basic shape of curves gained from the experiments was analyzed (Figure 
45). It showed three distinct sections. In the first section (relative displacement = 0.0-0.07), 
the displacement head had no contact to the plunger yet, no force was exerted on the 
system and the recorded pressure did not change. After both parts made contact with each 
other, the pressure increased relatively fast (relative displacement = 0.07-0.19) and a water 
flow was initiated. At a relative displacement of 0.19 a plateau was achieved where the 
water flow through the tube was in balance with the forces exerted on the system through 
movement of the displacement head. 
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Figure 45: Exemplary CPA pressure/displacement curve of a non-modified tube (L = 10 mm; ID = 0.5 
mm), showing the three distinct sections of a curve. (a) The displacement head was not in contact with 
the plunger and no force was exerted on the system. (b) The displacement head came in contact with the 
plunger, exerting a force on the liquid within the syringe. (c): Plateau/equilibrium area where the water 
flow was in balance with the force applied from the plunger. 
 
For determining possible size dependencies these measurements were performed on empty 
tubes with different lengths. However no significant differences were observed for the 
values of the plateau pressures (Figure 46). The figure showed, that the variation of the 
equilibrium pressures of empty glass tubes with different lengths was only minimal. This 
illustrated minimal influence of the empty glass tubes on the pressure development and 
future differences of hydrogel-filled samples were attributed to the presence of the gels.  
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Figure 46: Comparison of pressure-displacement curves of non-modified tubes (ID = 0.5 mm; L = 4-10 mm) at a 
displacement velocity of 0.01 mm/s. The values of the plateaus pressure almost the same for all lengths with only 
minimal differences. 
In a next step, the basic relation between displacement velocity and pressure values was 
determined (Figure 47). The graph showed, that an increase of the velocity of the 
displacement head directly lead to an increase of the plateau pressure. These results 
illustrated the importance for using the same displacement velocity between experiments in 
order to attain comparable results. 
 
 
Figure 47: Pressure displacement curves of CPA measurements on a empty glass tube (L = 10 mm; ID = 0.5 mm) with 
different velocities of the displacement head. An increase of the velocity led to higher values of EP. 
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2. Non-silanized tubes filled with hydrogels 
In a next step non-silanized, hydrogel-filled tubes were analyzed with CPA measurements 
to further verify the effectiveness of the incepted covalent immobilization concept (Section 
1.6). During sample preparation, hydrogels were usually easily removed already from the 
containing glass tubes when the tubing connecting the samples was removed (See 4.3.2). 
These low forces for the removal of the HA hydrogels were further quantified by 
subjecting non-silanized gel-filled tubes, that were successfully retrieved with hydrogels 
still inside, to CPA measurements (Figure 48). It was observed that after the start of the 
measurements the hydrogels were pushed out and the resulting curves. By analyzing the 
resulting pressure-displacement curves it was shown, that the plateau areas were similar to 
the results gained from empty tubes (Figure 46). This illustrated, that an immobilization of 
the hydrogels was necessary to ensure the function and the longevity of potential glaucoma 
implants. 
 
Figure 48: CPA measurements (Displacement velocity = 0.01 mm/s) on hydrogel-filled non-silanized tubes (ID = 0.5 
mm; L = 10 mm; Mn(HA)= 100 kDa; β(HA)= 15 mg/ml; TG = 0.57). No big differences to the curves of empty tubes 
(Figure 46) were observed. 
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3. Silanized and Hydrogel-filled tubes without liquid flow 
When performing CPA measurements on hydrogel-filled tubes, two different reactions of 
the sample to the external pressure were observed. Either a liquid flow was established 
which lead to a decreased pressure (discussed later) or the hydrogels within the tubes 
completely resisted any pressure-induced liquid flow. Instead the pressure increased 
linearly with the movement of the displacement head until the gels were forcefully ejected 
from the tubes resulting in a sharp drop of the measured force values (Figure 49). 
 
Figure 49: Pressure-displacement curve of a silanized and hydrogel-filled tube (Mn(HA)= 60 kDa; β(HA)= 15 mg/ml; 
TG = 0.18; hydrogels formed in TRIS/BSS (c(TRIS) = 0.4 mol/l)) that blocked a liquid flow through it’s interior. At a 
relative displacement of 0.38-0.4 the gel was forcefully ejected from the tube and the pressure dropped to similar levels 
than an unmodified sample (Figure 46). 
The graph showed, that the pressure increased to relatively high levels, compared to non-
modified tubes (Figure 46) or samples that allowed the passage of fluid (Figure 52). At the 
peak pressure, the hydrogels were forcefully ejected from the tubes (= “breaking point”) 
and the pressure dropped down to levels similar to empty tubes (Figure 45). At this time of 
the project, the majority of samples showed this behavior when exposed to an external 
pressure. While undesirable in respect to the model implant’s ability to regulate external 
pressures, it was utilized for analyzing the stability of the immobilization by quantifying 
breaking points. To that end a number of samples was prepared with different hydrogel 
parameters (β(HA); Mn(HA); TG) as summarized in Table 2 and breaking points 
determined with CPA (Figure 50). 
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Table 2: Overview over the gel-filled tubes with different 
parameters used for breaking point experiments. All hydrogels were 
formed in TRIS/BSS (c(TRIS) = 0.4 mol/L) 
Series	   TG	   β 	  [mg/ml] Mn	  [kDa]	  
1	   0.57	   15	   100	  
2	   0.57	   10	   100	  
3	   0.57	   15	   60	  
4	   0.57	   10	   60	  
5	   0.19	   15	   60	  
6	   0.23	   15	   100	  
7	   0.39	   15	   60	  
8	   0.42	   15	   100	  
 
 
Figure 50: Overview over the average median values for breaking points of at least four hydrogel-filled tubes (tube: L = 
10 mm; ID = 0.5 mm; hydrogels prepared in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) modified with the parameters as 
listed under (Table 2). Average breaking point values were constantly above 100000 Pa for all series. Error bars were the 
standard deviations between samples. 
The variation within one series of samples sometimes was relatively high, with some 
hydrogels breaking out of the tubes much earlier than others. The exact reason for this as 
of yet was unexplained. However, since all glass tubes were silanized in the same solution, 
it was attributed to random errors during hydrogel formation. The data further showed a 
tendency of gels within tubes with a higher degree of crosslinking to also possess a higher 
breaking point, with series #1 (Mn(HA) = 100 kDa; β(HA)= 15 mg/ml; TG = 0.57) being 
an exception. The data acquired within this thesis was not enough to make a conclusive 
statement on the relation between these gel parameters and the pressure values of the 
breaking points. However, and more importantly, they all showed breaking points of more 
than 100 kPa, which is sufficient to resist a removal from pressures encountered within the 
glaucomatous eye (<10 kPa)3. 
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As mentioned in Section 2.3.2, it was not possible to verify the presence of hyaluronan 
hydrogels on the interiors of titanium tubes due to them being non-light-transmissive. 
Therefore CPA measurements were conducted on hydrogel-filled titanium tubes to confirm 
the presence of hydrogels by determining the breaking points (Figure 51). 
 
Figure 51:  Curve of a breaking point CPA measurement of a hydrogel-modified (Mn(HA)= 100 kDa; β(HA)= 15 
mg/ml; TG = 0.57; hydrogels formed in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) titanium tube (L = 15 mm; ID = 0.3 
mm). The existence of a breaking point verified the presence of an immobilized hydrogel on the tube’s interior. 
These results verified, in addition to previously conducted immobilization experiments 
(Sections 2.2 and 2.3.2), that immobilizing hydrogels on the inside of small titanium tubes 
was also possible. Furthermore, the breaking point was much higher than the values gained 
for glass tubes (Figure 50). This verified the ability for the hydrogels in titanium tubes for 
withstanding pressures encountered in the glaucomatous eye. It was seen as final proof, 
that the concept for the covalent immobilization of hydrogels to titanium tubes established 
in Section 1.6 was applicable. The reason for the relatively higher breaking point compared 
to glass tubes (Figure 50) modified with hydrogels using similar parameters was attributed 
to the smaller diameter used for the titanium tube and is further discussed in Section 2.5.2.  
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4. Silanized Hydrogel modified tubes with liquid flow 
In some cases the silanized hydrogel-filled tubes established a liquid flow when exposed to 
external pressure and the pressure-displacement curve from a CPA measurement (Figure 
52). 
 
Figure 52: Exemplary CPA curve of a gel modified tube (Mn(HA)= 60 kDa; β(HA)= 15 mg/ml; TG = 0.18; hydrogels 
formed in TRIS/BSS (c(TRIS) = 0.4 mol/l, pH = 8.5)) where a passage of fluids through its interior was established. At 
the beginning the pressure increased linearly with the movement of the displacement head. At the peak pressure (here at 
0.18 rel. displacement) a liquid flow through the tube was observed, causing it to decline into an equilibrium pressure 
(EP) at which the forces exerted by the constantly moving displacement head and the liquid flow were in balance. 
The graph showed a linear increase of the pressure with the movement of the displacement 
head while no liquid flow was observed. At the peak pressure, in this example at a relative 
displacement of 0.18, a liquid flow was observed through the gel-filled stents. The pressure 
started to decline before going into an equilibrium (equilibrium pressure, EP) where the 
forces exerted by the movement of the plunger were in balance with the outflow rate of the 
liquid through the tube.  
Furthermore, the EP for gel-filled samples was higher than plateaus of non-modified tubes 
measured using the same displacement velocity (Figure 53). The equilibrium pressure of 
the tube containing a hyaluronan hydrogel was noticeably higher than of the non-modified 
sample. This proved, that the hydrogels within influenced passage of liquids through the 
tube’s interiors, requiring a higher pressure to maintain a steady flow compared to non-
modified samples. The mechanism of the hydrogel-controlled liquid flow was further 
discussed in Section 2.5.1. 
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Figure 53: Comparison of the pressure-displacement curves between a hydrogel-filled (Mn(HA)= 60 kDa; β(HA)= 15 
mg/ml; TG = 0.18, hydrogels formed in TRIS/BSS (c(TRIS) = 0.4 mol/l, pH = 8.5)) tube with an unmodified sample (L = 
10 mm, ID = 0.5 mm) using a displacement velocity of 0.025 mm/s.  
In order to be viable for comparative measurements it was necessary for the method to 
have a good reproducibility. Furthermore, it was important, that the properties of the 
samples would not change when repeatedly exposed to external pressures, for example by 
degradation of the hydrogels. In order to evaluate these properties of the setup and the 
hydrogels, a series of repeated CPA measurements was conducted on the same sample to 
see, whether any changes in the pressure-displacement curves would occur (Figure 54a) 
with a repetition 24 hours later (Figure 54b). The results showed repeated runs always 
resulting in similar values of EP, which cold be repeated 24 hours later. This demonstrated 
the reproducibility of the method necessary for comparative measurements between 
different samples. The results also indicated short-term stability of the hydrogels since 
changes in the curves, for example by gel deterioration, would have been observed. 
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Figure 54: (a): Pressure-displacement curves of repeated CPA measurements on the same hydrogel-filled tube (L = 10 
mm; ID = 0.5 mm; Mn(HA)= 60 kDa; β(HA)= 15 mg/ml; TG = 0.18; hydrogel formed in TRIS/BSS (c(TRIS) = 0.4 
mol/l; pH = 8.5)). (b): Pressure-displacement curves of the same sample 24 hours later. The EP’s were similar for all 
experiments. Noticeable was a different shape of the pressure-displacement curve of the first round of a series compared 
to subsequent measurements. The displacement velocity was 0.025 mm/s. 
One noticeable difference was the shape of the curves between the first and subsequent 
CPA measurements of one series of experiments. Pressure on the first round increased to 
values around twice the EP before hitting a peak where a liquid flow through the gel-filled 
tube was induced. However in subsequent rounds no peak pressures were observed and the 
equilibrium liquid flow was established directly instead. It indicated that an “activation” of 
the hydrogels within the tubes was necessary the first time they were exposed to external 
pressures in for inducing flow. On subsequent runs this “activation” was not necessary 
anymore. The same behavior was observed when the experimental series was repeated 24 
hours later on the same sample (Figure 54b), therefore this activation was not related to 
irreversible changes of samples. Rather a reversible process that “deactivated” the samples 
when not exposed to heightened pressures over a longer period of time was proposed and 
the nature of this effect was further explored in Section 2.5.1. Nonetheless, the results in 
Figure 54 showed that the pressure of the equilibrium flow was constant between different 
runs, illustrating the reproducibility of the method and its applicability for conducting 
comparative measurements on samples prepared with different parameters. 
The EP dependence on displacement head velocity was demonstrated already for empty 
tubes. Similar variations EPs with an accelerated speed of the displacement head (Figure 
55) was also shown with hydrogel filled tubes (Figure 47). The measurements illustrated, 
that not only the equilibrium pressure increased with displacement velocity. Also the time-
span required to achieve equilibrium was significantly higher at faster displacement rates. 
For that reason it was necessary to perform CPA measurements at relatively low velocities 
(0.005-0.02 mm/s). These results also further reinforced the requirement to perform 
comparative measurements with the same displacement velocities.  
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Figure 55: Pressure-displacement curves of CPA measurements of a gel-modified (Mn(HA) = 60 kDa; β(HA)= 15 
mg/ml; TG = 0.18; hydrogels formed in TRIS/BSS (c(TRIS) = 0.4 mol/l, pH = 8.5)) glass tube (L = 10 mm, ID = 0.5 
mm) at different displacement velocities. They illustrate the dependency of their shape on the displacement velocity. 
 
The main aspect of the glaucoma therapy was reducing intraocular pressures to “normal” 
levels less than 21 mmHg (ca. 2100 Pa).3 Optimizing the parameters of implants and 
hydrogels was necessary for achieving these target values. Therefore it was necessary to 
gain insight on how a variation of these parameters would influence the liquid flow. CPA 
was ideal for this task, since individual measurements were done quickly to evaluate a 
large number of samples. 
The yield of tubes allowing passage of fluids was low and the main focus at that point was 
optimizing sample preparation (see Section 2.5). Therefore some preliminary 
measurements were performed for evaluating the sensitivity of the method. To that end 
samples with varying parameters were prepared and analyzed with CPA. Due to a 
constantly low number of samples allowing liquid flow at that point, the amount of data 
was not exhaustive and more extensive series of measurements will have to be performed 
in the future. Still, although not conclusive, general parameter-dependent differences were 
observed. First, the lengths of glass tubes were varied (Figure 56) resulting in higher EP’s 
when length was increased. This was related to a higher amount of hydrogel within tubes, 
since unmodified samples did not show a similar relation. 
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Figure 56: Average equilibrium pressures determined by CPA measurements of glass tubes modified with hyaluronan 
hydrogels (Mn(HA) = 60 kDa; β(HA) = 15 mg/ml; TG = 0.18, gels synthesized in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 
8.5)), with different tube lengths (L = 2 mm – 10 mm; ID = 0.5 mm). Error bars were standard deviations. Due to a low 
amount of samples (2-3), significance was not established. A general relation between tube length and EP was still 
visible. 
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Furthermore EP dependencies on hydrogel concentrations were evaluated. To that end, 
HS-HA/MBAA with different HA mass concentrations were prepared and a number of 
glass tubes with the same length modified (Figure 58). The results showed, that an increase 
of the hyaluronan concentrations required increasing pressures to get a liquid flow through 
the tubes and to reach equilibrium. A further analysis on the mechanism of the dependence 
of the liquid flow through the stents can be found in Section 2.5.1. Still, these results 
illustrated the applicability of the CPA measurements for the comparison of the pressure 
resistance of model implants created with different parameters.  
 
Figure 57: Average equilibrium pressures of CPA measurements of HA-hydrogel modified glass tubes (L = 10 mm; ID 
= 0.5 mm) using different mass concentrations of hyaluronan (Mn(HA)= 60 kDa; β = 10-17.5 mg/ml; TG = 0.18; gels 
synthesized in BSS/TRIS (c(TRIS) = 0.4 mol/l; pH = 8.5)). Due to a low amount of samples (2-3), significance was not 
established. A general relation between tube length and EP was still visible. 
As mentioned before, a “normal” intraocular pressure is considered to be at a daily average 
of 21 mmHg (ca. 2100 Pa).3 Therefore it was then necessary to optimize the stents’ 
parameters in a way that the tubes would only allow a liquid passage while exposed to 
pressure values above 2100 Pa. It was attempted to measure potential flow barrier 
properties of the model implants using the CPA setup. First, an artificially high pressure 
value by pushing the plunger into the syringe at a constant rate with the displacement head 
was created. Next the displacement head was set to remain in a fixed position. As a result, 
forces exerted upon the system remained constant and changes to the pressure were 
dependent only on the sample reactions. However, a number of complications were 
encountered, which rendered the CPA setup unsuitable for this kind of measurement 
(Figure 58). 
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Figure 58: (a): The first 500 seconds of a pressure-displacement curve of a CPA measurement on a gel-filled tube 
(Mn(HA)= 60 kDa; β = 10 mg/ml – 17.5 mg/ml; TG = 0.18; gels synthesized in BSS/TRIS (c(TRIS) = 0.4 mol/l; pH = 
8.5)) with a stop of movement of the displacement head at 200 s. (b): The pressure-displacement curve of the whole CPA 
measurement. (c): Comparison of the long-term development of a gel-filled and an empty glass tube (10 mm, ID: 0.5 
mm) after the displacement head stopped moving. 
After stopping the displacement head, the pressure immediately dropped (Figure 58a). 
However a relatively strong noise influenced the course of the curve and reducing accuracy 
(Figure 58b). The reasons for this were unclear and potentially related to room pressures 
affecting the force sensor. Due to these variations, the CPA was too inaccurate for these 
kinds of measurements to a point where curves of hydrogel-modified and blank tubes 
aligned (Figure 58c).  
As a result the CPA method was not used for determining and optimizing the flow barriers 
of the model implants and another method was developed to conduct further measurements 
(Section 2.4.3). Still, it’s applicability for quickly evaluating general parameter 
dependencies and breaking of gel-modified tubes was demonstrated. Specifically the 
ability for quickly performing measurements on large amounts of samples in relatively 
short times makes it useful for future optimizations of implant parameters. 
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2.4.3. Hydrostatic pressure measurements 
As outlined in 2.4.2, the CPA method was very useful in quickly determining the behavior 
of hydrogel-modified tubes to external pressure, whether they permitted or resisted a liquid 
flow or broke when exposed to different levels of pressure. By using CPA measurements it 
was also possible to quickly compare the pressure resistance of samples created with 
different parameters. However the method was unsuitable for a determination of the 
pressure-barrier levels of the stents, especially for values less than 5000 Pa (Figure 58). 
The target pressure for the glaucoma treatment was at 2100 Pa3. For that reason second 
method was developed for specifically measuring the pressure-barrier values at lower 
levels. To that end, an experimental setup utilizing the hydrostatic pressure within a long 
glass capillary, further referred to as “Hydrostatic Pressure Application” (HPA), was 
utilized (Figure 59). It consisted of a glass capillary with an outlet that was placed on a 
commercially available balance and a sample connected to the outlet by elastic tubing. By 
filling the capillary with watery solutions (e.g. BSS) hydrogels within the tubes were 
subjected to hydrostatic pressures exerted from the liquid column. Mass changes were 
recorded by the balance and subsequently used to analyze the tubes’ reactions to the 
hydrostatic pressure. 
 
 
Figure 59: Experimental setup for the HPA measurements: A glass capillary with an outlet was placed on top of a 
balance and a hydrogel-filled tube was connected to the outlet. Hydrostatic pressure was applied on the sample by filling 
the capillary with liquid. Reactions of samples to hydrostatic pressures were analyzed by mass changes recorded from the 
balance. 
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For calculating hydrostatic pressure values affecting the samples from the masses recorded 
by the balance, a conversion constant KP was defined: K! = 𝑃𝑚	   Equation 2:4 
with “P” being the hydrostatic pressure and “m” the mass of the liquid column within the 
capillary. The hydrostatic pressure was calculated with the common formula P = 𝜌 ∗ 𝑔 ∗ ℎ	   Equation 2:5 
with “ρ“ as the density of the liquid, “g” as the gravity acceleration and “h” the height of 
the liquid column. 
Using the basic definition for density after the formula 𝜌 = 𝑚𝑉 	   Equation 2:6 
with “m” as the mass and V as the volume of the liquid column and the height being 
calculated from h =   𝑉𝐴	   Equation 2:7 
with “A” being the ground area and “V” being the volume of the liquid column and 
inserting them into Equation 2:5 KP is then defined as K! =    𝑃𝑚 =   𝑚 ∗ 𝑔 ∗ 𝑉𝑚 ∗ 𝑉 ∗ 𝐴 =   𝑔𝐴	   Equation 2:8 
and therefore only dependent on the gravity acceleration and the ground area of the liquid 
column. The use of KP allowed for a direct translation of the masses recorded by the 
balance into hydrostatic pressures affecting the hydrogel-filled tubes during HPA 
measurements. 
 
Due to the low amount of hydrogel-filled tubes available for passaging of liquids through 
their interior, similar to the CPA measurements (Section 2.4.2) only a few experiments 
were conducted. However, samples that did enable a controlled liquid flow and were 
measured with the HPA method illustrated the general applicability of the method for 
future experiments (Figure 60). 
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Figure 60: (a): Comparison pressure developments of HPA measurements without a sample, with an unmodified sample 
(L = 10 mm; ID = 0.5 mm) and a gel-modified tube (L = 6 mm; Mn(HA) = 60 kDa; β(HA) = 15 mg/ml; TG = 0.18; gels 
synthesized in BSS/TRIS (c(TRIS) = 0.4 mol/l; pH = 8.5)) of the first 1000 seconds. (b): Pressure development of the 
same measurement over the next 250 h. The graphs illustrate the ability of some hydrogel-modified tubes to control the 
hydrostatic pressure by draining liquid more slowly from the capillary than empty tubes (a) and that this drainage was 
stopped at pressure levels >0, in this case at 9000-10000 Pascal, effectively performing as a valve. Only four data points 
were shown for the hydrogel-filled tube in (a), since that measurement was performed long-term (the data points and the 
curve in (b) belong to the same measurement) and the intervals were longer in order to reduce the amount of data.  
Curves for unmodified and gel-modified tubes varied noticeably from each other, with the 
former dropping from a pressure of >20000 Pascal to zero Pascal within less than 17 
minutes (Figure 60a) while the later lowered the pressure to a level of 9000-10000 Pa, 
where the outflow of liquid from the capillary stopped (Figure 60b). This demonstrated the 
ability of HPA setups to determine pressure barriers of gel-filled tubes with less noise, 
compared to the CPA measurements (Section 2.4.2). More importantly it gave a clear 
proof-of-principle, that small tubes filled with hydrogels were able to act as pressure 
sensitive valves by allowing a passage of liquid only at pressure levels at certain 
thresholds. The HPA setup was also more similar as a model system to the human eye. An 
implant inserted for glaucoma therapy would encounter a “constant” starting pressure 
similar to the HPA setup instead of a rapidly and constantly increasing pressure as 
encountered in the CPA measurements. Therefore HPA was a valuable tool for analyzing 
valve functions of gel-filled tubes and was later used for determining further optimizations 
(Section 2.5.2). 
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2.4.4. Summary and conclusion 
In this chapter, several methods were used for characterizing hydrogel-filled tubes that 
acted as model glaucoma implants. In a first step, a few basic experiments were conducted 
to compare swelling of hydrogels immobilized to the inside of glass tubes (constrained 
gels) with non-immobilized samples (unobstructed gels). The aim was to see differences in 
swelling behaviors due to covalent immobilizations in tubes for establishing an incubation 
protocol before conducting further experiments. The results showed a stronger initial 
swelling of unobstructed gels before declining into a steady state lower than the 
constrained gels (Figure 42). This was related to TRIS residues within the hydrophilic 
networks from the gel synthesis (See Figure 43). Their presence caused an elevated initial 
osmotic pressure and water infiltration before diffusing themselves out of the hydrogels 
leading to their shrinking, again due a change of osmotic forces.109 Constrained hydrogels 
directly achieved a steady state that was higher than unobstructed samples. One probable 
cause was an inhibition of initial swelling and volume expansion due to physical barriers 
posed by the walls leading to decreased pore sizes and limited diffusion of TRIS. This was 
further enhanced by general limited molecule exchanged due to hydrogel/medium 
interfaces present only at the tubes ends. A further explanation for the lower reduction of 
masses and volumes of constrained gels were the physical limitations through the covalent 
immobilization preventing gels from expanding or contracting. Future experiments, for 
example by determining pore sizes of the networks with fluorescent probes90, or using 
constrained but non-immobilized hydrogels, can aid in a more in-depth understanding of 
this mechanism. 
Furthermore, two methods were established for allowing characterization of gel-modified 
tubes reactions to liquid pressures: The CPA (Section 2.4.2) was based on the continuous 
application of an external force to the plunger of a syringe connected to gel-filled tubes 
(Figure 44) and was employed for quick evaluations of basic properties of a large number 
of samples. These basic properties were, whether the gel would allow a liquid flow through 
the interior of the containing tube (Figure 52) or whether it would block any drainage 
through the sample destroying the hydrogels when certain pressure thresholds were 
reached (Figure 49). It was demonstrated that the immobilization of the hydrogels (See 
Section 2.3.2) was enough to withstand any potential pressures encountered in 
glaucomatous eyes (Figure 50). Furthermore, some samples used in CPA measurements 
showed passage of liquid when certain levels of pressure within the system were achieved 
(Figure 52, Figure 53). The method was further used to determine variations of the 
pressure resistance depending on different parameters such as tube length (Figure 56)) or 
hyaluronan concentrations within the hydrogels (Figure 54). The big advantage of this 
method was the low time-requirement to conduct measurements.  
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HPA (Section 2.4.3) was developed as a complementary method to the CPA and used the 
hydrostatic pressure generated by a water column (Figure 59) for evaluationg the potential 
of hydrogel-modified model implants to act as a pressure sensitive valve (Figure 60b). 
CPA could not provide this kind of data since it only gave pressure values relative to the 
movement speed of the syringe’s plunger (Figure 55). CPA was also not sensitive enough 
for detecting smaller variations in the pressure (Figure 58), which was required for 
determining the absolute pressure threshold where a liquid flow was enabled. HPA also 
mimicked the conditions within the aqueous humor better, where pressure did not 
continuously and relatively rapidly increase. The disadvantage of the HPA compared to 
CPA measurements was the relatively long time required to perform an individual 
evaluation of a sample which was days (Figure 60b), as opposed to the CPA, where 
measurements were performed within minutes. Nonetheless, both methods were very 
useful for evaluating different properties of the model implants and can be used for further 
optimizations in the future. 
However, one issue became apparent during measurements with these systems: The 
majority of samples did not perform as intended when exposed to liquid pressures. Instead 
they completely resisted any passage of liquid through their interiors with low yields of 
samples performing correctly (< 10%). An improvements of the yields by varying different 
parameters (β(HA), crosslinking density, etc.) was not possible and samples capable of 
pressure regulation were obtained at random. This made it difficult to acquire larger 
datasets for a more statistically significant characterization of the model tubes. Therefore 
respective measurements were set aside in favor of exploring the mechanism behind the 
liquid flow (See Section 2.5). 
Nonetheless, the general usefulness of CPA and HPA measurements for a characterization 
of hydrogel-filled model implants was successfully established. More importantly, the 
general ability of hydrogel-filled stents for regulating intraocular pressures was 
demonstrated. Therefore the focus in subsequent chapters lay on explaining the mechanism 
of the liquid flow and finding ways for improving the yield of functional samples. 
 
 
 
 
 
 
 
 
 
 
 
2. Results & Discussion 
 77 
 Optimization of the concept for creating intraocular stents 2.5.
2.5.1. The mechanism of liquid flow through gel-filled tubes 
It was already shown, that small glass and titanium tubes were successfully modified with 
hyaluronan hydrogels immobilized on their outer and inner surfaces (Section 2.3). 
Furthermore, two analytical methods were developed for analyzing reactions of hydrogel-
filled tubes to external liquid pressures (Section 2.4). Pressure induced liquid flow through 
these samples was successfully confirmed (Figure 52, Figure 53). Moreover the principal 
ability of these samples to act as pressure-sensitive valves by allowing a liquid flow until 
pressure dropped to certain thresholds (10000 Pa) were reached, was demonstrated (Figure 
60). These data sets already showed that the concepts for generating intraocular stents 
modified with hyaluronan outlined in Section 1.6 is possible. However, two problems 
remained: 
It was not possible to optimize the parameters required for generating a stent suitable for 
the reduction of liquid pressures to normal levels of bellow 21 mmHg (ca. 2100 Pa)205 yet. 
Therefore further testing and optimizing the model implant’s parameters was required. 
Secondly, and at that point more importantly, yields of functional model stents gained from 
established methods presented in previous chapters were too low. Many hydrogel-modified 
tubes did not enable for any drainage of liquid. Instead gels immobilized within the tubes 
completely resisted any liquid flow during CPA measurements and pressure levels 
increased until they were destroyed and ejected from the tubes (Figure 49). As a result, it 
was not possible to gain large datasets for statistically significant characterizations of the 
tubes’ pressure resistances. Furthermore, for a potential industrial manufacture, the process 
of stent production needed to be reproducible and reliable otherwise the amount of 
deficient products would create undesirable extra costs. Therefore the further focus of the 
thesis, presented in this chapter, was finding a way for improving reliability and 
reproducibility of the production process. 
The first step towards this goal was to gain understanding of pressure induced liquid flow’s 
mechanisms. To that end, an experimental setup was devised, where hydrogel filled glass 
tubes were connected on both ends to elastic tubing and placed on a small glass plate 
within a fluorescence microscope (Figure 61). A syringe containing solutions of 
fluorescein or BSS was connected to the setup. Pressure was created by pushing the 
solution manually with the syringe at the gel-filled tube while recording fluorescent signals 
of the tubes inside with a microscope (Figure 62).  
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Figure 61: Experimental setup for observing the mechanism of pressure induced liquid flow within hydrogel-filled tubes 
on a microscopic level. Samples were placed on a glass plate in the focus region of a fluorescence microscope. 
Fluorescent solutions or BSS were manually pressed into the tube and reactions of the hydrogels monitored. 
Figure 62a showed the beginning of a fluorescent pressure resistance (FPR) measurement 
before any external pressure was applied to the system. The observed location was the 
interface between the tubing containing the fluorescent solution and the examined sample. 
In Figure 62b, pressure was manually applied on the system and slowly increased. No 
liquid flow was detected at that point. The only change within the tube was a small bulge 
of the fluorescein solution, indicating slight compression of the hydrogel. This bulge 
increased gradually in small steps when pressure was further increased. When pressure was 
high enough to initiate liquid flow a channel formed at the side of the tube (Figure 62c). 
Figure 62d is a merge of several pictures recorded right after the gel flow started to show 
an extended section of the tube. The channel wandered to the center of the glass tube. 
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Figure 62: (a-c): Fluorescence images at different time-points of a fluorescent pressure resistance measurement. The 
location was at the interface between the gel-filled sample (L = 10 mm; ID = 0.5 mm; Mn(HA) = 60 kDa; β(HA) = 15 
mg/mL; TG = 0.18; gels synthesized in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) and the tubing. (a): Image taken 
before pressure was applied. (b): Pressure was applied on the fluorescent solution but no liquid flow was observed. (c): 
Picture from a time-point when the pressure just induced a liquid flow through the tube. (d): Combination of several 
images taken at almost the same time from the connection point and farther into the sample. 
Subsequently the time after channel formation, when a steady flow was established, was 
monitored further. To that end tubes modified with fluorescent hydrogels made from HS-
FA-HA were used and the tubes’ central parts were observed (Figure 63). Background 
fluorescence (Figure 63a) originated from the hydrogel itself since HS-FA-HA was used to 
create it. Figure 63b-f shows small amounts of liquid infiltrating the sample on a distinct 
path along the central axis. Figure 63g shows more liquid entering the channel, broadening 
it and fluorescein starting to infiltrate the polymeric network (Figure 63h-k) until it was 
distributed evenly in the whole tube (Figure 63l). 
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Figure 63: (a-l): Fluorescence images of an FPR measurement using fluorescein on a hydrogel-modified tube (L = 10 
mm; ID = 0.5 mm; Mn(HA) = 60 kDa; β(HA) = 15 mg/mL; TG = 0.18; gels synthesized in TRIS/BSS (c(TRIS) = 0.4 
mol/l; pH = 8.5)) at different time-points. Fluorescent liquid was observed to slowly infiltrate the tube along the center 
before opening to a channel. Subsequently the dye spread among the whole hydrogel. 
Subsequently the tube was rinsed with BSS (Figure 64) and the distribution of 
fluorophores monitored, which were flushed from the hydrogel. Instead of being removed 
evenly across the whole network, fluorophore concentration declined from the outer areas 
to the center axis of the tube. This indicated the main flow of liquid through the hydrogel 
concentrated there with the outer areas only slightly contributing to the passage of fluid. 
After complete removal, a darker streak in the middle of the gel was visible (Figure 64h-i). 
It hinted at a lower concentration of the fluorescent hydrogel at this position due to the 
presence of a channel. 
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Figure 64: (a-i): Fluorescence images of a hydrogel-modified stent (L = 10 mm; ID = 0.5 mm; Mn(HA) = 60 kDa; 
β(HA) = 15 mg/mL; TG = 0.18 gels synthesized in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)), saturated with 
fluorescein from a previous FPR measurement and rinsed with non-fluorescent BSS. The fluorophores were not washed 
out evenly among the whole tube and were concentrated in the middle, indicating the presence enhanced liquid flow at 
that point. This channel becomes slightly visible in image (h) and (i). 
 
For further investigating the presence of these channels, BSS solutions were pressed 
through samples with fluorescent hydrogels repeatedly. The darker areas were only 
observed when an external liquid pressure with BSS was applied on the tube initiating 
liquid flow (Figure 65) and were determined to be channels conducting the liquid flow. 
After pressure was removed they vanished (Figure 65c) and reformed at subsequent re-
applications of the external pressure (Figure 65d). This showed the formation of channels 
being directly related to pressure-induced liquid flow. 
 
Figure 65: Fluorescence pictures of a set of repeated pressure applications of BSS on a tube filled with fluorescent 
hydrogels (L = 10 mm; ID = 0.5 mm; Mn(HA) = 60 kDa; β(HA) = 15 mg/mL; TG = 0.18 gels synthesized in TRIS/BSS 
(c(TRIS) = 0.4 mol/l; pH = 8.5)): (a): Time-point before the first application of pressure. The gel was uniform within the 
tube. (b): Image from a time-frame where pressure was applied for the first time and a channel was visible running 
through the center of the gel. (c): Time-point after the first and before the second pressure application. The channel 
closed again. (d): Image from the second interval for a pressure application where the channel was visible again. 
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The presence of these channels was confirmed in all observed samples that allowed a 
liquid flow during CPA measurements. This indicated them being a necessary feature of 
the hydrogels to enable any pressure regulation. From these collected results a mechanism 
was proposed on the mechanism of channel regulated liquid flow (Figure 66). 
 
Figure 66: Proposed mechanism (a) and correlation with CPA measurements (b) for pressure-induced liquid flow 
through hydrogel-filled tubes. A “flaw” in the form of a small channel is located within the hydrogels. i) As long as the 
external pressure is bellow a certain threshold, the channel is “closed” due to a combination of elastic forces of and 
hydrophilic interactions between the interfaces of hydrogels. No water flow is established. ii) When the pressure is more 
than that threshold, water infiltrates the system, overcoming the hydrophilic forces and enacting compressive forces upon 
the hydrogels, which causes the channel to “open”. iii) These compressive forces of the external pressure and the elastic 
counter-forces are in balance, which establishes a constant channel size and enables liquid flow. 
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The proposed mechanism is based on the existence of a “flaw” within the hydrogel filling 
the interior of the tube. Due to their nature of consisting of hydrophilic networks70 their 
interfaces can interact with each other (H-bonds, etc.). Hydrogel also possess viscoelastic 
properties, which means the hydrogels within the tubes are able to be reversibly 
compressed.206,207 As long as external liquid pressures affecting the implant are bellow 
certain thresholds (“pressure barrier”) the channel remains “closed” due to a combination 
of hydrophilic interactions and elastic forces between HA molecules at the hydrogel’s 
interfaces (Figure 66i). When external pressures exceed that pressure barrier, the forces 
exerted on the hydrogel overcome the hydrophilic interactions and slightly compress the 
hydrogel, thereby “opening” the channel (Figure 66ii). As a result a water flow is 
established reducing the external liquid pressure. Since the hydrophilic interactions cannot 
re-form as long as the channel is open, the only forces influencing the liquid flow 
stemming from the pressurized liquid exerted on the hydrogel and the elastic counterforce 
originating from the compression of these hydrogels. Therefore the peak pressure observed 
in CPA measurements (Figure 66b) is only necessary for initial channel opening. When 
both forces are in balance, the channel gains a constant size and the external pressure is in 
balance with the liquid flow (Figure 66iii).  
The proposed mechanism is in good agreement with results obtained from the CPA 
measurements (Section 2.4.2, Figure 66). External forces were constantly affecting the 
liquid in the syringe causing a constant water flow during the duration of the 
measurements. For HPA measurement, where no additional external forces influenced the 
hydrostatic pressure of the liquid column, water-flow stopped when the pressure dropped 
to certain levels (Figure 60b). This was explained, according to this proposed mechanism, 
by the elastic counterforces overcoming the forces exerted from the hydrostatic pressure, 
thereby causing a relaxation of the hydrogel within the tube and channel closure. Further 
confirmation was found by the results of the FPR measurements with BSS (Figure 65), 
where the channel opened only during the application of an external pressure. The findings 
from the CPA measurements, where the curve on repeated measurements only showed a 
peak pressure on the first run (Figure 54), could be explained in a similar fashion. The 
remaining pressure within the closed chamber of the CPA after movement of the 
displacement head stopped prevented hydrogels from fully relaxing and fully closing the 
channels. As a result no extra forces were necessary on subsequent measurements 
performed immediately afterwards.  
However this theory was only speculation at that point and required further verification by 
future research. At that point it was sufficient however for explaining the experimental 
findings of CPA, HPA and FPR measurements. It also helped establishing protocols for 
physically creating such channels to induce the pressure regulatory effect (Section 2.5.2). 
The reasons of the channel’s origin within the hydrogels are also currently unexplained. 
Several potential reasons were considered. One possibility is the formation of hydrogels in 
the tubes not being uniform over the whole volume of their interiors. Instead the 
crosslinking between the HS-HA chains occurred predominantly at the surfaces of the 
substrates due to an increased HS-HA concentration from the simultaneously occurring 
immobilization reaction. This may have resulted in the hydrogels growing from the 
surfaces of the tube into the rest of the interior. 
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At the center axis not enough material was left to ensure tight crosslinking, which resulting 
in the formation the channel. Also it was demonstrated during swelling experiments with 
BSS (2.4.1), that hydrogels used in this thesis showed an initial volume gain followed by a 
reduction of masses due to the presence of TRIS within the hydrophilic networks. 
Comparing unobstructed gels with constrained samples also revealed that the mass (and 
volume) reduction did not occur in hydrogels within glass tubes. The covalent 
immobilization to the tubes’ walls preventing a gel contraction was seen as a possible 
reason for this. Concerning the channel formation, this inability of reducing its volume 
could lead to an osmotic force induced strain on the hydrogels and causing a tear within its 
body. However, these are only speculations and the mechanism for natural channel 
formation has not been further explored, especially since their presence within these 
hydrogel-filled model implants was completely random after sample preparation. Instead, 
other more reproducible possibilities to create these channels artificially have been 
explored (See 2.5.2). 
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2.5.2. Exploration of physical methods for creating small channels in hyaluronan 
hydrogels 
In the previous section it was demonstrated that the observed pressure-dependent liquid 
flow through hydrogel-filled tubes (Sections 2.4.2 and 2.4.3) was linked to the presence of 
small channels within the hydrogels (Section 2.5.1). Up to that point all attempts at 
optimizing the chemical parameters (crosslinking density of HS-HA, β(HS-HA), ratio of 
thiols to crosslinkers etc.) for more reproducibly creating hydrogel-filled tubes with these 
channels failed. Therefore creating these channels by the use of physical methods was 
attempted instead. Two concepts were further explored and the results are presented in this 
Section (Figure 67). 
 
 
Figure 67: Concepts for physically creating channels within hydrogel-filled tubes for artificially inducing the ability for 
liquid pressure regulation. (a): In the optical method covalently immobilized hydrogels were first prepared within tubes 
and a laser applied to “burn” the channel into the gel. (b): In the mechanical method a small fiber into was placed 
coaxially into the empty tube. After the gel formation the fiber was removed leaving behind the channel.  
An “optical” concept included the use of a CO2 laser for creating the channels (Figure 
67a). First, covalently immobilized hydrogels were formed within silanized tubes followed 
by the application of a laser strong enough to “burn” away the hydrogels in its path. This 
idea was inspired by the work of A. Holle who similarly generated artificial channels in 
PDMS.208  
The other “mechanical” method involved using small glass fibers placed coaxially within 
the tubes (Figure 67b). After hydrogel formation the fibers were removed and left behind 
channels in their previously occupied volume. In both methods subsequently swelling gels 
“closes” the channel after 48 hours as described in Section 2.5.2. Both methods allowed in 
theory to create channels with different widths. This would potentially allow, together with 
varying other gel properties (e.g. elasticity) adjusting the pressure regulatory levels of 
intraocular implants. 
One issue that came up early when designing the experimental setups was the size of the 
glass tubes. In previous sections mostly relatively small samples were used (L = 10 mm, 
ID = 0.5 mm) for creating and analyzing hydrogel-modified model implants.  
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According to the observations in Section 2.5.1 the original channel had to be relatively 
small in relation to the hydrogels. Otherwise blocking liquid flow at low pressures would 
not have been possible for a lack of “closed state”. Sizes of “open” channels in FPR 
measurements were estimated to be ca. 100µm (Figure 65) with “closed” states being even 
smaller. This created the problem, that among the available equipment no laser was small 
enough to create channels of the required size. Properly aligning laser and sample on that 
scale was also not possible without the use of computer-controlled movable sample 
holders. Also, producing and handling small glass fibers on that scale for the mechanical 
method would have required more elaborate methods than what was readily available. 
Instead of obtaining such equipment it was decided, for the pre-emptive experiments 
presented in this thesis, to scale up the size of the samples instead. If the concept proposed 
in this section could be verified to be applicable, more elaborate setups for a re-
miniaturization on sizes required for manufacturing glaucoma implants can be devised in 
the future. For these reasons larger glass tubes (L = 10 mm, ID = 5 mm) were obtained and 
the respective experiments on generating channels within hydrogel-filled tubes using the 
optical or mechanical method conducted on them instead of the previously used samples. 
 
Optical method 
By using a CO2 laser cutter it was possible to create holes within hydrogels of different 
sizes (Figure 68). However shapes of the channels were often irregular (Figure 68a) and 
not very reproducible since they heavily depended on the laser parameters such as power, 
movement speed, frequency, number of applications, etc. The biggest contribution to this 
irregularity was the focus point of the laser, which was only manually adjustable. 
Therefore it was not possible to create channels with a reproducible shape with the 
available setup. Still, the creation of the channels themselves, regardless of shape was 
possible at all times for most widths (Figure 68a/c).  
 
Figure 68: Two examples of hydrogel-filled tubes (L = 10 mm; ID = 5 mm; Mn(HA) = 100 kDa; β(HA) = 15 mg/mL; 
TG = 0.57; gels synthesized in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) with channels created by the application of a 
laser before (a/c) and after (b/d) swelling them in BSS. The channels were burned through hydrogels with 0.5 mm (a) 
and 1 mm (c) width. However, channel shapes often were irrgegular (a) and heavily dependent on the laser parameters. In 
both cases the channels were not seen visually after swelling for 48h in BSS (b/d). 
5 mm 5 mm
5 mm 5 mm
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Despite these issues during their formation a number of tubes with differently sized 
channels were subjected to HPA measurements (See Section 2.4.3). At this point it should 
be noted, that due to the irregular shapes of the channels generated by the laser application 
the “sizes” given for the channels were the channel widths the laser was programmed to 
produce (See Section 4.8.2) and did not necessarily represent their actual widths. 
 
Figure 69: HPA measurements of hydrogel-filled tubes (L = 10 mm; ID = 5 mm; Mn(HA) = 100 kDa; β(HA) = 15 
mg/mL; TG = 0.57; gels synthesized in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) with channels of different sizes 
created by the optical method. (a) Curve of a HPA measurement where no channel was formed (Laser setting: 0.1 mm). 
The pressure was increased manually step by step until the breaking point was reached (t = 7.25 min) and the water 
flowed out freely. (b): HPA measurement curve of a sample with a too large channel (Laser setting: 1 mm). Even after 
the first pressure increase liquid freely passed through the tube. (c): Curve of a HPA measurement, where the sample 
created by laser application was able to regulate the liquid flow (Laser setting: 0.35 mm), albeit on a lower level as 
required for intraocular pressure regulation.  
 
Channel diameter: 0.1 mm
Channel diameter: 1 mm
Channel diameter: 0.35 mm
2. Results & Discussion 
 88 
The results of the measurements were dependent on channel sizes and yielded different 
informations. At width settings too small for the laser (Figure 69a), it was often not 
possible to create a proper channel. As a result no liquid flow was detected when 
increasing hydrostatic pressures. Instead the curve showed a breaking point at 6000 Pa, 
where the whole hydrogel was ejected from the tube leading to an unimpeded liquid flow 
from the glass capillary. Breaking point values were much lower compared to CPA 
measurements on smaller tubes (Figure 50). This was explained in a changed ratio of the 
external forces being exerted on the hydrogel from the liquid and the immobilization forces 
that keeps the hydrogel inside. The basic formula P = 𝐹𝐴	   Equation 2:9 
 
with “P” as the pressure, “F” the force exerted and “A” being the targeted surface 
illustrates, that the hydrogel in the tube experienced a larger force from the liquid pressure 
due to the bigger diameter of the tube. In contrast the immobilization is related to the 
number covalent links between hydrogel and the inner surface. The immobilizing force of 
these bonds keeping the hydrogels inside of the tubes therefore also increased with the 
diameter of the tubes. However, the surface are of the hydrogels at the tubes ends, that is 
exposed to the hydrostatic pressure from the liquid column, increased according to the 
formula for a circular area. The formula is A! =   𝑟! ∗   𝜋	   Equation 2:10 
 
with AE being the surface area of the tubes entrance, r being the radius of the cylindrical 
tube, The inner surface ascends according to the formula for the inner surface of a cylinder 
according to 𝐴!" = 2 ∗   𝜋 ∗ 𝑟 ∗ ℎ	   Equation 2:11 
 
with AIS being the area of the inner surfaces of the tubes r being their radius and h their 
height of the cylinder. A comparison between both formulas shows a larger growth of AE, 
which is exposed to dependent on the tube’s radius than the area of the inner surfaces of 
the tube AIS the hydrogel is immobilized to. This growth can roughly be quantified, with 𝐴!𝐴!" =    𝑟2 ∗ ℎ	   Equation 2:12 
 
When the radius was increased from 0.5 mm to 5 mm the force exerted from external 
pressures on the hydrogels grew five times more than the immobilizing forces between the 
hydrogel and the inner surfaces of the tube. This resulted in the immobilization failing at 
lower pressures than observed during CPA measurements on smaller samples (Figure 50).  
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In this simplified model, other possible influences like the hydrogel’s own weight also 
increasing with the size or the channels created with the laser destabilizing the hydrogel’s 
integrity were excluded. A comparison between the CPA measurements of the breaking 
points of the smaller tubes (ID = 0.5 mm, see Figure 50) were much more than five times 
of the breaking points gained from the HPA measurements of the larger tubes (ID = 5 mm, 
Figure 69a). Still it was a sufficient explanation of the visible differences in breaking point 
values. 
Figure 69b showed the HPA measurement with a sample where the laser was set to create 
a channel with an ID = 1 mm. After initial pressure increase, liquid flow started 
immediately (0.4 – 0.75 min) with no pressure resistance observed. The width of the 
channel being too large for being properly “closed” by swelling was the most probable 
reason for this result. On a sample with the settings for an ID = 0.35 mm, however, it was 
possible to create pressure regulation, albeit for comparatively low level. This 
demonstrated, although a lot of optimization would be necessary in the future, that 
artificially creating channels using lasers for pressure regulation was possible. 
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Mechanical method 
A reaction chamber was designed for testing the mechanical method. The setup consisted 
of a sample holder with a circular incision and a small hole in the center of that incision 
(Figure 70). Silanized glass tubes (ID = 5 mm, OD = 7 mm, L = 10 mm) were placed into 
the holder. A lid with a similar incision and a hole in the center was placed on top of the 
sample and fastened with screws. Through the hole in the lid, a small glass fiber was 
inserted coaxially to the tube prior to hydrogel formation. After gelation the fiber was 
removed resulting in a physically created channel with the potential ability to regulate 
external liquid pressures. 
 
Figure 70: Concept of the experimental setup for artificially creating 
channels using the mechanical method. By inserting a glass fiber coaxially 
to the tube followed by hydrogel formation channels were formed after the 
fibers’ removal. 
 
Glass fibers with a thickness of 0.1-0.2 mm were obtained and successfully used with the 
aforementioned experimental setup for creating hydrogel-filled tubes (L = 10 mm, ID = 5 
mm) containing small channels (Figure 71a).  
 
Figure 71: Hydrogel-filled tube (L = 10 mm; ID = 5 mm; Mn(HA) = 100 kDa; β(HA) = 15 mg/mL; TG = 0.57; gels 
synthesized in TRIS/BSS (c(TRIS) = 0.4 mol/l; pH = 8.5)) with a channel created by the mechanical method directly after 
sample preparation was finished (a) and after 48 hours of incubation in BSS (b). There was no visual indication of the 
presence of the channel after the swelling in BSS. 
5 mm 5 mm
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Samples made with this method were subjected to HPA measurements. There was still the 
issue of hydrogels being ejected from the tubes at relatively low pressures (See Figure 
69a). Nonetheless, pressure regulation of hydrogel-filled tubes with channels made by the 
physical method could be demonstrated by HPA (Figure 72). 
 
Figure 72: HPA measurement of a hydrogel-filled tube (ID = 5 mm) with channels formed using the small glass fibers 
(diameter = 0.1 mm). The pressure dropped to an average level of 2500 +/- 200 Pa after 2 hours (a) with long-term 
variations (b) mostly originating from pressure fluctuations within the lab. 
At a hydrostatic pressure of >6000 Pa, a slow liquid flow was detected that reduced the 
pressure to 2500 +/- 200 Pa, where it remained constant over the next 10 hours (Figure 
72a). Long-term measurements (Figure 72b) showed fluctuations of the pressure, which 
was attributed to changes in the air pressure within the lab affecting the balance. Future 
improvements therefore might be to conduct these measurements in an environment 
without environmental pressure fluctuations. Nonetheless, the results demonstrated a 
general ability of hydrogel-filled tubes created with the physical method for regulating 
external pressures. 
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2.5.3. Summary and conclusion 
In this section, the mechanism of the ability of hydrogel-filled tubes for pressure regulation 
was investigated (Section 2.5.1). Reactions of glass tubes filled with fluorescent hydrogels 
made from HS-FA-HA when exposed to elevated pressures of fluorescent solutions 
(Figure 63) and BSS (Figure 65) were observed. Water flow through the samples was 
enabled by the presence of small channels running coaxially through the tubes. 
Furthermore the presence of these channels only when samples were subjected to elevated 
pressures was demonstrated (Figure 65). From these findings, a theory for the mechanism 
of the pressure-regulatory properties of the gel-filled tubes was proposed (Figure 66). 
Hydrogels within tubes possess a flaw in the form of a channel, which in its natural state is 
closed due to hydrophilic interactions of the hydrogels. When a certain threshold for an 
external liquid pressure is reached forces exerted on the hydrogel open the channel, 
allowing for passage of liquid. The process is reversible and the channel closes when the 
elastic counterforces of the hydrogel surpass the external forces enacted by the pressurized 
liquid. 
Furthermore, a few basic experiments were conducted for artificially creating these 
channels within the hydrogels (Section 2.5.2). Two potential methods have been explored 
to achieve this goal. The optical method used a laser to “burn” channels into hydrogel-
filled tubes and the physical method inserted small glass fibers coaxially into the tubes 
prior to gel formation (Figure 67). Creating channels within gel-filled tubes (Figure 68 and 
Figure 71) and enabling them to regulate external liquid pressures was successfully 
demonstrated using HPA measurements (Figure 69 and Figure 72). The results in this 
chapter show, that it is generally possible to create HA hydrogel filled tubes with the 
potential to regulate the intraocular pressures with these methods. The concept for creating 
implants with the ability for treating glaucoma by regulating intraocular pressures was 
thereby proven. 
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3. Summary and Outlook 
3.1.1. Summary and Discussion 
The aim of this thesis was the development of a new type of medical implant for glaucoma 
therapy by grafting hyaluronan hydrogels on outer and inner surfaces of titanium tubes. 
The main idea was, that a hydrogel on outer surfaces, with a proper selection of 
parameters, would be able to facilitate cell adhesion and improve biocompatibility. 
Hydrogels on implant’s interiors would be able to prevent migration of cells to their 
insides and clogging of the implant. Furthermore they act as valves to regulate intraocular 
pressure, which is the main aspect of a successful glaucoma therapy.1 In order to fulfill 
these goals a number of steps have been undertaken for developing methods to create small 
tubes with their outer surfaces and interiors modified by hyaluronan hydrogels. They 
performed as model implants for future research. All methods have been developed in 
respect to a potential industrial manufacturing process of these implants, where further 
requirements concerning a possible simplicity, low costs and low hazardousness of the 
production steps have to be taken into account. . 
Synthesis of starting materials 
The first part of this thesis was concerned with synthesizing starting materials for creating 
hydrogels made from hyaluronic acid (Section 2.1). Modification of HA with thiols (HS-
HA) by a peptide coupling reaction was adapted from Shu et al.101 and successfully 
implemented. Degrees of substitution with thiols (thiolation grade) between 0.2 to 0.6 (n/n) 
were achieved by varying reaction times (10 min – 2 h). Furthermore, by examining HA 
with different molecular masses (Mn = 10 kDa, 60 kDa and 100 kDa), a size dependency of 
thiolation grades was revealed (Figure 21) with smaller size HA resulting in smaller 
amounts of active thiols. There are some speculations about reasons for these findings. It 
was expected, assuming a diffusion-limited reaction209, that saccharide chains of a smaller 
size would be more mobile and therefore react quicker than larger size counterparts. But 
since secondary and tertiary structures of hyaluronan in watery solutions are diverse, 
complex and not fully understood121 a possible reason might be a higher amount of 
intramolecular interactions of smaller-size HA. This may have resulted in a tighter 
structure (random coil etc.) and blocking access to reaction sites. Larger size hyaluronan 
on the other hand might form more intermolecular interactions, thereby creating more 
loose and mobile tertiary structures with more access to its reaction sites. But as already 
mentioned, this is so far speculation and with deeper understanding of hyaluronan 
structures in solutions, an answer might be found in the future. Still, thiolation grades were 
comparable to results published by Shu et al.102, where modification of larger HA (Mn = 
120 kDa) resulted in higher values for thiolation grades compared to polysaccharides 
examined in this thesis. 
In addition to the modification with thiol groups, fluorescent labeling of hyaluronan with 
fluoresceinamine (FA) was established (Section 2.1.1). This was achieved by adapting a 
NHS/EDC mediated peptide coupling reaction between amines of FA and carboxyl 
functions of hyaluronan similar as described in by Ogamo et al. and Belder et al.186,210 
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However the method was modified with an exclusion of organic solvents and only 
performed in watery solutions with parameters adapted from Sehgal et al.189 to improve the 
adaptability for potential industrial applications. In order to change hydrogel properties 
(Mn, hydrophilicity etc.) as little as possible synthesis parameters of FA-HA were selected 
for achieving low degrees of substitution (0.006 – 0.012 (n/n)). These numbers were 
comparable to the commonly used method developed by Ogamo et al.186 but without using 
organic solvents. 
In a next step, both methods for modifying hyaluronan with thiols and fluorescent labels 
were combined to create hyaluronan that simultaneously formed hydrogels and had 
fluorescent properties (Section 2.1.3). Since both reactions were competing for the same 
active sites of hyaluronan, the sequence was developed in a way to allow reproducing the 
grade of modification with thiols (thiolation grade, TG) (Figure 22). It was shown that the 
additional modification with FA did not have an impact on thiolation grades when using 
this sequence (Figure 25). Thiolated and fluorescently labeled hyaluronan (HS-FA-HA) 
was subsequently used to analyze their immobilization to glass and titanium surfaces 
(Section 2.2.3). Furthermore, hydrogels made from HS-FA-HA had fluorescent properties 
(Figure 38), which were used for analyzing an immobilization of these hydrogels into 
small tubes (Section 2.2.3) and their reaction to external liquid pressures (Section 2.5.1). 
These fluorescent HA hydrogels were already very useful for the experiments conducted in 
this thesis. In the future they may also find alternative uses in other areas of research, for 
example analyzing enzymatic degradation 190, cellular uptake 188 and other applications of 
hyaluronan hydrogels as biomaterials211. Especially their non-toxicity in addition to their 
inexpensiveness makes them a more probable candidate than for example quantum 
nanodots.212 
In conclusion, the methods for the synthesis of starting materials to create (fluorescent) 
hydrogels have been well established and should also be sufficient for an industrial 
production because of inexpensive starting materials, scalability of the involved reactions 
and minimal use of harmful materials. By using different reactions times it was easily 
possible to modulate thiolation grades for potentially creating hydrogels with different 
crosslinking densities and properties176 and manufacturing hydrogel-modified implants 
with the required abilities for glaucoma treatment. 
 
Immobilization of hyaluronan hydrogels on glass and titanium surfaces 
The next step, after synthesizing starting materials, was developing protocols to crosslink 
HS-HA into hydrogels and immobilize them on surfaces of model glaucoma implants. As 
outlined before (Section 1.6), a Thiol-Michael Addition between HS-HA and acrylamides 
was adapted from literature (Section 2.3.1).101,176 The main modification was implementing 
a buffer to enable a better control of the pH in small volumes. N,N’-
Methylenebisacrylamide (MBAA) was used as model crosslinker to allow longer handling 
times for modifying tubes with hydrogels (Section 2.2.3). The other crosslinker tested was 
poly(ethyleneglycol) bis(acrylamide) (PEGDA), which was not suitable since crosslinking 
occurred too quickly (< 5 min) (Figure 36).  
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For immobilizing hydrogels, the proposed method (Section 1.6) of grafting epoxide groups 
to glass and titanium surfaces with subsequent hydrogel formation and immobilization in 
one step was successfully implemented. In order to modify test surfaces with these reactive 
groups a reaction between surface-bound hydroxides with silanes was selected.173  
To that end protocols involving the surface hydroxylation/cleaning with a commercially 
available basic cleaning solution (Extran MA01) followed by incubation in silane/toluene 
solutions using (3-Glycidyloxypropyl)tri-methoxysilane (GPS) (Section 2.2.1) was 
implemented. Other surface activations, such as plasma173 or piranha solution197, had the 
disadvantages that they were potentially dangerous (piranha solution) or required a more 
expensive setup (plasma). Additionally they did not guarantee homogeneous surface 
modification for small tubes due to either a partial shielding of the tube’s interiors against 
reactive species (plasma) or bubble formation (piranha solution). Applying Extran 
probably resulted in a lower amount of hydroxyl groups on the surfaces, a lower number of 
epoxides attached and a less powerful immobilization. However, it was an inexpensive and 
almost non-hazardous method to activate samples and lowered the risk of accidents as well 
as production costs. Furthermore subsequent measurements showed hydrogels 
immobilized within model implants were able to resist pressures usually encountered 
within the glaucomatous eye (< 10000 Pa)3 (Figure 50 and Figure 51), thereby validating 
the use of Extra. In the same manner using toluene/silane solutions for silanization 
guaranteed homogeneous exposure of all surfaces of the small tubes to the silanes. While 
toluene is an organic solvent replacing it by water was not possible for further improving 
the non-hazardousness of the method, since silanes, as well as the epoxide would be 
hydrolyzed in such an environment. Nonetheless, it was shown, that the methods 
established in this thesis to form and covalently immobilize hyaluronan hydrogels 
selectively on the outer and inner surfaces of small glass and titanium tubes in one step 
was possible (Section 2.2.3 and Section 2.4.2 for the interior of titanium tubes). This 
provided a cheap and efficient way for selectively grafting hydrogels to different parts of 
potential glaucoma stents opposed to other methods that would require multiple steps 
(Section 1.6). The concept allows creating the hydrogels on the inside and the outside of 
the stents with different properties to manipulate cell adhesion (See Section 1.1) on an 
industrial scale. 
 
The pressure behavior of HA hydrogel filled tubes 
The main feature of using implants for glaucoma therapy is their ability to regulate 
elevated intraocular pressures9,19. One goal of this thesis was using hyaluronan hydrogels 
to act as pressure-sensitive valves for reducing pressures within a glaucomatous eye 
without draining too much liquid, thereby preventing hypotony32. For evaluating the 
capabilities of hydrogel-filled model implants to perform this function it was necessary to 
see how they would react when exposed to external liquid pressures.  
Before performing experiments concerning this issue, a number of basic swelling 
measurements were conducted for comparing hydrogels immobilized within glass tubes to 
non-immobilized “unobstructed” gels (Section 2.4.1).  
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Both types showed differing swelling rates with unobstructed gels initially absorbing water 
at a higher rate up to 62 times their calculated dry masses in the first 16 hours. Over the 
following 270 hours they contracted to a steady state with only 45 times their calculated 
dry masses (Figure 42). This initial volume expansion followed by deswelling was linked 
to the presence of TRIS residues from the sample preparation. Their presence in and 
subsequent diffusion out of the hydrogels during swelling influenced the osmotic forces109 
over time (Figure 43).  
This caused initial swelling followed by deswelling of unobstructed hydrogels. Instead of 
following the same behavior, constrained gels swelled to 55 times their calculated dry 
masses within 45 hours where they remained without significant changes for the rest of the 
observed duration. Limited initial swelling was inhibited by the physical barriers of the 
glass walls. Also covalent immobilization of hydrogels to these surfaces prevented 
hydrogel contraction afterwards. As a result deswelling of constrained gels was not 
possible, retaining higher volumes and amounts of liquid compared to the unobstructed 
samples. The mechanism was not fully explained though and further experiments, 
potentially using fluorescent probes to evaluate the pore size and diffusion rates within 
unobstructed and constrained hydrogels92, are necessary in the future. The in-depth 
analysis of this behavior was beyond the scope of this thesis and the HS-HA/MBAA 
hydrogels were only model systems. Therefore any such attempts were foregone until a 
proper crosslinker for influencing cell adhesion would be selected. 
For evaluating hydrogel-filled model stent’s reactions to external liquid pressures, two 
experimental setups were designed (Sections 2.4.2 and 2.4.3). In the “Continuous pressure 
application” (CPA) method, hydrogels were subjected to steadily increasing forces from 
liquid within a syringe (Figure 44). This method allowed determining the pressure levels 
where covalent immobilization of the hydrogels within the tubes failed, resulting in their 
removal (= breaking point) (Figure 49). Breaking points of immobilized hydrogels in small 
tubes (ID = 0.5 mm; L = 10 mm) (> 100000 Pa; (Figure 50)) were far above levels 
encountered in the glaucomatous eye (< 10000 Pa)3, verifying the potential applicability 
for manufacturing glaucoma implants. Also a number of hydrogel-filled tubes enabled 
controlled liquid flow when forces from the liquid exceeded certain thresholds (0.12 MPa 
up to 0.25 MPa depending on sample parameters) (Figure 53). Preliminary experiments 
further illustrated, that the resistance of the model implants was dependent on their 
parameters such as length (Figure 53) and the concentration of hyaluronan used to 
synthesize the hydrogels (Figure 54). An interesting effect was observed when several 
repeated CPA measurements were performed on a single sample. Similar to previous 
measurements the pressure first rose to a peak value (0.23 – 0.27 MPa) before declining 
into a steady state (0.1 MPa), while on subsequent measurements it was achieved directly 
(Figure 54a). This effect was recreated 24h later (Figure 54b), hinting at a reversible 
change within the hydrogel. At first unexplained its mechanism was later related to the 
presence of small channels within the hydrogel-filled tubes (Section 2.5.1) discussed 
further down.  
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Additionally the “hydrostatic pressure application” (HPA) method was established, which 
used a setup to expose hydrogel-filled tubes to hydrostatic pressures (Figure 59), which 
reflected the eye’s environment in a more realistic way than the closed systems of the CPA 
setup. HPA was successfully used for showing the potential ability of HA gel modified 
tubes acting as pressure-sensitive valves. A flow of liquid through these samples was only 
observed when pressure levels were above certain thresholds (Figure 60). However, 
pressures where liquid flow stopped (ca. 10000 Pa) were too high for target values in 
glaucoma therapy (21003). Therefore, further optimizations were required to adjust the 
implant’s pressure regulation accordingly with HPA being an effective method for 
achieving these optimizations in the future. The method was further utilized later for 
examining the applicability of processes for reproducibly generating this pressure 
regulatory effect (Section 2.5.2). 
CPA and HPA confirmed the general functionality of the model-implants for potentially 
regulating pressure of glaucomatous eyes. More research will be required in the future to 
optimize the implants’ parameters including tube size and gel properties until the required 
intraocular pressure of 2100 Pa can be achieved. The CPA and HPA methods developed in 
this thesis are complementary methods that can be used for the necessary follow up 
studies. However, to also provide enough samples for such optimization the reproducibility 
of stents had to be improved first. A first step in this direction was understanding the 
underlying mechanism of liquid flow, which was the main focus of the rest of this thesis. 
 
Exploration of the liquid flow mechanism through hydrogel-filled tubes and physical 
creation of channels 
While the general potential for generating pressure-induced liquid flow with hydrogel-
filled tubes was shown, further understanding the mechanisms of this process was 
required. Optimizing the yields of functional samples for a more efficient data collection 
and potential mass production was also necessary before further characterizations were 
feasible. To that end, an experimental setup was created for monitoring liquid flow through 
hydrogel-filled tubes on a microscopic level. It utilized the fluorescent properties of 
hydrogels created from HS-FA-HA by monitoring their behavior within small glass tubes 
with a microscope (Section 2.5.1, Figure 59). Measurements with fluorescent solutions 
(Figure 63) and BSS (Figure 65) exposed the existence of small channels conducting liquid 
flow observed during CPA and HPA previously. These channels were only present when 
pressure was applied to the samples (Figure 65b/d) and were confirmed for all HA-
modified tubes allowing pressure-induced liquid flow. A theory was proposed, that these 
channels naturally exist in a closed state due to interactions between and elastic forces of 
the hydrogel interfaces on their inside (Figure 66a). The channels opened when the 
external pressure exceeded a certain threshold to overcome these forces, enabling passage 
of liquid. A steady state was achieved when the forces from external pressures were in 
balance with the elastic counterforces from the hydrogels (Figure 66c). When pressure 
dropped low enough due to gels relaxing and their elastic counterforces closed the 
channels, thereby stopping liquid flow. 
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This theory was supported by iterative opening and closing of these channels (Figure 65) 
via application and removal of external pressures. Those results hint at a reversible 
mechanism, most probably due to the viscoelastic properties of hydrogels113,207 allowing 
for repeated opening and closing. This mechanism also explained the findings from CPA 
and HPA experiments. During CPA measurements, as mentioned before, pressures initially 
rose to a peak value (0.23-0.27 MPa) initiating liquid flow and subsequently declined to a 
steady state (ca. 0.1 MPa) (Figure 54). On subsequent rounds this peak was not observed 
and steady state was achieved immediately. This was explained by a residual pressure 
remaining in the closed system of the CPA setup preventing the hydrogels from fully 
relaxing and closing the channels. As a result subsequent measurements did not require 
additional forces to re-open the channels and induce flow, ultimately leading to the results 
shown in Figure 53. Similarly, the stop of liquid flow when pressures dropped to certain 
thresholds during HPA measurements on some samples (Figure 60) was explained by 
elastic counterforces of the hydrogels closing the channel.  
In conclusion this theory supported all experimental results of the CPA and HPA 
measurements as well as the channels observed on a microscopic level. Future experiments 
on a macroscopic scale should be able to further confirm this theory. Alternatively 
distributing additional dyes, fluorescent micro-beads e.g. within the hydrogels or only in 
the channels to illustrate possible deformations should be possible as well. 
Following this theory possibilities have been explored for creating these channels 
artificially and reproducibly (Section 2.5.2). Two concepts were tested: An optical method 
applied a CO2 laser for burning channels into crosslinked hydrogels within tubes was 
designed (Figure 67a). And a mechanical method, where a small fiber was inserted 
coaxially into tube prior to gel formation (Figure 67b) was tested. Performing these 
modifications on previously small tubes (ID = 0.5 mm) would have required a more 
elaborate setup to align samples with the laser or fibers. Therefore both methods were 
tested on larger tubes (ID = 5 mm), where it was possible to perform the necessary 
experiments manually and with standard lab equipment.  
For both setups, channels were generated within hydrogel-filled tubes (Figure 68, Figure 
71). Subsequent HPA measurements showed their ability for regulating hydrostatic 
pressures of the water column in the capillary with final pressure levels at 2500-3000 Pa 
(Figure 69, Figure 72). Concluding from these results it was decided that these methods 
were good candidates for creating hydrogel-enhanced glaucoma stents with the ability to 
regulate intraocular pressure of glaucomatous eyes. More research is required in the future 
however, since experiments regarding an artificial channel creation in this thesis were only 
conducted with "large" (ID = 5 mm) tubes. Therefore, in a next step, possibilities for 
miniaturization have to be explored, since glaucoma implants are usually of a much 
smaller size (<1 mm OD).35,213  
To that end both designs show a number of advantages and potential problems. The optical 
method is probably very suitable for the miniaturization itself, since these days lasers of 
nanoscale sizes exist214 that could be adapted for creating smaller implants.  
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However, preliminary results in this thesis illustrated, that channels would often not form 
homogeneously (Figure 68a). As a result many parameters (Laser type, laser power, 
placement of focus area, movement speed, etc.) influencing this process have to be 
optimized for reproducing samples with the same properties. The physical method would 
be easier in terms of parameter optimization since channel sizes only depend on the 
thickness of utilized fibers. The downside is a dependency on using small-scale materials 
and their handling. Fibers smaller than < 0.1 mm in diameter have to be aligned coaxially 
within small tubes (OD = 0.6 mm and less)213 For this, utilizing robotics is the most 
probable solution. Both methods, however, might simplify optimizing the pressure 
regulatory abilities of the implants, without overly adjusting hydrogel parameters. Instead 
varying the channels’ diameters might be sufficient to adjust implants for lowering 
intraocular pressure to normal levels (2100 Pa)3. Still, more research is necessary to 
examine, which of these methods is more reliable and cost-effective for a mass production 
of implants and how to conduct an optimal miniaturization. 
 
 
 Outlook 3.2.
The results of this thesis, comprising most importantly starting material synthesis, the 
immobilization of HA hydrogels to glass and titanium tubes and pressure related 
experiments on these model implants, are fundamental steps towards a new type of implant 
for glaucoma treatment. Further research has to be conducted for designing and optimizing 
hydrogel-modified model stents to employ them in medical applications and production in 
an industrial scale. First crosslinkers for HA-hydrogel polymerization with the desired cell 
attachment regulating properties as described in Section 1.6 have to be found and tested. 
Promising candidates could be the desmosine-inspired crosslinkers developed by Hagel et 
al.176 HA hydrogels created with these crosslinkers have to be further characterized 
concerning swelling behavior, elastic modulus, cell attachment and long-term stability. 
Some basic data concerning swelling has already been shown in this thesis. Still, a more 
thorough exploration of the swelling behavior in respect to the finally used crosslinker, 
crosslinking density, hyaluronan size and HA concentrations prior to crosslinking have to 
be conducted for a better understanding of the system. Closely related to this topic is the 
elastic modulus of the crosslinked networks depending on the same parameters than the 
swelling.176 Elasticity is of importance since cell adhesion behavior is dependent on the 
target surfaces stiffness.215 It is also of interest to investigate a correlation between 
swelling, elastic modulus and the pressure resistance behaviors presented in Sections 2.4 
and 2.5. Even more interesting is the influence of elastic modulus on the channel opening 
and closing mechanism described in Section 2.5.1. More specifically, how changes of the 
hydrogel parameters impact swelling, elasticity and in turn pressure resistance. In addition 
cell experiments have to be performed with the HA hydrogels for finding compositions 
with cell adhesive properties on the outside of the tubes and cell repellent properties on the 
inside. Gels in the tubes’ interiors are the challenging part since they have to perform as 
valve and as cell repellant at the same time.  
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Furthermore long-term stability experiments with model-implants modified with HA gels 
fulfilling the said requirements need to be conducted. Specifically, whether the hydrogels 
would be enzymatically degraded, which was something the fluorescent hydrogels 
established in this thesis could be used for. It would also be important to examine, if the 
immobilization of the gels to the tubes’ surfaces deteriorates and whether their pressure 
regulatory abilities change over time. Since glaucoma implants need to be in use for an 
extended period of time, the long-term stability has to be tested probably over the course of 
several years.  
Another very important area for future research is optimizing the methods established here 
for generating smaller-size implants. Their general applicability, as presented in this thesis, 
for creating the envisioned glaucoma implants (See Section 1.6) has been verified. 
However, they were so far only performed on model systems, which were too large for the 
actual implantation into the human eye. Especially the physical insertion of channels 
within hydrogels discussed in Section 2.5.2 requires further optimization of the methods 
for applying them to smaller tubes. For “burning” channels into hydrogels a thinner laser-
beam has to be selected and systems to exactly align laser and sample need to be 
established, probably by utilizing robotics. Afterwards optimizing parameters (laser power, 
etc.) is necessary for reliably creating channels with defined sizes and properties. The setup 
for creating these channels with a microfiber also needs to be improved for exactly 
aligning them coaxially within tubes.  
A solution will probably be found again in the field of robotics, where manipulations on 
such small scales are not an issue. In addition, setups need to be developed for establishing 
large-scale industrial manufacturing processes. 
The in vivo performance of the new implants also needs to be explored. To that end animal 
tests will be necessary for confirming a potential non-hazardousness of the new implants in 
vivo. Furthermore the properties of implants concerning an improved biocompatibility as 
well as the pressure regulation envisioned in Section 1.1 need to be examined, especially 
concerning inflammatory responses. Finally clinical trials have to be conducted for 
showing an improvement of the glaucoma therapy with HA gel modified implants 
compared to other established designs43 and treatments.9,24,28 Specifically whether 
occurrence of bleb fibrosis is reduced by using these new types of hydrogel-modified 
implants. 
Although much more research will have to be done in the future before a commercial 
product can be realized, the fundamental methods and steps for the final objective, a new 
superior implant for the treatment of glaucoma, have been established in this thesis. This 
brought the vision of an improved glaucoma therapy for millions of affected people 
worldwide one step closer to reality. 
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4. Materials and Methods 
 Modification of Hyaluronan 4.1.
Hyaluronic acid was functionalized with thiol groups for immobilization and crosslinking 
as well as with fluorescein for visualization. 
4.1.1. Materials 
Hyaluronic acid of different sizes (Mn = 10 kDa; 60 kDa; 100 kDa) was bought from 
Lifecore Biomedical (Chaska, U.S.A). N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC; CAS: 25952-53-8), deuterium dioxide (D2O; “100%”; CAS: 7789-
20-0), N-Hydroxysuccinimide (NHS; CAS: 6066-82-6), 3,3’-Dithiodipropionic acid 
(DTPA; CAS: 25952-53-8), (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
(HEPES; CAS: 7365-45-9) and fluoresceinamine, isomer I (FA; CAS: 3326-34-9) were 
bought from Sigma Aldrich (St. Louis, U.S.A.). Ethanol (EtOH; p.a.; CAS: 64-17-5), 
sulfuric acid (H2SO4; 95-98%, CAS: 7664-93-9), sodium chloride (NaCl; p.a.; CAS: 7647-
14-5), magnesium sulfate (MgSO4; p.a.; CAS: 7487-88-9) and hydrochloric acid (HCl; 
37%; CAS: 7647-01-0) were purchased from Carl Roth (Karlsruhe, Germany). Sodium 
hydroxide solution (NaOH; 6 mol/L; CAS: 1310-73-2) was obtained from Merck 
(Schwalbach, Germany). Low size, low polydispersity HA (Mn = 60 kDa) was purchased 
from Lifecore Biomedical (Chaska, U.S.A.). 5,5’-Dithiobis(2-nitro-bencoic acid) (DTNB) 
was purchased from Serva Electrophoresis GmbH (Heidelberg, Germany). 1,4-
dithiothreitol (DTT; CAS: 3483-12-3) was purchased from biomol (Hamburg, Germany). 
For lyophilization, a freeze dryer (model: P8K-E-85-4) from Dieter Piatkowski 
Forschungsgeräte (Munich, Germany) was used. 1H-NMR spectra were obtained using a 
Bruker Spectrospin 300 Ultrashield (Bruker, Billerica, U.S.A.). Absorbance measurements 
were performed with a Tecan infinite M200 (Tecan, Männedorf, Switzerland). The 
ultrasonicator (Bandelin Sonorex; 60/240 W; 35 kHz) was obtained from Bandelin 
electronic (Berlin, Germany). 
 
4.1.2. Modification of hyaluronan with thiol groups 
Synthesis of 3,3’-dithiobis(propanoic hydrazide) 
The protocol was adapted and modified according to a publication of Vercruysse.190 10 g 
(48 mmol) of 3,3’-dithiobis(propanoic acid) (DTPS) were dissolved in 100 mL of EtOH, a 
few drops of concentrated H2SO4 were added, and the mixture heated under reflux and 
oxygen exclusion. The solution was concentrated to 40 ml under reduced pressure (40° C; 
100-150 mbar) and transferred to a separatory funnel by the addition of 120 ml ethyl 
acetate. Two washing steps of the organic phase were conducted using first 60 ml ddH2O 
followed by 60 mL of a saturated NaCl solution. After a drying step using MgSO4, the 
solvent was removed under reduced pressure (40° C; 240 mbar) yielding the oily 
propanoic ester intermediae product. The ester was re-dissolved in 30 ml EtOH and added 
drop-wise to a stirred solution of 30 ml hydrazide hydrate in 20 ml EtOH.  
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The mixture was heated under reflux for 6 hours, after which the propanoic ester was fully 
consumed, as determined by thin-layer chromatography. A crystallization of 3,3’-
dithiobis(propanoic hydrazide) DTPH started at room temperature and was completed at 4° 
C over night. The solvent was drained and the raw product was washed with hexane and 
dried under vacuum at 50° C for several days, yielding a white crystalline solid. Success of 
the reaction was determined via 1H-NMR (D2O) (see Section 6.2). 
 
Modification of hyaluronan with 3,3’-dithiobis(propanoic hydrazide) 
The protocol was adapted and modified according to a publication of Shu et al.101 1 g (2.5 
mmol) HA was dissolved in 100 ml ddH2O (β = 10 mg/ml) and the pH adjusted to 4.75. 
1.33 g DTPH were added and, after complete dissolution was achieved by prolonged 
stirring, the reaction was initiated by the addition of 960 mg EDC. The reaction was kept at 
room temperature for 10 min to 2 h depending on the desired thiolation grade while the pH 
was constantly re-adjusted to 4.75 with HCl (1 mol/l). After the required time the reaction 
was stopped by elevating the pH to 7.0. The mixture was O2-purged with Argon (30 min) 
and 5 g DTT were added before adjusting the pH to 8.5, followed by stirring for 24 h at 
room temperature in sealed round-bottomed flasks. The pH was lowered to 3.5 and the 
solution dialyzed with HCl (pH = 3.5) until a sample of the dialysis buffer remained 
colorless after the addition of 1 mL to 3 mL of a basic (pH = 8.5) DTNB solution (β = 1 
mg/ml). The purified product was frozen and lyophilized, yielding thiolated hyaluronan 
(HS-HA) with a colorless solid foam-like appearance. Products were stored at -20° C in 
parafilm-sealed falcon tubes. 
 
Evaluation of the reaction time dependency of the thiolation grade 
These experiments were conducted to gain information on the thiolation grade in relation 
to different reaction times. 1 g (2.5 mmol) HA was dissolved in 100 ml ddH2O (β = 10 
mg/ml) and the pH was adjusted to 4.75. 1.33 g DTPH were added and, after complete 
dissolution was achieved by prolonged stirring, the reaction was initiated by the addition of 
960 mg EDC. The pH was constantly re-adjusted to 4.75 with HCl (1 mol/l). At set time 
intervals (10 min; 30 min; 60 min), 25 mL samples were drawn from the mixture and 
transferred into 50 mL round-bottomed flasks where the reaction was stopped by an 
increase of the pH to 7.0 using NaOH (6 mol/l). The reaction of the remaining fraction was 
stopped after 120 min by raising the pH 7.0 using NaOH (6 mol/l). All fractions were 
oxygen purged for 30 min with argon before 1.25 g DTT were added and the pH adjusted 
to 8.5. Disulfide reduction commenced for 24 hours at room temperature in sealed round-
bottomed flasks. The pH was lowered to 3.5 and the solution dialyzed with HCl (pH = 3.5) 
until a sample of the dialysis buffer remained colorless after the addition of 1 mL to 3 mL 
of a basic (pH = 8.5) DTNB solution (β(DTNB) = 1 mg/ml). The products were four HS-
HA fractions with different grades of thiolation. 
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Analytical methods 
General success of the HA modification with thiols was determined with 1H-NMR while 
the grade of thiolation was determined with a modified Ellman’s test. For the NMR 
measurements, 3-5 mg of the thiolated HA were dissolved in D2O and spectra recorded at 
300 MHz. 
For the Ellman’s test, a serial dilution of cysteine in HCl (β(Cysteine) = 0.015 mg/mL-0.15 
mg/ml; pH = 3.5) and a sample solution of HS-HA in HCl (β(HA) = 5-10 mg/ml; pH = 
3.5) were prepared. 50 µL of the sample and serial dilution were distributed in a 96-well 
plate (8 wells for each dilution and sample) and 150 µL of a mixture consisting of 3 mL 
DTNB in a basic solution (β(DTNB) = 1 mg/ml; pH = 8-10), 15 ml ddH2O and 2 ml TRIS 
solution (c(TRIS) = 1 mol/L; pH = 8.5) were added. After a 10 min incubation at room 
temperature, the absorbance in each well at λ = 412 nm was measured. The absorption of 
the serial dilution was plotted against the cysteine concentrations (= concentrations of –SH 
groups). A linear fit was performed using the commercially available “Origin” software 
and a linear equation calculated, which was subsequently used to calculate the amount of 
thiol groups in the sample solutions. These values were subsequently used to calculate the 
total mass of thiopropoionic hydrazide groups attached to the HS-HA using the formula m!"# = 𝑛!"# ∗𝑀!"# =   𝑛!" ∗𝑀!"# 	   Equation 4:1 
with mTPH as the total mass of TPH, nTPH the amount of TPH, MTPH the molar mass of TPH 
and nSH the amount of thiols in the sample. The total mass of HA was calculated after the 
formula m!" =   𝑚! −   𝑚!"# 	   Equation 4:2 
with mHA as the mass of the hyaluronan fraction and m0 the total masses of the HS-HA 
sample. From mHA the amount of HA in the sample (nHA) was calculated. Finally the 
thiolation grade (TG) was determined with TG =    𝑛!"𝑛!"	   Equation 4:3 
 
The Ellman’s test was performed at least three times on each sample to determine the 
average thiolation grade with the standard deviation forming the error bars. 
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4.1.3. Modification of hyaluronan with fluorescent markers 
Binding of Fluoresceinamine to HA 
640 mg (1.8 mmol) of FA was dissolved in 40-50 ml of ddH2O by the drop-wise addition 
of NaOH (6 mol/l) followed by alternating ultrasonication (240 W; 35 kHz) and manual 
shaking until it fully dissolved. The mixture was added to a solution of 500 mg HA (1.3 
mmol) in 100 ml HEPES buffer (c(HEPES) = 0.1 mol/l; pH = 7.0). After stirring for 30 
min, the reaction was initiated by the addition of 656 mg (4.2 mmol) EDC and 1 g NHS 
(8.7 mM) and maintained for 5 hours. NaOH (6 mol/L) was added drop-wise to the 
resulting viscous and cloudy solution until it cleared. Dialysis was performed against 
diluted NaOH (pH = 10.0), with frequent changes of the dialysis medium until it remained 
colorless for an extended period of time. The product solution was frozen and lyophilized 
to yield a solid yellow foam-like substance of fluorescein-marked hyaluronan (FA-HA). 
 
Analytical methods 
Reaction success was determined visually by confirming the yellow color of the product. 
In order to determine the degree of substitution (n(FA)/n(disaccharide units) a serial 
dilution of FA (β(FA) = 0.007-0.07 mg/ml) in borate buffer (c(borate) = 0.1 M; pH = 8.5) 
and a sample solution of FA-HA (β (FA-HA) = 2.5 mg/ml) were distributed in a 96-well 
plate (8 wells each). The absorbances of the serial dilution and samples were measured at λ 
= 440 nm, and the values of the serial dilution plotted against their concentrations using the 
commercially available “Origin” software. The linear fit was obtained and the linear 
equation calculated using the same software, which was subsequently used to gain the total 
amount of FA and their respective total masses in the sample by using their measured 
absorptions. The total masses of HA and amounts were gained using the formula  n!" =   𝑚! −   𝑚!"𝑀!" 	   Equation 4:4 
with nHA the total amount of HA, mFA the total mass of FA and m0 the total combined 
masses in the sample and MHA the molar mass of HA. Subsequently the degree of 
substitution was determined by  d. s.=    𝑛!"𝑛!"	   Equation 4:5 
with d.s. as the degree of substitution, nFA the total amount of FA gained from the 
experimental values and the linear equation and nHA the total amount of HA obtained from 
Equation 4:4. 
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4.1.4. Combined modification of hyaluronan with fluorescein and thiol groups 
1 g (2.5 mmol) HA were dissolved in 100 ml MilliQ water (β = 10 mg/ml) and the pH 
adjusted to 4.75. 1.33 g DTPH were then added, and after complete dissolution by 
prolonged stirring, the reaction was initiated by the addition of 960 mg (5 mmol) EDC. It 
was kept at room temperature for 10 min to 2 hours depending on the desired thiolation 
grade while constantly re-adjusting the pH to 4.75 with HCl (1 mol/l). Afterwards, the 
reaction was stopped by raising the pH to 7.0 and the solution was dialyzed against 
distilled water. 2.38 g HEPES (10 mmol) were added, the pH re-adjusted to 7.0. 640 mg 
(1.8 mmol) FA were dissolved in 40-50 ml water by the drop-wise addition of NaOH (6 
mol/l), ultra-sonication (240 W; 35 kHz) and manual shaking followed by addition to the 
HA solution. After stirring for 30 min, the reaction was started by the addition of 656 mg 
(4.2 mM) EDC and 1 g NHS (8.7 mM) and maintained for 5 hours. Concentrated NaOH (6 
mol/l) was added drop wise to the resulting viscous and cloudy solution until it became 
clear (pH = 10-11). Dialysis was performed against NaOH (pH = 10), with frequent 
changes of the dialysis medium until it medium remained colorless for an extended period 
of time. The mixture was O2-purged with Argon (30 min) and 5 g DTT were added before 
adjusting the pH to 8.5, followed by stirring for 24 h at room temperature. The pH was 
then lowered to 3.5 and the solution dialyzed with diluted HCl (pH = 3.5) until a sample of 
the dialysis buffer remained colorless after the addition of a basic (pH = 8.5) DTNB 
solution (β(DTNB) = 1 mg/ml). The purified product solution was frozen and lyophilized, 
resulting in the thiolated, fluorescently labeled hyaluronan (HS-FA-HA) with a solid 
yellow foam-like appearance. Products were stored at -20° C in parafilm-sealed falcon 
tubes. 
 
For a comparison of the thiolation grade between HS-HA and HS-FA-HA the HA/DTPH 
mixture was split into two fractions. One fraction was further modified with FA following 
the protocol established in Section 4.1.3 to produce HS-FA-HA. The other fraction was 
further processed to HS-HA following the protocol established in Section 4.1.2. The 
protocols were scaled appropriately to accommodate the reduced amount of HA due to the 
fractioning. 
 
Analytical methods 
The methods described in sections 4.1.2 and 4.1.3 were applied to determine the thiolation 
grade and the degree of substitution of FA. 
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 Immobilization of hyaluronan to glass and titanium surfaces 4.2.
Surfaces of glass and titanium were silanized and fluorescently labeled hyaluronan 
covalently immobilized. 
4.2.1. Materials 
Glass slides (18 x 18 mm) (Article number: 0657), were obtained from Carl Roth 
(Karlsruhe, Germany). Glass tubes (borosilicate, OD: 1 mm; ID: 0.5 mm; length: (2-20 
mm) were manufactured at the glass workshop of the Max Planck Institute for Intelligent 
Systems, Stuttgart. Titanium tubes (ID: 0.3 mm; OD: 0.5 mm) were obtained from 
Euroflex GmbH (Pforzheim, Germany) and cut to 10 mm length by the workshop of the 
Max Planck Institute for Intelligent Systems, Stuttgart. The setup for the partial 
silanization of flat surfaces was manufactured by the precision mechanics workshop from 
the Max Planck Institute for Intelligent Systems in Stuttgart. Extran®MA 01 (Extran) 
alkaline solution was obtained from Merck (Schwalbach, Germany) as well as (3-
Glycidyloxypropyl)trimethoxysilane (GPS), 3-(Aminopropyl)triethoxysilane (APTES) 
were bought from Sigma Aldrich (St. Louis, Germany). 1H,1H,2H,2H-
Perfluorotrichlorosilane (PFS) obtained from abcr GmbH & Co. KG (Karlsruhe). A two-
component dental glue (Picodent twinsil® speed 22) was obtained from Picodent 
(Wipperfürth, Germany). For contact angle measurements a Contact Angle System (OCA) 
from Dataphysics (Filderstadt, Germany) was used. The fluorescence measurements were 
performed on an Axiovert 200M with a 38 HE eGFP (Ex: 470/40 Em: 525/50) filterblock 
(Zeiss, Oberkochen, Germany). The ultrasonicator (Bandelin Sonorex; 60/240 W; 35 kHz) 
was obtained from Bandelin electronic (Berlin, Germany). 
 
4.2.2. Basic silanization protocol 
Glass slides or titanium sheets were immersed in Extran for >2 h, rinsed in MilliQ water, 
dried in an N2 stream and immersed in a 2% (v/v) solution of silane in toluene (99.9%) for 
24 hours. The silanized samples were cleaned with two sonication steps (240 W. 35 kHz), 
toluene followed by EtOH, for 15 min each. The same protocol was applied for the 
silanization small (ID = 0.5 mm) and large (ID = 5 mm) tubes in the following sections. 
The only addition to this protocol was to avoid the formation of air bubbles on the tubes’ 
interiors. 
 
Analytical methods 
Success of the silanization was determined by comparing the surface energies of 
unmodified and silane-modified samples. A serial dilution with different amounts of 
volume fractions Φi of ethyleneglycol and ddH2O was prepared according to (Table 3). 
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Table 3: Serial dilution used for the determination of the surface energies of silanized surfaces. ΦW and ΦE denoted the 
volume fractions of water and ethyleneglycol respectively and γLV the liquid/surface tension according to Tsierkezos et 
al.200 
ΦW	   ΦE	   γLV	  
0	   1	   49.15	  
0.6	   0.4	   54.97	  
0.9	   0.1	   60.69	  
1	   0	   72.58	  
 
The average contact angles of the water/ethyleneglycol mixtures were recorded on 10 
different points of the surface of a silanized glass or titanium slide. This was achieved by 
manually placing a small drop on the surface with a syringe. Using the built-in camera an 
image of the drop’s silhouette was taken and the contact angles on both sides of the drop 
determined by the accompanying program. From these two contact angles the median 
contact angle was calculated. For each sample ten drops were analyzed and the average 
median contact angle from all drops was determined. This process was repeated with all 
sample solutions of the serial dilution, with extensive rinsing first with EtOH (99%) and 
ddH2O to clean the sample surfaces in-between the measurements. 
Data analysis was conducted after the simplified formula established from Balkenende et 
al.198 
𝑐𝑜𝑠𝜃 = −1+Φ2 𝛾!"𝛾!" 𝑒!!,!!!"#$%(!!"!!!")! 	   Equation 4:6 
 
with Θ being the contact angle, γSV the surface-vapor and γLV the liquid-vapor tensions. 
The exponential term was treated as being a constant 1 for simplification. By plotting 
cosΘ against (γLV)-0.5 using the “Origin” software followed by a linear fit with the y-axis 
intersection at -1 it was possible to calculate γSV from the slope. The absolute error of the 
slope was calculated by Origin from the fitting of the slope including the individual 
standard deviations of each data point. 
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4.2.3. Immobilization of hyaluronan on partially silanized flat surfaces 
Immobilization of HA 
HS-FA-HA was prepared as described in Section 4.1.4. Flat glass and titanium slides 
silanized with GPS were prepared following the basic protocol in Section 4.2.2. Partial 
silanization was achieved by the use of a “silanization chamber” that was constructed to 
modify 18mm x18 mm glass or titanium slides (Figure 73). 
 
Figure 73: (a): Schematic drawing of the setup used for a partial silanization of flat samples with GPS. By placing the 
liquid container on top of the flat glass or titanium sheet in the sample holder and filling it with a silane/GPS mixture, 
only the part of the sheet’s surface in contact with the silane solution was silanized. (b): The picture shows a 
disassembled and (c) a fully assembled setup. 
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The Extran treated and H2O rinsed substrates were placed in the sample holder and the 
liquid container placed on top, guided by the metallic pillars. Pressure was applied to the 
liquid container by placing and tightening the screws along the threads to prevent a leakage 
of liquid between the interfaces of substrate and container. See Figure 73c for an 
assembled setup. 1 mL of GPS/toluene solution (2% v/v) was injected into the liquid 
container with a syringe and the entrance sealed with a small glass plate (18 mm x 18 mm) 
to prevent an evaporation of toluene. Silanization commenced at room temperature for 
24h. Afterwards, the samples were removed and cleaned by ultra sonication (240 W; 35 
kHz) first in toluene followed by EtOH for 15 min each. 
Directly after cleaning the samples were immersed in a 10 mg/ml HS-FA-HA solution (TG 
= 0.32) for 24 h at 37°C resulting in the formation of a layer of disulfide-crosslinked gel. 
The plates were washed manually, first by immersing them in water and careful shaking 
followed by rinsing in a water jet (low pressure). If the immobilization was successful, 
residual HS-FA-HA gel remained only on silanized parts. The samples were dried in air 
and the residues were further analyzed using fluorescence microscopy. Images of the 
whole area with the gel residues were taken with the Axiovert and put together into a 
combined picture manually using the freeware “Inkscape” (www.inkscape.com) program. 
 
4.2.4. Selective hyaluronan immobilization on the outer and inner surfaces of small 
glass and titanium tubes 
Immobilization of HA 
Glass and titanium tubes were silanized with GPS following the protocol in Section 4.2.2. 
Special care was taken to avoid air bubbles during the immersion in either Extran or the 
silane/toluene solutions. 
For a modification of the inner surfaces of tubes with fluorescent HA, they were connected 
to each other in series with short pieces of plastic tubing (see Figure 74a). FA-HA solution 
in PBS (β(FA-HA) = 3 mg/ml; pH = 7.4) was injected into the setup using a syringe. In 
order to modify the outer surface of the tubes, both ends were sealed with dental glue 
immediately after silanization (see Figure 74b) and immersed in an HS-HA solution in 
PBS (β(FA-HA) = 3 mg/ml) for 24 h. After an incubation period of 24 h at 37° C in a cell 
incubator, the samples were rinsed manually with ddH2O using a syringe (modification on 
the inside) or by a full immersion (modification outside), and then further washed by 
placing them in a PBS-Tween solution (β(Tween) = 1 mg/ml; pH = 7.4) on a vibrating 
plate (~60 rpm) for 7 days at room temperature. 
 
Figure 74: (a): Experimental setups used for the selective immobilization of FA-HA to the inner (a) or outer (b) surfaces 
of small glass tubes silanized with GPS. (a): The samples were connected with small pieces of elastic tubing. (b): A 
watertight polymer (dental glue) was grafted to the entrances of each individual tube. 
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Analytical methods 
The quality of the hyaluronan immobilization was assessed by fluorescence microscopy. 
For comparison, a non-silanized sample, which was subjected to the same FA-HA 
modification and washing protocols except the silanization, was placed alongside the test 
sample. Bright-field and fluorescence images were made manually and the signals between 
silanized and non-silanized samples were compared. 
  
 Creation and immobilization of hyaluronan hydrogels 4.3.
Hydrogels were formed by a reaction between thiolated hyaluronan and bi-functional 
acrylamides. Also hydrogels were immobilized on silanized surfaces. 
4.3.1. Materials 
N,N’-Methylenebis(acrylamide) (MBAA) was obtained from Carl Roth (Karlsruhe, 
Germany). Poly(ethylene glycol) dicarylamide (PEGDA) was obtained from Sigma 
Aldrich (Schnelldorf, Germany). Tris(hydroxymethyl)-aminomethan (TRIS) was obtained 
from Serva (Heidelberg, Germany) and “Balanced Saline Solution” (BSS) was obtained 
from Beaver Visitec (Waltham, U.S.A.). Molds for the creation of macroscopic gels (See 
Figure 84) were designed using the Autodesk Inventor Professional 2014 (64-Bit Edition) 
software from Autodesk (San Rafael, U.S.A.) and the “Replicator 2” software from 
Makerbot (New York City, U.S.A.). They were 3D-printed using the Makerbot Replicator 
2 and polylactide (PLA), both obtained from Makerbot. Simultaneously, molds made from 
PTFE were manufactured by the precision mechanics workshop of the Max-Planck-
Institute for Intelligent Systems in Stuttgart. QCMD tubing (Tygon® ST R-3607; ID = 
0.64 mm) was obtained from Ismatec (Wertheim, Germany) and TPP tubing  (ID = 0.51 
mm) was obtained from Helix Medical (Kaiserslautern, Germany). 2-component dental 
glue (Picodent twinsil® speed 22) was purchased from Picodent (Wipperfürth, Germany). 
For fluorescence measurements, an Axiovert 200M with a 38 HE eGFP (Ex: 470/40; Em: 
525/50) (Zeiss, Oberkochen, Germany) was used. 
 
4.3.2. Formation of hydrogels 
General procedure 
Hyaluronan hydrogels were synthesized by mixing HS-HA or HS-FA-HA solutions with 
MBAA or PEGDAA solutions. To that end, modified HA and crosslinker (CL) were 
dissolved separately in a solution of TRIS in BSS (0.4 mol/l; pH = 8.5), which was O2 
purged using Argon gas before use. The total masses of HA and CL, and the required 
volumes of the solvents for the HA and CL solutions, depended on the desired final mass 
concentration of HA after mixing, the target ratio of the crosslinkers’ acrylamide groups to 
the number of active thiols, and the total required volume of the HA/CL mixture for each 
individual experiment. The HA and the CL solutions were mixed in a ratio of 
V(HA)/V(CL) = 7:3 and individual concentrations of starting materials in the individual 
solutions calculated based on that ratio (See Table 4). 
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Table 4: MBAA concentrations in [mg/ml] for creation of hydrogels depending on thiolation grades (TG) and HA 
concentrations 
  β(HA) [mg/ml] 
  10.0 12.5 15.0 17.5 
TG 
0.19 1.20 1.50 1.80 2.10 
0.23 1.44 1.80 2.16 2.52 
0.39 2.35 2.93 3.52 4.11 
0.42 3.51 3.14 3.76 4.39 
0.57 3.29 4.11 4.93 5.75 
 
For the PEGDA crosslinker gelation started within 30 s at room temperature, and within 5-
8 min when both solutions were cooled to 0 °C in an ice bath, resulting in a sharp increase 
of viscosity. Full gel formation was achieved in under <5 min (RT) or >15 min (0°C). HS-
HA/MBAA solutions formed gels after an incubation over night at 37 °C, under oxygen 
exclusion in order to minimize disulfide formation. If not immediately used afterwards, the 
resulting hydrogels were immersed in BSS for long-term storage. 
 
Generation of macroscopic non-immobilized and immobilized gels 
For the synthesis of macroscopic gels, 450 µL of the HA/CL mixture was poured into the 
molds. Small glass or titanium slides were placed on top and secured with adhesive tape 
and the molds turned upside down This resulted in the mixtures resting on top of the 
silanized samples, allowing interaction between the thiol groups and the epoxides (See 
Figure 75). All samples were placed into a petri dish, which was flushed with argon for 30 
s and sealed with Parafilm followed by an incubation at 37 °C for 24 hours. For 
immobilized hydrogels slides silanized with GPS were used. Non-immobilized hydrogels 
were created by using non-silanized slides. 
 
 
Figure 75: Schematic drawing for the formation and immobilization of macroscopic hydrogels on flat silanized samples. 
(a): The HS-HA/MBAA solution as filled into the mold and the silanized sample was placed on top and secured with 
adhesive tape (not shown). (b): The setup was turned upside down to bring the HS-HA/MBAA solution in contact with 
the surface of the sample. (c): After gel formation and immobilization occurred, the hydrogel-modified plate was 
removed from the mold. The same setup was also used for an immobilization on glass samples. For the creation of non-
immobilized gels, unmodified slides were sued. 
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Modification of small tubes with hydrogels 
In order to modify the inside of the glass tubes, the samples were connected in series using 
short QCMD tubing (length = 1 - 2 cm) to form a long channel (see Figure 74a), and an 
HS-HA/MBAA mixture was manually injected using a syringe. The whole setup was 
placed into a plastic petri dish, which was subsequently flushed with argon and sealed with 
parafilm. The petri dishes were placed at 37 °C for 24 hours before the QCMD tubing was 
removed and the glass samples placed in BSS for 48 hours before performing further 
measurements on them. 
For a selective modification of the outer surface, the ends of the tubes were sealed with 
dental glue (Figure 74b) and immersed in an HS-HA/MBAA solution in a small beaker. 
After flushing with argon and sealing the beaker with parafilm, it was placed in a cell 
incubator at 37 °C for 24 hours. Afterwards, the glue was removed and the samples stored 
in BSS for at least two days prior to further measurements.  
 
Modification of large glass tubes (ID = 5 mm) with hydrogels 
The tubes were placed within the special sample holders and the lid fastened on top with 
the screws. Through the hole in the lid, the HS-HA/MBAA mixtures were injected with a 
syringe. The hole was sealed with a small glass plate (18 mm x18 mm) and the whole 
setup placed in a cell incubator at 37° C for 24 hours. Afterwards the lid was removed and 
the hydrogel-modified sample retrieved. For a picture for the whole setup compare Figure 
81c without using a glass fiber. 
 
Analytical methods 
The immobilization of macroscopic gels on flat titanium and glass slides was confirmed by 
rinsing the samples in water manually. To that end, the slides were first inserted into 
ddH2O and shaken by hand, then carefully subjected to a low to medium strength water 
flow. Immobilization was deemed a success when the gel remained on the slides 
throughout and after this procedure. 
Immobilizations of hydrogels on glass and the outer surfaces of titanium tubes with 
hyaluronan were confirmed by using HS-FA-HA for the modification and observing the 
samples with fluorescence microscopy. For that bright-field and fluorescence images were 
taken from every part of the tubes and manually put together using the freeware program 
“Inkscape” (www.inkscape.com). The covalent immobilization of the hydrogels to the 
inner surfaces of the Ti tubes was confirmed indirectly during pressure resistance 
experiments (see section 4.5). 
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 Swelling behavior of hydrogels 4.4.
Immobilized and non-immobilized hydrogels were incubated in BSS to compare their 
swelling behavior. 
4.4.1. Materials 
Molds for the creation of the macroscopic hydrogels were the same as in Section 4.3. Glass 
tubes (ID = 5 mm; OD = 7 mm; L = 10 mm) were manufactured at the glass workshop of 
the Max-Planck Institute for Intelligent Systems in Stuttgart, Germany. BSS was obtained 
from Beaver Visitec (Waltham, U.S.A.) and TRIS was bought from Serva (Heidelberg, 
Germany). For lyophilization a freeze dryer (model: P8K-E-85-4) from Dieter Piatkowski 
Forschungsgeräte (Munich, Germany) was used.  
 
4.4.2. Experimental procedure 
Data acquisition 
Non-immobilized macroscopic HA-hydrogels were created following the protocol in 
section 4.3. by filling the HS-HA/MBAA mixtures into custom-made molds (see Figure 
84). Hydrogels immobilized to the inner surfaces of large tubes were prepared following 
the protocol for large tubes in Section 4.3.  
For swelling-over-time experiments, the hydrogels’ masses were recorded before swelling, 
and afterwards placed in a TRIS in BSS solution (c(TRIS) = 0.4 mol/l). At regular time 
intervals (ca. 24h, 48h or 72h), the gels’ masses were recorded after carefully draining and 
blotting away excess fluids.  
 
Data analysis 
For each set of experiments, four gels were prepared individually and swollen 
simultaneously. In order to analyze the swelling of hydrogels immobilized to the inner 
surfaces of large tubes, the masses of the hydrogels were gained by a determination of the 
total mass of the hydrogel + tube and subtracting the mass of the empty tube recorded 
before the modification with hydrogels. The swelling ratios were analyzed by calculating 
the relative mass gain at the different time-intervals using the formula 𝑚!"# = 𝑚𝑚! 
with mrel being the relative mass, m the absolute mass and m0 the starting mass recorded 
directly after the gel formation was finished. Theoretical dry masses were calculated from 
the combined mass concentrations of HS-HA and MBAA and the total volumes. 
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 Pressure resistance measurements of hyaluronan-hydrogel modified 4.5.
tubes 
A linearly increasing pressure was applied to hydrogel-filled tubes to evaluate their 
immobilization stability and potential to allow liquid flow. 
4.5.1. Materials 
Measurements were performed using a BOSE Electroforce Series 3200 from Bose 
(Framhingham, U.S.A.) connected to a computer using the “WinTest” software. The 
holder for the pressure chamber was designed using the Autodesk Inventor Professional 
2014 (64-Bit Edition) software from Autodesk (San Rafael, U.S.A.) and the “Replicator 2” 
software from Makerbot (Munich, Germany). The design was 3D-printed with PLA using 
the Makerbot Replicator 2 from Makerbot. For the manufacture of the pressure chamber, a 
5 ml Omnifix® syringe with a a Sterican® metallic needle (0.8 mm x 12 mm) from B.Braun 
(Melsungen, Germany), QCMD tubing (Tygon® ST R-3607, ID = 0.64 mm) from Ismatec 
(Wertheim, Germany) or TPP tubing  (ID = 0.51 mm) from Helix Medical (Kaiserslautern, 
Germany), and two component quick-setting epoxide glue (UHU Plus 2k-Epoxidkleber) 
from UHU® (Bühl, Germany) were used. 
 
4.5.2. Measurements 
Construction of the “pressure chamber” 
The Sterican® metallic syringe needle was manually cut down to a length of 1-1.5 cm and 
attached to the tip of the 5 ml Omnifix® syringe. Appropriate tubing (QCMD tubing for 
glass samples, PPA tubing for titanium samples) was connected to the shortened needle 
and the joints were sealed off by generously mixing the two component quick-setting glue 
at a 1:1 ratio and generously spreading it onto the to be sealed parts of the setup with a 
disposable plastic spatula. This was followed by drying for >2 hours to ensure a full 
solidification of the glue. See Figure 76 for pictures of the assembled pressure chambers. 
 
Figure 76: Images of the assembled pressure chambers used in CPA measurements for glass (a) and titanium (b) tubes. 
The use of quick-setting glue is illustrated, which was used to seal the syringe-needle and needle-tubing joints for a 
prevention of leakage during experiments. 
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Assembly of the experimental setup and measurements 
Small hydrogel-filled glass (ID = 0.5 mm) or titanium tubes were created according to the 
protocol in section 4.3. In order to assemble the setup for CPA measurements the sample 
holder was mounted to the 225 N load cell. The pressure chamber was then filled with 5 ml 
BSS, cleared of air bubbles, and placed in the sample holder. A hydrogel-modified glass or 
titanium tube was connected to the tubing of the pressure chamber and a second short piece 
of tubing was fastened to the other end. The setup was raised until the syringe’s plunger 
almost touched the displacement head. See Figure 77 for a picture of the assembled setup. 
In order to perform a pressure resistance measurement on the above-mentioned samples, 
the BOSE was programmed to move the displacer down a maximum of 5 mm with a fixed 
predetermined movement rate (0.005 mm/s-0.1 mm/s). Simultaneously the force readout 
from the 225 N force sensor was recorded. In order to save time, the measurements were 
only carried out until the pressure-time relationship had reached equilibrium and were then 
manually stopped, even when the maximum displacement of 5 mm was not yet achieved. 
 
Figure 77: Schematic drawing (a) and image (b) of the assembled setup for CPA measurements using a BOSE force-
meter. 
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Data Analysis 
The force values were normalized to a starting value of zero and divided by the area of the 
syringe’s plunger to obtain pressure values. The displacement was divided by the 
maximum displacement achieved during the experiment to get the relative displacement. 
Pressure was plotted against relative displacement using the commercially available 
“Origin” software to enable further data analysis:  
In order to examine breaking points, the peak pressure was identified where the hydrogels 
were removed from the tubes. 
For a determination of the equilibrium pressure (EP), all data points in the EP region were 
used to calculate an average equilibrium pressure. The standard deviation of the average 
pressure was so low (<0.5%), that it was disregarded for further calculations. Each sample 
was measured three to five times and a mean value of the obtained equilibrium pressures 
with a standard deviation was calculated. The average pressures of several samples 
fabricated with the same set of parameters were combined into a weighted average value. 
 
 Hydrostatic pressure measurements 4.6.
Hydrostatic pressure was applied to hydrogel-filled tubes in order to evaluate their pressure 
regulation abilities. 
4.6.1. Materials 
A glass capillary (height: 2 m, ID: 9,3 mm) with an outlet and a valve was manufactured 
by the glass workshop of the Max Planck Institute for Intelligent Systems in Stuttgart (See 
Figure 78). The mass changes within the capillary were recorded with a KERN 572 scale 
from Kern & Sohn GmbH (Balingen-Frommern, Germany) connected to the COM1 port of 
a computer. Markus Weiler, a co-worker, wrote the program for reading out the data sent 
from the balance to the COM1 port at variable time intervals. QCMD tubing (Tygon® ST 
R-3607, ID = 0.64 mm) was bought from Ismatec (Wertheim, Germany) and TPP tubing 
(ID = 0.51 mm) was purchased from Helix Medical (Kaiserslautern, Germany). 
 
4.6.2. Measurements 
Experimental setup 
HA hydrogel modified glass or titanium tubes were created according to the protocols 
established in section 4.3. The glass capillary was placed on the scale, which was 
connected to the computer and programmed to constantly transmit the current measured 
mass. The valve of the outlet was closed, the capillary filled with BSS and elastic tubing 
connected to the outlet. The valve was opened for a short time to remove the air from the 
setup. See Figure 78 for exemplary pictures of the setups for small and large hydrogel-
filled samples.  
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Figure 78: (a): Schematic drawing of the setup used for HPA measurements. (b/c): Image of the lower part of the setup 
used for the HPA measurements on small glass tubes (ID = 0.5 mm) (b) or large glass tubes (ID = 5 mm) (c) using 
different tubings for the connection to the glass capillary. 
 
A second piece of tubing was connected to the other end of the sample and laced into a 
beaker to collect outflowing liquid. In order to minimize evaporation during long-term 
measurements, the top entrances of the capillary and the beaker were sealed with parafilm 
containing small holes to allow for pressure equalization. 
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Data collection 
The data readout program was started to collect the masses recorded by the balance at 
regular time intervals (2 sec – 30 min), depending on how quickly the mass changed, and 
the valve was opened to initiate the experiment. Measurements were conducted until the 
average mass did not change significantly over an extended period of time. 
 
Data analysis 
The zero-point mass was determined to be the height of the liquid column, where no more 
flow was detected through an empty tube. The recorded masses from the measurements 
were normalized with this zero-point mass and transformed into pressures according to the 
conversion constant established in Section 2.4.3. The gained pressure values were plotted 
versus the measurement time to get the pressure-over-time curves. 
 
 Microscopic pressure-flow experiments 4.7.
Pressure was applied to hydrogel-filled tubes while observing them in a microscope in 
order to analyze the mechanism of pressure-induced liquid flow. 
4.7.1. Materials 
QCMD tubing (Tygon® ST R-3607, ID = 0.64 mm) was bought from Ismatec (Wertheim, 
Germany) and TPP tubing (ID = 0.51 mm) from Helix Medical (Kaiserslautern, Germany). 
BSS was obtained from Beaver Visitec (Waltham, U.S.A.). Fluorescein was purchased 
from Sigma Aldrich (St. Louis, U.S.A.). A 5 ml Omnifix® syringe with a Sterican® 
metallic needle (0.8 mm x 12 mm) was obtained from B.Braun (Melsungen, Germany). 
For fluorescence measurements, an Axiovert 200M with a 38 HE eGFP (Ex: 470/40; Em: 
525/50) filterblock (Zeiss, Oberkochen, Germany) was used. 
 
4.7.2. Measurements 
Experimental setup 
Small hydrogel-filled glass tubes (ID = 0,5 mm; L = 10 mm) were prepared with HS-HA 
or HS-FA-HA according to the instructions in Section 4.3. Before use, CPA measurements 
(Section 4.5) were performed to examine, whether establishing a liquid flow through the 
samples was possible. The tubes were connected on both ends to QCMD tubing, which 
was then fastened to an object holder with adhesive tape. The setup was placed in the 
Axiovert microscope and the end of piece of QCMD tubing was connected to the syringe, 
which was filled either with BSS or fluorescein solution. The needle was shortened 
manually to a length of 0.5-1.0 cm to allow for a better insertion. The end of the other 
QCMD tubing was placed into a small beaker to the side of the microscope to collect any 
fluids pressed through the system (= “outlet”). See Figure 79 for an overview of the 
experimental setup. 
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Figure 79: (a): Image of the assembled setup to perform microscopic pressure-flow experiments. (b): Picture of the 
setup placed in the Axiovert microscope prior to flow measurements. 
 
Data acquisition 
The Axiovert microscope was programmed to record a time-lapse with intervals of one 
second and the measurement started. The pressure of the liquid in the syringe, BSS or 
fluorescein dissolved in NaOH (0.1 mol/l, pH = 12), was slowly increased manually by 
pressing on the syringe plunger until a liquid flow was detected in the time-lapse. At that 
point the pressure was kept as constant as possible by hand. If the syringe contained the 
fluorescence solution, pressure was maintained until the time-lapse showed an equal 
distribution of fluorescein within the hydrogel. Afterwards, the fluorescein-saturated tube 
was exposed to the same treatment using a blank BSS solution until the fluorophores were 
removed. For repeated channel opening and closure experiments, pressure was applied 
manually to the syringe filled with pure BSS until the channel was visible and maintained 
for an extended period of time (ca. 30 s). Then application of forces on the plunger was 
stopped until the channel was closed and this status was then maintained for another 30 s. 
This sequence was repeated several times. 
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Data Analysis 
The individual frames from the time-lapse were edited using the open-source ImageJ 
software. First, all images were imported and a stack was created using the “Images to 
Stack” command. This stack was then saved as a “.avi” video file. The stack was further 
modified by lowering the brightness and increasing the contrast to better visualize the 
channels. 
 
 Artificial creation of channels in hydrogels 4.8.
Two methods were used to artificially generate channels within hydrogels for enabling 
them to regulate external liquid pressures. 
4.8.1. Materials 
For laser cutting an “Epilog Zing 16” CO2 device from cameo (Stuhr, Germany) was used. 
For the mechanical creation of channels with small fibers, a sample holder for the 
modification of large glass tubes (ID = 5 mm) with hydrogels (See Figure 81) was 
manufactured by the precision mechanics workshop. The glass fibers necessary to create 
the channels in this setup (diameter = 0.1 mm) were provided by the glass workshop of the 
Max Planck Institute for Intelligent Systems in Stuttgart.  
 
4.8.2. Channel creation and pressure measurement 
Sample preparation 
Hydrogel-filled large glass tubes (L = 10 mm; ID = 5 mm) were prepared according to the 
protocols in Section 4.3 using the custom-made reaction chamber without a glass fiber 
(Figure 81). 
For the channel creation with lasers the gel-filled tubes were subsequently placed in the 
laser cutter with the entrance of the tube facing the direction of the beam (Figure 80). The 
commercially available “Corel Draw” software was used to draw a circle with the target 
diameter of the channel with the thickness of the stroke set to “hairline”. The parameters 
for the laser cutter were set to 50% movement speed, frequency = 5000 Hz (100%) and a 
100% laser power. The focus was adjusted manually to a point roughly in the first quarter 
of the hydrogel facing the laser beam. One to three laser applications were conducted until 
a channel formed. 
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Figure 80: Schematic drawing of the experimental setup to create artificial channels in hydrogel-filled tubes using a 
commercially available laser cutter.  
 
For a channel creation using the mechanical method, a small glass fiber (diameter ca. 0.1 
mm) was inserted through the hole of the lid down into the circular incision of the sample 
holder, displacing the HS-HA/crosslinker mixture in the process. See Figure 81 for a visual 
representation of the experimental setup. The assembly with the silanized tube containing 
the HS-HA/MBAA mixture and the glass fiber were then placed into a cell incubator at 
37° C for 24 hours. Finally the glass fibers were removed leaving behind a channel in the 
gel. 
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Figure 81: (a): Schematic drawing of the experimental setup used for the creation of hydrogels channels in large (ID = 5 
mm) hydrogel-filled tubes. (b): Picture of a disassembled setup. (c): Picture of a fully assembled setup containing a 
silanized sample. The same setup, without the fiber, was also used in general to immobilize hydrogels within these glass 
tubes. 
 
HPA measurements 
Prior to HPA measurements, the samples were incubated in BSS at room temperature for 
48 hours to allow for a swelling of the gels within the tubes to close the artificially 
generated channels. The samples were then connected to the HPA empty glass capillary 
using a piece of elastic tubing (See Figure 78b). The data-readout program for the balance 
on the computer was started and BSS was filled into the capillary in intervals until a liquid 
flow through the tube was detected, resulting in continued measurements until no more 
changes in masses were detected. The data analysis was conducted similarly to the HPA 
measurements in Section 4.6. 
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6. Appendix 
 List of abbreviations 6.1.
POAG:   Primary open-angle glaucoma 
IOP:    Intraocular pressure 
PEG:    Poly(ethylene glycol) 
PNIPAM:   Poly(N-isopropylacrylamide) 
PHEMA:   Poly (hydroxyethyl methacrylate) 
HA:    Hyaluronic acid 
GAG:    Glycosaminoglycan 
DTPH:   Dithiobis(propionic hydrazide) 
DTBH:   Dithiobis (butanoic hydrazide) 
DTT:    Dithiothreitol 
FA:    Fluoresceinamine 
HS-HA:   Hyaluronic acid modified with thiol groups 
FA-HA:   Hyaluronic acid modified with fluoresceinamine 
HS-FA-HA:   Hyaluronic acid modified with thiol groups and fluoresceinamine  
BIS or MBAA:  N,N’-Methylenebisacrylamide 
EDC:    N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide 
NHS:    N-Hydroxysuccinimide 
TG:    Thiolation grade = Degree of substitution of HS-HA with thiol 
groups 
GPS:    Glycidyloxypropyl)trimethoxy-silane 
PFS:    1H,1H,2H,2H-Perfluoro-trichlorosilane 
APTES:   (3-Aminopropyl)triethoxysilane 
PBS:    Phosphate buffered saline 
BSS:    Balanced salt solution 
TRIS:   Tris(hydroxymethyl)aminomethane 
PEGDAA:   Poly(ethylene glycol) diacrylamide 
BIS or MBAA:  N,N’-Ethylenebis(acrylamide) 
CPA:    Continuous pressure application 
HPA:    Hydrostatic pressure application 
EP:    Equilibrium pressure 
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DTNB:   (5,5'-dithiobis-(2-nitrobenzoic acid) 
PLA:   Polylactide 
PTFE:  Polytetrafluorethen (Teflon) 
 
 Additional 1H-NMR’s of DTPH and unmodified hyaluronan 6.2.
 
Figure 82: (a): 1H-NMR of DTPH. The triplets at δ = 2.9631 ppm and 2.6376 ppm belong to the –CH2-CH2- functions 
of DTPH. The smaller peaks were attributed to either 13C satellites or impurities. (b): 1H-NMR of unmodified HA (Mn = 
60 kDa). The multiplett at d = 4-3 ppm belonged to the -(CH)- groups of the polysaccharide backbone and the singulett at 
δ = 2,1 ppm was attributed to the –CH3 of the glycosamin. 
a)
b)
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 pH changes in unbuffered BSS due to diluting HS-HA 6.3.
 
Figure 83: Image of pH stripes immersed into an unbuffered BSS solution before (a) and after (b) the dissolution of HS-
HA (Mn = 60 kDa, β = 15 mg/mL, TG = 0,18) illustrating the necessity of using buffers. 
 
 Blueprints of molds for creating macroscopic hydrogels 6.4.
 
Figure 84: Blueprint (a) of molds used for creating the macroscopic hydrogels made from PLA (b) and PTFE (c).  
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 Blueprints of sample holder for CPA measurements 6.5.
 
Figure 85: Blueprint (a) and image (b) of holder for CPA measurements. The holder was 3D printed in two parts as seen 
in (b) and glued together manually. The syringe could be inserted from the top as shown in Figure 44. 
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 Blueprints of setup for partially silanizing glass and titanium slides 6.6.
 
Figure 86: Blueprint (a) and image (b) of the setup used for partially silanizing flat glass and titanium slides.  
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 Blueprints for the setup for filling large glass tubes (ID =  5 mm; OD 6.7.
= 7 mm; L = 10 mm) with hydrogels 
 
  
Figure 87: Blueprint (a) and image (b) of he sample holder used for immobilizing HA hydrogels within large glass tubes 
(L = 10 mm; ID = 5 mm; OD = 7 mm). The circular incisions were designed to exactly fit with the glass tubes. Holes 
were large enough to allow glass fibers to a maximum diameter of 0.9 mm. 
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 Publication derived from this thesis 6.8.
European Patent Application: 
Number: 15002024.6 
Title: “Intraocular device and method for preparing the same” 
Patent owner: Max Planck Society for the Advancement of Science 
Inventors: Prof. Dr. J.P. Spatz, Dr. Fania Geiger, Michael Thaller, Dr. Heike Böhm, Dr. 
Christian Lingenfelder 
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   eingereichten	   Dissertation	   zu	   dem	   Thema	   „Hyaluronan	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   Die	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   oder	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   Wahrheit	   erklärt	   und	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